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1
INTRODUCTION

Heavy Metal Cadmium

Source and Exposure of Cadmium

Cadmium (Cd), a group MB transition metal along with zinc and mercury in
the periodic table, is a relatively rare natural element found inside the earth’s
crust and is often in association with the sulfide ores of zinc, copper and lead.
There is approximately about 6 million tons of naturally occurring Cd in the world
based on zinc resource containing about 0.3% Cd. It is also estimated that each
year about 25,000 to 30,000 tons of Cd are released into the environment
(ATSDR, 1999). Cadmium is a soft, ductile, silver-white heavy metal with no
known beneficial effect but is associated with high toxicity. In 1993, the
International Agency for Research on Cancer (IARC) classified Cd and Cd
compounds as group 1 human carcinogens (IARC, 1993). Since 1997, the
Agency for Toxic Substances and Disease Registry (ATSDR) has ranked Cd in
the top seven on the list of the most hazardous substances in the environment
(ATSDR, 1999). Cadmium naturally exists in various chemical forms, such as
cadmium oxide, cadmium chloride, cadmium sulfate, cadmium sulfide and
cadmium carbonate. Several inorganic cadmium compounds such as cadmium
chloride, acetate and sulfate are quite soluble in water, whereas cadmium oxide,
carbonate and sulfide are almost insoluble. Cd is released to the biosphere
through both naturally occurring sources and human industrial activities. The
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major natural sources for Cd deposits onto the earth surface come from volcanic
emissions and rock weathering; the major natural routes for Cd emission into the
atmosphere are through volcanoes, airborne soil particles, sea spray, biogenic
material and forest fires (WHO, 2003).
Cd is also heavily deposited into the environment due to human activities
and industrial practices such as production of plastics, tobacco and batteries, as
well as welding, electroplating and fossil fuel burning (WHO, 2003) (summarized
in Table 1). This deposition of Cd has increased substantially in recent times due
to commercial use. Cd is an indispensable component of technology associated
with numerous applications in the electronics, communications, power generation
and metal processing industries. The average annual production of Cd
throughout the world dramatically increased from only 20 tons in the 1920s to
about 12,000 tons in 1960-1969, and since 1987 has stayed relatively the same
at around 20,000 tons (IARC, 1993). Unfortunately with our modern life
depending on telecommunication devices, electronic necessities and power tools
(especially rechargeable batteries for laptops, cell phones, PDA and iPods) as
well as in the potential applications such as hybrid electric vehicles and solar
cells, there exists a potential to build-up significant quantities of Cd in our
environment. Therefore, this will require more regulations and efforts globally to
manage and control the release of Cd into the environment.

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

3
Table 1
Summary tables of cadmium deposition via human activities and industrial
practices

1.1 Cadmium consumption by end-uses in the Western World and European
Union
_______________
Western World (1990)
European Union (2000)
Application
Ni-Cd batteries
Pigments
Stabilizers
Plating
Alloys
Others
Total

Cd (tons)/year
9100
3300
1650
1320
500
660
16500

Cd (tons)/year
1900
300-350
150
200
30-40

%
55
20
10
8
3
4
100

%
73
12
6
8
1

-

-

1930-1990

100

1.2 Global emission of cadmium into the air in the mid 1990s
Economic sector
Non-ferrous metal production
Stationary fossil fuel combustion
Iron and steel production
Waste disposal (incineration)
Cement production
Total

Air emission (tons)
2171
691
64
40
17
2983

%
73
23
2.0
1.3
0.6

1.3 Global cadmium releases into the land in 1983
Source category
Coal fly ash, bottom fly ash
Atmospheric fall-out
Urban refuse
Agricultural and food wastes
Logging and other wood wastes
Wastage of commercial products
Animal wastes, manure
Municipal sewage sludge
Fertilized
Peat (agricultural and fuel use)
Solid wastes, metal manufacturing
Miscellaneous organic wastes including excreta
Total to soil
Mine tailings
Smelter slags and wastes
Total discharge on land

1000 tons
1.5-13
2.2-8.4
0.88-7.5
0-3
0-2.2
0.78-1.6
0.2-1.2
0.03-0.25
0-0.11
0-0.08
0-0.11
0-0.01
5,6-38
2.7-4.1
1.6-3.3
10-45

% of discharge to land
26
19
15
6
4
4
3
0.7
0.5
0.2
0.1
0.0
12
9
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1.4 Sources of cadmium to waste disposal in the European Union in 2000
Non-ferrous metals processing
Cadmium processing
Cement production
Iron and steel processing
Coal ash
Sewage sludge
Phosphate processing
Total industrial sources
Municipal waste or mixed, direct input to landfills
MSWI ashes
Total municipal waster or mixed
Total on land

Tons/year
419
400
280
230
113
70
60
1572
800
150
950
2522

% of total
17
16
11
9
4
3
2
62
32
6
38

The data in Table 1 were adapted from the World Health Organization 2003
publication (WHO, 2003).

Since the metal Cd itself will not be degraded in nature, it will stay in
circulation in the environment. Hence, the risk to humans and other living
organisms to Cd exposure will increase over time. For the non-occupationally
exposed and non-smoking general population, the major route of Cd exposure is
via food intake. Cigarette smoke, on the other hand, represents an additional
exposure of Cd, which may equal or exceed food intake. Data from experimental
animals and humans have shown that absorption via lungs (up to 50% of the
inhaled Cd may be absorbed) is higher than gastrointestinal absorption. On
average 5% of the total oral intake of Cd is absorbed via the stomach, but the
range varies (3% - 20%) by the types of diet and nutritional status of each
individual (ATSDR, 1999; WHO, 1992).
The majority of accumulated Cd in the food chain starts from foliar
absorption of atmospheric Cd or root intake from soils. Excessive levels of Cd
can easily be found in contaminated industrial areas or in areas using
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commercial fertilizers derived from rock phosphate and sewage sludge. Among
agricultural products, milk has the lowest Cd concentration (about 1 pg/kg). The
concentration of Cd in fruit, fish and meat is in the range of 1-50 pg/kg and IQ300 pg/kg in staple foods such as wheat, rice and potatoes. The highest Cd
levels, around 100-1000 pg/kg, are found in mammal’s internal organs such as
kidney and liver as well as in certain species of scallops, mussels, and oysters
(Satarug et at., 2003; WHO, 2000). In 1992, the World Health Organization
(WHO) established safety standards for tolerable Cd intake of 7 pg/kg of body
weight/weekly, which relatively equals a daily tolerable intake level of 70 pg of Cd
for the average 70-kg man and 60 pg of Cd for the average 60-kg woman. In
general, the estimated average dietary Cd intake from food is about 30 pg (10-40
pg) per day (Table 2) which lies within the safety range of the WHO guideline. In
recent years however this safety standard of Cd intake has been challenged
especially under certain conditions such as living in a highly polluted area or
eating Cd-contaminated food where Cd uptake has been found to be several
hundred microgram per day (Jarup et al., 1998; Satarug et a/., 2003).
Table 2
Cadmium content in foods and estimated daily intake
Cd content (mg/kg)________ Exposure (|jg per day)
Max.
Typical
Intake
Extreme
Typical
g per day
Vegetables, including potatoes
0.1
0.05
250
25
12.5
Cereals, pulses, legume, rice, wheat grain
0.2
0.05
200
40
10
Fruit
0.05
0.01
150
7.5
1.5
Oilseeds and cocoa beans
1.0
0.5
1
1.0
0.5
Meat of cattle, poultry, pig, sheep
0.1
0.02
150
15
3.0
Liver of cattle, poultry, pig, sheep
0.5
0.1
5
2.5
0.5
Kidney of cattle, poultry, pig, sheep
2.0
0.5
1
2.0
0.5
Fish
0.05
0.02
30
1.5
0.6
Crustaceans, molluscs
2
0.25
3
6.0
0.75
Total
93.5
30.0
Food item
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The data in Table 2 were adapted from Satarug et at. (2003).

Health Effects of Cadmium

Due to its unusually long biological half-life (estimatedly 20-40 years in
humans) and the ability of it to bio-accumulate, the Cd concentrations in tissue
and organs increase with age. In addition, only a small part of the absorbed Cd
(in general about 0.007% but with large individual variation) will be excreted daily
in the urine, the main route of extraction (ATSDR, 1999). Once absorbed, Cd
enters the bloodstream and is transported to other parts of the body such as liver,
kidneys, lungs, pancreas, placenta, testis and bone. It is estimated that 50-85%
of the body’s burden of Cd is stored in both the liver and kidney (ATSDR, 1999).
It is estimated that by age 20-25, the average Cd concentration in the liver is
around 1-2 pg/g wet weight and by age 50-60, the average Cd concentration in
the kidney is around 40-50 pg/g wet weight (ATSDR, 1999). The liver is the
primary organ for initial Cd accumulation. Continuous chronic exposure of low
levels of Cd leads to chronic accumulation in the kidneys, which increases the
risks for renal damage and kidney diseases (Thevenod, 2003). As a human
carcinogen and one of the most hazardous toxic substances in the environment,
chronic exposure to Cd has also been associated with various types of cancers
in the lung, liver, kidney, stomach and prostate as well as several toxicities such
as hepatoxicity, nephrotoxicity, neurotoxicity and cardiotoxicity (Patrick, 2003;
Rikans and Yamano, 2000; Thevenod, 2003).
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In addition, Cd also has been associated with elevated blood pressure and
hypertension. A study has shown hypertension in pregnant woman smokers is
related to significantly higher blood Cd concentration (Kosanovic et al., 2002).
Effects on bone (osteoporosis) were also seen at doses of 10-30 mg of Cd per kg
of diet or in drinking water exceeding 10 mg of Cd/liter. The itai-itai disease, that
causes osteomalacia with various grades of osteoporosis accompanied by
severe renal tubular disease, was the first Cd poisoning report and occurred in
Japan in 1950. Chronic oral exposure can lead to renal dysfunction that will affect
the resorption function

of the proximal tubules and cause proteinuria,

aminoaciduria, glucosuria and phosphaturia (Inaba et al., 2005; Kazantzis, 2004).
The disturbances in renal handling of phosphorus and calcium by Cd may further
cause hypercalciuria and formation of kidney stones. In some cases under
chronic and high occupational exposure of Cd, respiratory insufficiency and
obstructive lung disease can occur (ATSDR, 1999).

Cellular Molecular Effects and Mechanisms of Cadmium

After Cd enters into systemic circulation via either the lungs or intestines,
most of the Cd in the blood is bound to plasma proteins such as albumin and
ferritin and then is transported to target organs. In addition, due to the high
affinity of Cd for sulfhydral groups on biomolecules, another pool of Cd in the
blood is likely conjugated with cysteine, glutathione (GSH) and other thiol
containing molecules. The liver is by far the primary organ that takes up the
greatest quantity of Cd during the initial hours after exposure. An experiment
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performed by Zalups and Barfuss (2002) has shown, in a rat model, that the liver
efficiently takes up the Cd from the blood and less than 1% of the initial dose of
Cd after an intraveinous injection of 5 pmol/kg was remaining in the total blood
volume within 1 hr after exposure.
Although several theories have been proposed or tested, in general the
detailed mechanisms for Cd transport (influx/efflux) in hepatocytes (liver cells in
culture) have not yet been thoroughly characterized. First, Cd may enter
hepatocytes by complexing with proteins whose role is assisting the transport of
nutritionally essential metals, ions or cations, across cellular membranes. For
example, iron uptake by hepatocytes involves the endocytosis of transferrin and
ferritin by receptor-mediated processes (Thorstensen and Romslo, 1987). Hence,
receptor-mediated endocytosis of specific protein-Cd complexes such as
albumin-Cd, ferritin-Cd, metallothionein-Cd (MT-Cd) or GSH-Cd is a potential
mechanism for Cd transport in hepatocytes (DelRaso et al., 2003; Pham et al.,
2004).

Similarly,

the

proton-coupled

divalent

metal

transporter

(DMT1)

translocates divalent metal cations (e.g. Zn2+, Cu2+ and Fe2+) and appears to be
expressed in the plasma membrane of hepatocytes. It is also experimentally
shown that DMT1 can transport Cd2+ into enterocytes (Trinder et al., 2000) while
the metal transport protein 1 (MTP1), also located on cell membranes, was
suggested to participate in metal efflux. It is highly possible that these two
systems (influx by DMT1; efflux by MTP1) work in conjunction to transport Cd.
Addidtionally, Cd unlikely will enter a cell by a specific mechanism or route
because it is not an essential cation, hence, it likely will take the existing
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transport routes for essential cations. Other transporting mechanisms have been
proposed based on the similarity and chemical property of Cd as an ionic and
divalent element that may mimic other essential elements. Ca2+ and Ca channels,
for example, are favored by many investigators; the size of Cd2+ (99 pm ionic
radius) and Ca2+ (97 pm ionic radius) are also very similar. Cd ions have been
shown to interfere with the Ca signaling and inhibit the movement of Ca ions in
certain types of Ca channels such as voltage-gated calcium channels (Belyaeva
et al., 2001; Bergeron and Jumarie, 2006; Martelli et al., 2006). Other
transporters, such as zinc transporters, ATP-binding cassettes and multiple drugresistance protein 2 (MRP2), have also been proposed to be involved in
transportation of Cd (Martelli et al., 2006; Zalups and Ahmad, 2003).
In regard to detrimental effects of Cd at the cellular and molecular level,
Cd is reported to bind and deplete glutathione (GSH), the major reducing buffer
and antioxidant compound in most cells, especially in liver (Blazka and Shaikh,
1992). In our previous report, we also showed Cd was able to deplete GSH in a
time and concentration dependent manner (Xu et al., 2003). Cellular damage
indices including lipid peroxidation, lactate dehydrogenase (LDH) leakage, DNA
fragmentation and cell death, including necrosis and apoptosis, have been
reported (El-Maraghy et al., 2001; Galan et al., 2000; Hart et al., 1999; Lopez et
al., 2006; Xu et al., 2003). At the protein level, disturbing activities of diverse
enzymes including antioxidant enzymes and DNA repair enzymes were also
documented under cadmium exposure even with very low doses (Elbekai and ElKadi, 2005; Lutzen et al., 2004). At the gene level, expression levels for a host of
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genes including immediate early genes, proto-oncogenes, redox sensitive
transcription factors, heat shock proteins and stress senstive genes are all
documented to be in some way affected (Liu et al., 2002; Mumtaz et al., 2002;
Zhou eta/., 1999).
The long-term consequence of the detrimental effects associated with Cd
exposure has been linked to the generation of reactive oxygen species (ROS)
(Belyaeva et al., 2006; Leonard et al., 2004; Pourahmad et al., 2003). Abnormal
production of ROS can lead to an imbalance in redox homeostasis known as
oxidative stress, a key factor suggested to play a role in toxicity and chronic
diseases (Wattanapitayakul and Bauer, 2001). Since Cd is not a Fenton metal
and cannot directly generate ROS, several indirect mechanisms for increased
ROS and oxidative stress have been proposed. Once again, the ability of Cd to
bind to and deplete GSH stands out as a plausible mechanism responsible for
redox disturbance inside a cell. In addition, Cd binds to sulfhydryl groups of
proteins with a relatively high affinity compared to other metals under normal
physiological conditions (Larabee et al., 2005; Miles et al., 2000; Stillman et al.,
1987). Another proposed hypothesis is that Cd can directly interfere and/or
displace essential metals/ions (e.g. Zn, Cu, Fe, Se, Mg, Ca) and further perturb
enzyme activity (Belyaeva et al., 2001; Kopera et al., 2004). All of the above
potential mechanisms are accountable for changing the redox environment,
thereby, increasing ROS and subsequent oxidative stress observed under both
acute and chronic conditions.
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Cell Signaling Regulatory Network

The ability to dynamically coordinate cellular activities with environmental
stimuli is a crucial event for cellular homeostasis and survival. Once a specific
stimulus (primary messenger) arrives, synchronized cellular signaling and
communication begin. To simplify the concept, the players that respond to
external stimuli in a complex signaling regulatory network generally include (a)
proteins (e.g. receptors or channels) on the membranes that receive or transport
the signal from the stimulus, (b) the numerous intracellular signaling cascades,
with various cross-talk potential, transmitted by second messengers (e.g.
chemicals, biomolecules, metabolites) and proteins, and (c) the interaction and
transformation between these enzymatic controls including diverse posttranslational protein modifications (e.g. phosphorylation, dimerization, acetylation,
oxidation, glycosylation, ubiquination). All of the above coordinate the cellular
signaling networks with the ultimate goal to induce physiological or biochemical
responses for that stimulus. In this section, we will introduce three cell signaling
related topics including (1) reative oxygen species, (2) redox regulation between
oxidative stress challenge and antioxidant network, and (3) mitogen activated
protein kinase (MAPK) signaling cascades.

Reactive Oxygen Species

Molecular oxygen (0 2) is essential for survival of all aerobic organisms.
Cellular energy metabolism occurs by using 0 2 as an electron acceptor to
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produce energy, ATP, through a series of complex biochemical reactions via the
electron transport chain in the mitochondria. However, during the different stages,
the transfer of a single electron to O2 is possible. Therefore, the formation of
reactive oxygen species (ROS) such as hydrogen peroxide (H2 O2 ), superoxide
(O2 ’) and hydroxyl radical (OH‘) can be generated during oxidative metabolism.
Moreover, the chance for abnormal production of ROS increases rapidly when a
cell faces stress or environmental challenges such as hyperoxia, inflammation,
UV exposure, ionizing irradiation, heavy metals and certain oxidant chemicals
(Belyaeva et al., 2006; Thannickal and Fanburg, 2000; Wattanapitayakul and
Bauer, 2001). Abnormal production of ROS introduces the risks of imbalanced
redox homeostasis and oxidative stress.

Fortunately,

cells have robust

antioxidant defense systems to counteract the increased levels of ROS, including
numerous low moleulcar weight antioxidant compounds (e.g. GSH, vitamin C and
E, p-carotene, lipoic acids, coenzyme Q, bilirubin) and diverse antioxidant
enzymes (e.g. catalase, superoxide dismutase, glutathione peroxidase) (Andres
and Cascales, 2002; Casalino et al., 2004; Franco et al., 1999; Valko et al., 2006).
However, oxidative injury does arise when cellular ROS overwhelms this internal
antioxidant capacity. The long-term consequences of oxidative stress have been
associated with the pathogenesis of a variety of toxicities and diseases, including
atherosclerosis, diabetes, chronic inflammatory diseases, neurological disorders,
cardiovascular diseases and cancer (Kazantzis, 2004; Wattanapitayakul and
Bauer, 2001; Valko et al., 2006).
Reactive oxygen species can be divided into two categories as either free
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radicals carrying unpaired electrons (e.g. 0 2‘ and OH') or non-radical compounds
such as H20 2. A s shown in Equation 1, the reactivity of molecular oxygen
increases upon acceptance of one, two or three electrons to form 0 2\ H20 2 and
OH' respectively.
Stressor (Reactive oxygen species):
0 2 -> 0 2' -► H20 2 -► 'OH + OH“ -» 2 H20

[Equation 1]

Metalsn+ + H20 2 —>metalsn+1 + 'OH + OH”

[Equation 2]

Protector (Antioxidant enzymes):
2 0 2‘ ” + 2H —> H20 2 + 0 2 {superoxide dismutase}

[Equation 3]

H20 2 —►H20 + 0 2 {catalase}

[Equation 4]

2GSH+ H20 2 —>■ GSSG + 2H20 {glutathione peroxidase}

[Equation 5]

Among these ROS, 0 2" acts as an initiator to form other reactive
intermediates, therefore, cells have a group of special enzymes, superoxide
dismutases (SOD), whose function is to neutralize these reactive superoxides
and prevent further damage (Equation 3). The non-radical H20 2 is not highly
reactive compared to other free radicals; however, due to its ability to easily
penetrate cell membranes and its ability to further transform to OH', it brings
potential threats as well. Additionally, H20 2will react with reduced iron or copper
ions to generate OH’ via a Fenton reaction (Equation 2). Luckily, another
wonderful series of antioxidant enzymes like catalase (CAT) and glutathione
peroxidase (GPx) work together to neutralize H20 2 (Equation 4 and 5). The
hydroxyl radical (OH'), the most reactive ROS, is considered as the main initiator
of oxidation damage on most of the macromolecules (DNA, RNA, proteins, lipids)
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in a cell. Lipid peroxidation, for instance, will enhance the permeability of cell
membranes and initiate a series of detrimental consequences. Another complex
group of reactive radicals that also actively participate in cellular signaling and
initiating biological responses belongs to the category of reactive nitrogen
species (RNS) such as nitric oxide and its by-products (nitrate/N03‘, nitrite N02",
peroxynitrite/ONOO', 3-nitrotyrosine). Similar to ROS, the overproduction of RNS
will

generate

nitrosative

stress

and

can

potentially cause

damage

to

biomolecules over time. While the chemistry and subsequent physiological
consequences of RNS are interesting, they are beyond the scope of this project
and thus this review focuses only on ROS.
It must be emphasized that before ROS-induced oxidative stress
overwhelms the system, low amounts of ROS, especially H2 O2 , can serve as a
potent signaling molecule to participate in a variety of signal transduction
cascades (Harris and Shi, 2003; Leonard et al., 2004; Rhee, 2006). The signal
transduction cascades stimulate a variety of physiological responses in a cell,
such as activation of transcription factors and regulation of gene expression to
help the cells properly respond to the different kinds of stimuli. Literature has
shown that low concentrations of ROS in fact stimulate proliferation and enhance
survival in a wide variety of cell types (Takada et al., 2003). More excitingly,
emerging evidence supports ROS-induced oxidative modifications as an evolving
strategy in various cell signaling and biological processes (Biswas et al., 2006;
Filomeni et al., 2002; Klatt and Lamas, 2000), which opens a new scientific
territory for discovery.
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Redox Regulation between Oxidative Challenge and Antioxidant Network

For cell survival, there must be a delicate balance between antioxidants
and oxidants as well as an antioxidant network against oxidative stress. As
mentioned above, prior to producing damage, low amounts of ROS can function
as a second messenger and participate in signaling. Chronically accumulated
ROS, if not neutralized by antioxidant defense systems, on the other hand, brings
toxicity and disease. Marvelously, besides the classical and well characterized
antioxidant enzymes, other biomolecules, proteins and peptides work in concert
to maintain cellular redox homeostasis (summarized

in Figure

1 A-C).

Thioredoxin (Trx red/Trx oxi) and glutathione (2GSH/GSSG) are wonderful
examples of additional antioxidant systems inside a cell (Flolmgren et al., 2005;
Nordberg and Arner, 2001). The similarity between these two systems lies in that
they both use cysteine residues/thiols on their structure and the electrons
provided by NADPFI to participate in redox reactions and maintain cellular
components in a reduce state (Figure 1C). Tripeptide GSFI (L-y-glutamyl-Lcysteinylglycine) is the most abundant antioxidant with high concentrations (1-10
mM) inside a cell and is predominantly generated in the liver. The synthesis of
GSFI utilizes the consecutive actions of glutamate-cysteine ligase/GCL (formal
name as y-gultamylcysteine synthetase/GCS; EC 6.3.2.2) and GSFI synthetase
(GS; EC 6.3.2.3) to link three amino acids (glutamate, cysteine and glycine)
together (Figure 1B).
The reduced form of glutathione (GSFI) scavenges ROS, therefore,
protecting sulfhydryl groups of other macromolecules in the cell from damage. In
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addition, GSH conjugates with electrophilically reactive metabolites as well as
harmful chemicals including Cd and serves as a cofactor for numerous GSHdependent

antioxidant enzymes

glutaredoxin/Grx

(also

peroxidase/GPx.

Moreover,

such

as glutathione

as

thioltransferase)

known

GSH/GSH-dependent

S-transferase/GST,
and

enzyme

glutathione

systems

and

Thioredoxin (Trx)/Thioredoxin Reductase (TrxR) systems work in concert to
provide reducing equivalents that participate in oxidation-reduction reactions. All
of these potent regulators inside the complex antioxidant regulatory network help
to keep biomolecules, especially proteins, away from ROS-induced oxidative
damage that includes oxidization on the cysteine residue (R-SH) to become
sulfenic acid (R-SOH), sulfinic acid (R-S02H) or the unrescuable sulfonic acid (RS 0 3H) (Figure 1C). More excitingly, it is now recognized that the regulation of
redox balance and subquent modifications can be a cellular strategy participating
in cell signaling as well as modulating various biological processes and molecular
activities (Pompella et al., 2003; Schafer and Buettner, 2001). These proposed
redox

modifications

include

(1)

protein

inter-disulfide

formation

or

glutathionylation (the external mixed disulfide bond formation between GSH and
target protein) (Ghezzi, 2005), (2) the new concept of redox sensor/redox switch
like the ratio of 2GSH/GSSG and TrxSS/Trx(SH)2 (Biswas et al., 2006) and (3)
the potential modifications on zinc-sulfur center/zinc finger domains (llbert et al.,
2006) have started to gain significant attention recently. The fundamental
chemistry common in these concepts is derived from the sulfur/cysteine redox
chemistry and may help to explain the unusual high concentration of GSH
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existing in all living cells. It is attractive to speculate that the dynamic regulation
between glutathionylation and deglutathionylation, not only can be viewed as a
temporary protective mechanism to prevent further oxidative insult on proteins,
but also can actively serve as a redox switch to participate in cellular signaling
and regulation.
Abbreviations and/or synonyms in Figure 1:
IA. The concept of redox balance
GST: glutathione S-transferase
CAT: catalase
SOD: superoxide dismutase
GPx: glutathione peroxidase
GSH: glutathione
IB. The synthesis of GSH, the major non-enzymatic antioxidant in living cells
Glu: glutamate
Cys: cysteine
Glv: glycine
GSH: glutathione,
BSO: DL-Buthioneine-(S, R)-sulfoximine
GCL: glutamate cysteine ligase = CGS: y-gultamylcysteine synthetase
Gclc: GCL catalytic subunit = GCS heavy chain
Gclm: GCL regulatory subunit = GCL modifier subunit or GCS light chain
GS: GSH synthetase
IC. The major antioxidant regulatory network
Reactive oxygen species: 02'", OH' and H20 2
Classical antioxidant enzymes: CAT, SOD and GPx
Additional major antioxidant systems:
(1) Glutathione (GSH) and GSH-dependent enzymes
(2) Thiroredoxin (Trx) and Thireoredoxin Reductase (TrxR)
Electron Provider:
nicotinamide adenine dinucleotide phosphate system (NADP+/NADPH)
Protein modifications on cysteine residues via oxidative challenge:
R-SH (reduced/native form), R-SOH (sulfenic acid), R-S02H (sulfinic acid), and
R-S03H (sulfonic acid)
Other representative antioxidant enzymes:
glucose-6-phosphate dehydrogenase (G6PDH) and sulfiredoxin (Srxn)
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Figure 1. Overview of redox regulation between oxidative challenge and
antioxidant network.
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Mitogen Activated Protein Kinase (MAPK) Signaling Cascades

Cellular proteins, especially those localized in the cytosol, are another
important group engaged in cell signaling. In particular, proteins kinases and
phosphatases are the central players that participate in signaling cascades.
Through phosphorylation, the kinases increase their activity and further are able
to either phosphorylate cytosolic substrates or translocate into the nucleus where
they can phosphorylate a variety of nuclear transcription factors that influence
cellular processes. Mitogen activated protein (MAP) kinase cascades are among
one of the most common and important intracellular signaling systems. In general,
they receive signals from upstream regulators such as proteins sitting on and/or
complexing with membrane proteins or directly from the intercellular second
messengers. The common external stimuli are growth factors, mitogens,
cytokines and other environmental stressors. Once a stimulus arrives on the cell
surface, the classical mechanism for MAPK (ERK)-pathway activation of the
upstream event is initiated via receptor protein tyrosine kinase (RPTK) activation
(Kyriakis and Avruch, 2001). The signal is then passed through phosphotyrosinedocking proteins (generally complexing with RPTK) to adaptor proteins (generally
complexing with docking protein) and then to a guanine exchange factor (GEF;
generally complexing with adaptor proteins). The GEF further facilitates the
activation of small G-proteins. The small G-protein (Ras, in the ERK pathway, for
example) on the membrane will in turn activate the first player of the MAP kinase
cascade, MAPKKK (Raf, in the ERK pathway, for example) (Kyriakis and Avruch,
2001; Schaeffer and Weber, 1999).
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The MAP kinase cascades are composed of three groups of kinases
activating in a sequential order: MAP kinase kinase kinase (MAPKKK) to MAP
kinase kinase (MAPKK) to MAP kinase (MAPK). To date, there are four major
subfamilies of MAPKs identified in mammalian cells, the extracellular signalregulated kinase (ERK1/2)/mitogen-activated protein kinase (p44/42 MAPK), cJun N-terminal kinase (JNK)/stress-activated protein kinase (SAPK), p38 MAPK
and big mitogen-activated protein kinase (BMK)/extracellular signal-regulated
kinase (ERK5) (Hazzalin and Mahadevan, 2002; Johnson and Lapadat, 2002;
Kyriakis and Avruch, 2001) (Summarized in Figure 2). Generally speaking, the
MAPKs are activated under diverse stimuli and are engaged in numerous cellular
activities such as proliferation, differentiation, movement, cell death and
metabolism (Ding and Templeton, 2000; Hazzalin and Mahadevan, 2002; Karin,
1995; Martinez-Mier et al., 2002). Subtle differences in their activation are noted,
ERK1/2 (p44/42 MAPK) and ERK5 (BMK) are generally activated by growth
factors and cytokines to promote cellular proliferation; JNK and p38 are generally
activated under stress conditions such as chemical and environmental insults to
promote stress-driven protection (or sometimes damage) responses (Frippiat et
al., 2002; Gupta et al., 1999; Karin, 1995; Wu et al., 2004). Even though they
may seem distinct, all MAPK signaling cascades however are closely linked and
work in concert with additional cross-talk between each of the pathways. Hence,
it is a challenge to study and dissect the role of each family member. Previously,
we have shown that Cd (1 pM and 4 pM) initially increased p44/42 MAPK activity
after a 6 hr exposure, and pretreating with antioxidants before Cd exposure
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reduced p44/42 MAPK activity (Xu et al., 2003). The continuing project will
investigate another MAPK member, the stress sensitive protein JNK, under Cd
exposure in primary rat hepatocytes.
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Figure 2. Overview of mitogen activated protein kinase signaling cascades.
The simplified MAPK kinase cascade is composed of a chain of three groups of
protein kinases that establish a sequential activation pathway. Via this complex
chain reaction, various extra- and intracellular stimuli are transmitted, resulting in
the activation of gene expression and appropriate biological responses.
Abbreviations and/or synonyms:
MAPKKK= MEKK (MEK Kinase) = MLK; MAPKK = MEK = MKK; MAPK: big
mitogen-activated protein kinase (BMK), extracellular signal regulated kinase
(ERK), stress-activated protein kinase (SPAK)/Jun N-terminal kinase (JNK); Tpl2:
tumor progression locus 2 = Mitogen-activated protein kinase kinase kinase 8
(Map3k8); c-Raf: RAF proto-oncogene serine/threonine-protein kinase (Raf-1);
ASK1: Apoptosis signal-regulating kinase 1 = mitogen-activated protein kinase
kinase kinase 5 (MEKK 5 = MAP3K5); Stat: signal transducer and activator of
transcription; NFAT4: T cell transcription factor NFAT4 = Nuclear factor of
activated T-cells, cytoplasmic 3 (NF-ATc3); ATF2: activating transcription factor 2
= cyclic AMP-dependent transcription factor ATF-2 = cAMP response elementbinding protein (CRE-BP1); MEF2C: myocyte-specific enhancer factor 2C; CHOP:
C/EBP-homologous protein (CHOP) = DNA damage-inducible transcript 3 (DDIT3) = growth arrest and DNA-damage-inducible protein (GADD153)
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Gene Expression Regulatory Network

The expressions of genes are necessary for biological processes and
cellular regulation. Under various stimuli, different sets of genes will be activated
to assist in maintaining a cell’s homeostasis. How does a cell know what gene
should be activated under the specific time and conditions; what response will
the gene or gene product/protein participate in? The clue lies in both the
information received (e.g. the specific signals transmitted through specific
signaling cascades and modifications) and the specific transcription factors
recruited at that specific moment. In each moment, unique information is passed
and processed through coordinated network efforts. It is in connecting these
individual and sequential moments in a regulatory symphony that will yield a
perfect tune rather than chaotic discord. In this section, we will introduce three
related topics on gene expression (1) regulation of gene expression, (2)
transcription factor activator protein 1 (AP-1), and (3) integrated gene expression
and cellular responses.

Regulation of Gene Expression

Generally speaking, activation of gene expression is regulated by very
complex transcriptional machinery in addition to posttranscriptional events (e.g.
splicing, export, stability and degradation of RNA). The large numbers of
transcription factors in the human genome (about 2000 genes code for
transcription factors/TFs) state their significance in participating in gene
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regulation (Zawia, 2003). Transcription factors can be divided into two groups:
the general (constitutive) transcription factors like TFII and the inducible
(conditional) transcription factors like NFkB and AP-1 (Brivanlou and Darnell,
2002). The general transcription factors bind at the TATA box and are part of the
core promoter, where RNA polymerase binds to initiate transcription of the genes.
The inducible transcription factors, which are activated under different stimuli,
bind to specific sequences (cis elements) upstream of the promoter region and
modulate the rate of transcription of the initiation complex. In order to appreciate
the beauty and delicacy of this highly sophisticated transcriptional machinery that
provides living cells with their remarkable ability to respond and adapt rapidly, we
must first recognize some of the basic structures and general components of a
transcription factor.
As shown in Figure 3, first of all, the DNA-binding Domain (DBD) of a
basic transcription factor is indispensable for recognition and interaction with the
specific sequence of DNA. Based on the structure (domain/motif) similarity, the
major subgroups of DBD include (a) zinc fingers (ZF) such as SP-1, Egr1, twocysteine two-histidine ZF, and multi-cysteine ZF transcription factors, (b) helixturn-helices such as octomer-binding proteins/Oct, and (c) basic regions that are
either adjacent to leucine zipper motifs in proteins, AP-1 or CREB for example, or
adjacent to helix-loop-helix motifs as in MyoD or HIF1. Secondly, the
Dimerization Domain (DD) includes leucine zipper motifs or helix-loop-helix
motifs and is usually required for most transcription factors to form an active
functional complex of transcription factors and to facilitate DBD domain-DNA
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binding. Single subunits cannot bind to DNA alone; the complexed dimer is
required for DNA binding since the DNA-binding elements tend to occur as two
halves, to which each monomer of the dimer binds. Thirdly, the Ligand-Binding
Domain (LBD) involves interaction and binding of diverse ligands (e.g. hormones,
vitamins, metabolites and toxins) that are found in most of the nuclear receptors.
Ligand binding results in a conformational change that can further cause either
homodimerzation of the nuclear receptor or its association with a coactivator or
corepressor. Fourthly, the Activation Domain (AD) or Repression Domain (RD)
involves the interaction of transcription factors with the basal transcription
machinery resulting in enhanced or decreased transcription (Garvie and
Wolberger, 2001; Latchman, 1997; Mitchell and Tjian, 1989; Pabo and Sauer,
1992).
In evaluating these general structures of a single transcription factor, one
can realize that the complexity of transcriptional regulation not only exists at the
binding/interaction level of the entire final machinery complex, but also exists at
the initial combinatorial choice of the transcription factor itself. By varying
combination, dimerization, and interaction with coactivators or corepressors, the
responsive gene expression can be regulated either positively or negatively to
facilitate the whole transcription regulatory network in a highly dynamic and
flexible fashion for cellular demands.
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Figure 3. Overview of general components for transcription regulation.
(1) The basal (constitutive) transcription, shown on the right of the figure,
requires the binding of general transcription factors (GTF) and RNA polymerase
to the TATA box of the core promoter region to form the core promoter complex.
(2) The inducible (conditional) transcription, shown on the left of the figure,
requires specific transcription factors and other proteins to form a regulatory
complex under specific stimuli. The interaction between this inducible regulatory
complex and the core promoter complex activates or represses RNA polymerase
and thereby influences the rate of transcription of target genes.
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Transcription Factor Activator Protein 1 (AP-1)

In order to turn on specific genes responsible for a unique stimulus,
activation of specific transcription factors plays a central role in bridging upstream
signaling and downstream transcription of the responsive gene for the proper
biological and/or physiological response. Accumulated evidence has suggested
MAPKs to be part of the upstream signal pathway of activator protein-1 (AP-1)
activation (Gupta et al., 1999; Karin, 1995; Moreno-Manzano et al., 1999). AP-1
is a sequence-specific redox sensitive transcription factor and plays an important
role in cellular response to diverse stimuli including the presence of ROS as well
as heavy metals (Becuwe et al., 2001; Karin, 1995; Puga et al., 2000; Twaroski
et al., 2001). The active or functional dimer of AP-1 is able to interact with DNA
and is composed of various combinations of subunits from Jun (e.g. Jun/c-Jun,
JunB, JunD), Fos (e.g. Fos/c-Fos, FosB, Fra1/fos-like antigen 1, Fra2/fos-like
antigen 2), and activating transcription factor (ATF) (e.g. Atf2, Atf3, Atf4, B-Atf)
subfamilies (Shaulian and Karin, 2001; Van Dam and Castellazzi, 2001). In
addition, AP-1 is one of the bZIP (basic region leucine zipper) super family
members (currently there are 56 members identified in humans) and recent
findings have shown or suggested that the members of AP-1 are able to
interact/dimerize with other bZIP family members such as members of the
musculoaponeurotic fibrosarcoma (Maf) family (e.g. c-Maf, MafB, MafA, small
Mafs/MafG/F/K) and the nuclear factor-erythroid 2 (NF-E2) family (e.g. NF-E2,
Nrf1, Nrf2, Nrf3) (Karin et al., 1997; Motohashi et al., 2002) (summarized in
Figure 4).
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Figure 4. Overview of transcriptional regulation of AP-1 transcription factor.
The dimeric AP-1 transcription factor complex controls diverse biological
processes, such as cell proliferation and differentiation, by regulating gene
expression in response to positive and negative stimuli.
Abbreviations and/or synonyms:
TPA: tumor promoter phorbol-ester 12-o-tetraadecanoyl phorbol 13-acetate
cAMP: cyclic adenosine monophosphate
ATF: activating transcription factor = cAMP response element-binding protein
(CREB and/or CREBP)
B-ATF: ATF-like basic leucine zipper transcriptional factor
JDP: Jun dimerization partners/proteins
bZIP: basic region-leucine zipper
Maf: musculoaponeurotic fibrosarcoma
Nrl: Neural retina-specific leucine zipper
Nrf: Nuclear factor erythroid 2-related factor = NFE2-realted factor
NFE2: nuclear factor erythroid 2
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Therefore, even though AP-1

is among one of the best studied

transcription factors, it is still a great challenge to identify all responsible proteins
that participate and the mechanism of induction under different stimuli. Among so
many potential AP-1 members to investigate, c-Jun particularly stirs our interest.
First, c-Jun (also called Jun) is one of the nuclear substrates for the stress
sensitive signaling protein JNK, which is already planned for investigation in this
current project. Second, c-Jun is categorized as an immediate early (IE) gene in
response to various stimuli, and the gene product, c-Jun protein, is a necessary
component of functional AP-1 (Jun-Jun homodimer; Jun-Fos or Jun-ATF
hetrodimer). Third, our previous results showed that Cd activated p44/42 MAPK
activity in hepatocytes (Xu et al., 2003). Therefore, it will be of significant interest
to investigate the connection between the signaling protein JNK and the
transcription factor AP-1 under Cd exposure in our primary rat hepatocyte in
culture model.

Integrated Gene Expression and Cellular Responses

The main purpose of gene activation is no different from cellular signaling
and enzymatic activation in that the activation is used to help a cell achieve
homeostasis and

maintain

proper function.

Under environmental

stress,

depending on the intensity (concentration/toxicity) and length (exposure time) of
a stimuli, the cooperative cellular responses will be adjusted in a dynamic fashion.
Under low dose of Cd exposure for example, a cell may try and is able to protect
itself by turning on the expression of genes to increase its protection capacity,
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and the consequent cellular responses may participate in growth/survival
responses such as cell cycle regulation, proliferation and differentiation. An array
of genes that control a number of biological processes or molecular functions will
need to be expressed. For example, the mitogen activated kinases, stress
sensitive transcription factors and proteins, antioxidant genes, cyclin and cyclin
dependent kinases (for cell cycle/cell division regulation), and antiapoptosis
genes such as Bcl2 family could all be the potential players involved in the
protection of a cell under early Cd insult. There are studies to support this early
natural ability of a cell to protect itself. For example, metallothionein gene/protein
(MT) is a classical example of a protein that is increased rapidly in response to
metals. Once induced, MT-1 can sequester and minimize the harmful effects of
Cd to the cells (Li et al., 1998; Zhang et al., 2003). In a study using non-toxic
doses of Cd to investigate the gene expression profiles in the testes of mice, the
data clearly show, at the earliest time point (12 hrs) investigated, that there are
genes related to stress and/or protective response such as early growth
response protein 1 (Egr1) and heme oxygenase 1 (HO-1), as well as genes
related to (anti)-apoptosis such as Bcl2 (Bcl2l2), and others related to
proliferation and cell cycle control such as growth arrest and DNA-damageinducible 45 (Gadd45) (Zhou et al., 2004).
On the other hand, under some conditions like high exposure to a toxin, a
cell may be unable to protect itself. Instead, genes participating in either
damage/death linked responses such as protein degradation, cell death
(apoptosis/necrosis),

or uncontrolled

cellular proliferation,

and
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cell cycle

dysregulation toward neoplastic development may be stimulated. The genes in
ubiquitin-proteasome degradation system (UPS), the genes in death signaling
and apoptosis regulation, the genes influencing cell cycle control, and the
dysregulated or overexpressed genes as repressor or activator in proliferation
will likely be involved under toxic or chronic conditions. The same report
described above for the gene expression profile in mice testes also investigated
the expression of genes at a longer time point (72 hrs). These results showed
that many genes involved in cell cycle such as cyclin B1 and cell division cycle 2
(Cdc2), as well as genes involved in DNA repair such as DNA mismatch repair
protein (Msh2) are all down-regulated (Zhou et al., 2004). Another study using a
lethal concentration of Cd to investigate cellular damage showed that caspase 3
and caspase 8 (indicator proteins involved apoptosis) were activated and there
was damage to the mitochondria, as well as chromatin condenstation and DNA
fragmentation (Coutant et al., 2006). A study investigating the effects of chronic
exposure to Cd demonstrated that the increase level of Cd accumulation in
tissues was accompanied with a decrease in activities of several antioxidant
enzymes scuh as glutathione peroxidase, glutathione reductase and glucose-6phosphate dehydrogenase in liver (El-Maraghy et al., 2001). The disturbace in
these antioxidant genes was characterized as one of the crucial triggers for
future damage and toxicity.
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Progression of Modern Experimental Techniques Pertinent to Metabolic
Studies: A Brief Review

The liver is an amazing organ with its ability to perform numerous
biochemical reactions, maintain a wide degree of metabolic homeostasis and
detoxify various harmful materials at every given moment. The other remarkable
and unique capacity of the liver comes from its regeneration ability. In
mammalian models, the liver is still capable of maintaining its function even after
70% of the liver is removed by partial hepatectomy; while the whole organ
undergoes regeneration to restore itself back to normal size within one week
(Fausto,

2000; Michalopoulos and

DeFrances,

1997; Taub, 2004). The

hepatocytes, which make up 80% of the liver volume and 60% of its total cell
number, carry out most of the regulatory functions of liver. Thus it is a classical
and ideal model to use in regard to investigating liver cellular molecular
mechanisms. The first technique for large-scale preparation of isolated
hepatocytes was described in 1953 (Anderson, 1953), which happened to be the
same year of the discovery of the structure of the DNA “double helix” that has led
us into the modern molecular biology era (Watson and Crick, 1953). The
successful

preparation

of

intact

isolated

hepatocytes

from

animals

by

recirculating perfusion of collagenase-treatment passing through a liver was
achieved in 1969 (Berry and Friend, 1969). Since the mid-1970's, the use of
primary hepatocytes in culture, which can be maintained and treated in a
chemically defined solution, have become an imperative tool for identifying
potential mechanisms specific to a unique treatment in relation to metabolism as
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well as toxicology. Use of these cells for years helped in our understanding of the
relationship of the expression of genes in response to changes in metabolism or
to a chemical insult. However, the techniques used at the time only allowed for
the evaluation of one gene at a time.
Excitingly in the year of 2003, the 50th anniversary of the discovery of the
DNA double helix, the 15 year Human Genome Project achieved its goal to
complete the decoding of 3 billion human DNA sequences as well as many other
species’. A new modern era of molecular biology known as “-omics” arrived.
Embracing this new world of modern biology, new terminology such as
Functional Genomics- the interpretation of the function of DNA sequences on a
genomic scale (Carpenter and Sabatini, 2004; Witkamp, 2005); Toxicogenomicsthe measurement of global gene expression changes in biological samples
exposed to toxicants (Waters and Fostel, 2004); Proteomics- the large scale
study of proteins in their structure and functions (Witkamp, 2005); and
Metabolomics- the investigation of global metabolite profiles in a system under a
given set of conditions (Rochfort, 2005), all state the systematic and large scale
approach contemplated to dissect the complex biological regulatory networks
with the assistance of high-throughput techniques

(e.g.

GeneChip/DNA

microarrays, protein microarrays), advanced analytical techniques (e.g. mass
spectrometry/MS,

high-performance

liquid

chromatography/HPLC,

nuclear

magnetic resonance/NMR), as well as continuously expanded bioinformatics.
While many of these new approaches were developed to deal with large scale
study, the science itself is still in its infancy and the ultimate challenge of

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

34
interpreting and making sense of the data generated remains. It is exciting to
know, however, that the integrated knowledge that will arise from these
multidisciplinary studies may shorten the gap in our understanding of the
complexity of life and will lead us into another exciting era closer to prediction
and prevention of disease in the future.

Significance of the Study

With an increasing health concern and awareness of the risk of exposure
to environmental pollutants and toxic chemicals nowadays, understanding the
molecular mechanisms specific to a toxin like cadmium is one of the fundamental
tasks in preventing detrimental effects. A comprehensive knowledge of the
biological effects of cadmium especially those early molecular mechanisms
applied by cells upon initial exposure is extremely important since cadmium, a
very toxic non-essential metal and human carcinogen, has became an
irreplaceable component in our modern technological world. The early molecular
events associated with heavy metal exposure play a significant role to potentially
orchestrate downstream physiological processes. Therefore it is of significance to
find out what are the early responses upon cadmium exposure. To take a global
and comprehensive approach, toxicogenomics adapts the advantage of
genechip/microarray technology to investigate the expression

pattern of

thousands of genes on one gene chip. Using this approach, a significant number
of papers using microarrays have investigated either acute (toxic concentration
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for short exposure time) or chronic (sub-toxic/low concentration for long exposure
time) effects induced by chemicals and drugs with the hope to identify specific
potential biomarkers linked to toxicity (Ellinger-Ziegelbauer et al., 2004; Ito et al.,
2006; Liu etal., 2002; Luhe etal., 2005). However, less attention has focused on
characterizing the early sensing and response mechanisms especially under
tolerable and/or physiological concentrations of low dose condition with a short
exposure time.
It is in studying theses early events where we are provided with an
opportunity to understand the potentially protective mechanisms naturally utilized
by a cell. It is also the realistic approach to the study of Cd exposure since we
are exposed primarily to low concentrations; but since it can bioaccmulate, it will
also reach toxic levels. Without a doubt, identifying markers of exposure as well
as the responsive genes participating in the first line of defense upon early Cd
exposure is of significance to help us understand how a cell recognizes a
potential toxicant and also how it can protect itself. A long term gain is to
understand and elucidate how to naturally balance the internal antioxidant
potential and protection against oxidative stress and environmental toxins like Cd.

Objectives of the Study

The goal of this project is to identify key proteins/genes that participate in
Cd-induced molecular events and propose potential early sensing and regulatory
mechanisms that the cells apply prior to oxidative stress induced cellular damage.
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Here we hypothesize that at low dose and short time of exposure to Cd, the cells
are able to sense and reprogram their internal signaling cascades and gene
expression patterns to adapt and protect against Cd insult. To test this
hypothesis, we propose the following specific aims for investigation:

Aim 1: To establish that a stress sensitive signal transduction cascade and
subsequent induction of a stress gene occurs under low dose/short times of Cd
exposure.
Approach: We will investigate the effect of Cd on the activity of the signal protein
JNK by western blot analysis, the expression of c-Jun gene by northern blot
analysis and the induction of transcription factor AP-1 DNA binding by
electrophoretic mobility shift assay analysis. Several antioxidants and specific
inhibitors of signal proteins will also be used to elucidate the cellular traffic.

Aim 2: To use a global transcript profiling approach to identify potential genes
used by a cell engaged in sensing and protection against the early Cd insult.
Approach: The exposure time will be chosen based on the results in aim 1 and
the Affymetrix GeneChip® RAT RAE230A arrays, contanning 15,923 transcripts
(genes and expressed sequence tags), will be used.

Aim 3: To investigate the possibility that changing the cellular redox environment
is able to influence the downstream gene regulation.
Approach: In addition to Cd, antioxidants (NAC) and oxidants (BSO, inhibiting
GSH synthesis) will be included and the Applied Biosystems TaqMan®
quantitative Real Time PCR technique will be used to quantify expression levels.
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MATERIALS AND METHODS

Primary Rat Hepatocyte Isolation and Maintenance

Male Sprague-Dawley rats (Harlan, Kalamazoo, Ml) weighing 200-300g
(8-10 week old) were housed and maintained on Lab Diet 5001 standard rodent
diet with drinking water ad libitum in an Institutional Animal Care and Use
Committee approved facility. Animals were food deprived 48 hours prior to
hepatocyte isolation and anesthetized with an intra-peritoneal injection of
pentobarbital (45-50 mg/Kg). Hepatocytes were isolated using the collagenasehyaluronidase perfusion and digestion method (Stapleton et al., 1993). Briefly,
the liver was first perfused via the portal vein with a perfusion solution containing
0.148 M NaCI, 0.01 M HEPES, 0.017 M fructose, 0.49 mM EGTA, 6 ml of 0.5 %
phenol red, and 6 unit/ml heparin in water. Then a digestion solution containing
100 pg/ml collagenase D, 93 unit/ml hyaluronidase, 160 unit/ml trypsin inhibitor,
and 0.2 % BSA in water was followed. The partially digested liver was excised
and forced through three layers of gauze over a beaker containing perfusion
solution, and then centrifuged at 50 xg for 3 minutes at 4 °C. The supernatant
was aspirated and the cell pellet was suspended, washed, and centrifuged with
cold Waymouth’s MB 752/1 (Sigma-Aldrich Corporation, St., MO) medium
containing 0.5 % Bovine Serum Albumin (BSA). The final cell pellet obtained
after three times washing and centrifuging was gently resuspended in the
medium and an aliquot was used to determine cell concentration. The viability of
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the cell was checked with a hemocytometer using the trypan blue dye exclusion
method. Cells of greater than 85 % viability were then used in this study. The
cells were plated at 90 % confluency on sterilized Falcon-3002 60 mm tissue
culture dishes coated with collagen; maintained in Waymouth’s medium
containing BSA and supplemented with gentamicin (10 pg/ml) (Sigma) under a
humidified atmosphere of 5 % CO2 and 95 % air at 37 °C for 4 hrs. After 4hr of
attachment incubation, the media was aspirated and the cells were washed once
with 1 ml of BSA free Waymouth’s medium and then incubated with 4 ml of fresh
medium without BSA for an overnight incubation.

Cell Treatments and Processing

For the first part of this project to investigate Cd-induced signaling and
gene expression, the treatment conditions were set as follows: primary
hepatocytes were treated with 4 pM cadmium chloride (CdCI2) at various times (1,
3, 6 hrs). Based on previous work from our laboratory, 4 pM CdCI2 was chosen
as the experimential concentration, since we could measure the activation of
signal proteins, JNK and ERK, as well as an increase in G6PDH gene expression
at 6 hrs of exposure (Maki, 2000). In addition, the early cytotoxic parameters,
increases in LPO and LDH leakage, were measured only after 12 hrs and 24 hrs
of exposure with 4 pM CdCI2 (Xu, 1999). Several antioxidants such as Trolox (a
water soluble vitamin E), reduced GSH (in ethyl ester form), N-acetylcysteine,
carnosol, carnosic acids, and rosmarinic acid (the latter three natural antioxidants
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are extracted from the plant rosemary) have been frequently used for various
studies in our laboratory (Goel, 2005; Maki, 2000; Xu, 1999). In this current
project to study the potential role of ROS in Cd-induced molecular activities, the
cells were pretreated for 1 hr with either 10 mM N-acetylcysteine (NAC) (Sigma)
or 0.5 pg/ml carnosol (CAR) (Kalsec, Kalamazoo, Ml), two of the most effective
antioxidants, followed by a media change prior to the addition of CdCI2. For the
study of MAPK inhibitors, the cells were pretreated for 1 hr with 20 pM SP600125
an inhibitor of JNK (Calbiochem, San Diego, CA), 25 pM PD098059 an inhibitor
of MEK1 which is the upstream signal protein of ERK (Promega, Madison, Wl),
or 10 pM SB203580 a p38 MAPK inhibitor (Promega) followed by a media
change prior to the addition of CdCI2.
For the second part of this project to identify Cd responsive genes using a
global transcript profiling approach and verifying expression changes by qRTPCR, primary hepatocytes were treated with 4 pM CdCI2 at various times (1, 3
hrs). To investigate potential mechanisms of induction, the GSFI synthesis
inhibitor: DL-Buthioneine-(S, R)-sulfoximine (BSO) (Sigma) treatment were used
at either 0.4 mM or 1 mM BSO for various times (3, 6, 12 hrs). For the antioxidant
treatment, cells were pretreated for 1 hr with 10 mM NAC followed by a media
change prior to the addition of either CdCI2 (1, 3 hrs) incubation or BSO (12 hrs)
plus Cd (1 hr) incubation (total 13 hrs). After cell treatment under various
conditions, the cells were first processed by removing the media and washed
twice with 1 ml of cold phosphate buffered saline (PBS) before further
procedures of isolating either protein or mRNA.
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Proteins Isolation and Western Blot Analysis

Protein Isolation

For cellular protein isolation, the cells from one 60 mm tissue culture dish
were lysed by adding 1ml of 1x cell lysis buffer (20 mM Tris, 150 mM NaCI, 1 mM
EDTA, 1 mM EGTA, 1 % triton, 2.5 mM sodium pyrophosphate, 1 mM (3glycerolphosphate, 1 mM sodium vanadate, and 1 pg leupeptin) from the JNK
Assay Kit (Cell Signaling Technology, Danvers, MA) and manufacturer’s
instructions followed. After 5 minutes incubation, the cells were scrapped off and
collected. The samples were sonicated 4 times at 25 % of output power for 5
seconds (Sonic Dismembrator 50, Fisher Scientific) and centrifuged at 16,000 xg
for 10 minutes at 4 °C. The supernatants were transferred to a new eppendorf
tube and the total protein content of the sample was measure by using the Micro
BCA Protein Assay Kit (Pierce, Rockford, IL).

Western Blot Analysis

The activity of JNK was measured using the JNK Assay Kit using the
protocols provide by the manufacturer. Briefly, an equal amount of protein (250
pg) from cell lysate was used to perform the kinase reaction with c-jun fusion
protein as the substrate. Then 20 pi of the sample was electrophoresed in a 10 %
SDS-polyacrylamide gel at 100 mV for 1.5 hr. The proteins were then transferred
to a PVDF membrane (Immobilon-P, Milipore, Bedford, MA) using a standard
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semi-dry electroblotting apparatus (NOVEX, San Diego, CA). After blocking with
5 % (w/v) non-fat dry milk, the membranes were incubated with a specific
antibody to phospho-c-Jun at Ser63 residue (1:1000 dilution) overnight. Blots
were washed three times with 0.1 % Tween-20 in Tris-buffered saline (0.02 M
Tris base and 0.14 M NaCI in water) and then incubated with horseradish
peroxidase-conjugated anti-rabbit IgG (1:2000 dilution) and anti-biotin antibody
(1:1000 dilution) for one hour at room temperature, The membrane was washed
and the bands were detected by chemiluminescence (HRP-Western Detection
Kit, Cell Signaling). Developed membranes were exposed to Kodak XAR-5 film
and bands were quantitated using scanning densitometry (NIH Image). The
results are presented as the mean ± S.E.M. of N number of animals used for
each experiment. The comparisons within groups were performed by one-way
analysis of variance

(ANOVA) followed

by Student-Newman-Keuls test.

Statistical significance was tested at p < 0.05.

RNA Isolation and Northern Blot Analysis

RNA Isolation

Total RNA was extracted using TRIzol reagent (Life Technologies, Grand
Island, NY) and manufacturer’s instructions followed. Briefly, the steps included
using TRIzol reagent to lyse cells from one 60 mm tissue culture dish,
centrifuging to separate RNA from phenol-coloroform phase which contains
protein and DNA, precipitating RNA with isopropyl alcohol, washing RNA with
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ethanol before the final centrifuging for RNA. The concentration of RNA was
determined by measuring absorbance at 260 nm of UV spectrometry.

Northern Blot Analysis

Total RNA (20 pg) was treated with formaldehyde and subjected to
electrophoresis in 1.0 % agarose gel at 65 mV for 90 minutes and then
transferred to “Gene Screen” (NEN/DuPont) in 20x SSC buffer (0.3 M sodium
citrate and 3 M NaCI in DEPC water). After transfer, the membrane was
hybridized in PerfectHyb™Plus hybridization buffer (Sigma) with [32P]dCTP
random-prime (3000 Ci/mmol, Amersham Biosciences, IL) labeled cDNA for cJun (Stapleton et al., 1993). After hybridization, the membranes were washed
and exposed to a phosphorimager screen and/or subjected to autoradiography
at -70°C with Kodak X-OMAT film and intensifying screens. The bands were
quantitated using scanning densitometry, STORM 860 imager (Molecular
Dynamics, Sunnyvale, CA). Amount of c-Jun mRNA was normalized to the
control probe, li-actin (Cleveland et al., 1980). The results are presented as the
mean ± S.E.M. of N number of animals used for each experiment. The
comparisons within groups were performed by one-way analysis of variance
(ANOVA) followed by Student-Newman-Keuls test. Statistical significance was
tested at p < 0.05.
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Nuclear Protein Isolation and Electrophoretic Mobility Shift Assay

Nuclear Protein Isolation

Nuclear extracts were prepared as described by Mercier et al. (1999) with
some modifications. Hepatocytes from two 60 mm tissue culture dishes were
pooled and processed. Briefly, cells were washed in cold PBS, resuspended in
1ml ice-cold buffer A (10 mM Hepes, pH 8.0, 1.5 mM MgCI2, 10 mM KCI, 1 mM
DTT, 0.5 mM PMSF), incubated on ice for 15 min and centrifuged for 5 min at
2500 xg at 4 °C. The pellet was resuspended in buffer A at five times the cell
pellet. Cells were lysed by passing through a 29.5-gauge needle of an insulin
syringe 5 times and centrifuged at 2500 xg for 5 min at 4 °C. The nuclei were
then resuspended in one packed cell volume of buffer C (20 mM Hepes, pH 8.0,
1.5 mM MgCb, 25 % glycerol, 420 mM NaCI, 0.2 mM EDTA, 1 mM DTT, 0.5 mM
PMSF) and incubated on ice for 30 min with occasional shaking. The nuclear
suspension was centrifuged at 16,000 xg for 20 min at 4 °C. The supernatant
(nuclear protein) was then aliquoted and immediately frozen at -70°C for future
use. Protein concentration was determined by using the Micro BCA Protein
Assay Kit (Pierce).

Electrophoretic Mobility Shift Assay (EMSA)

The AP-1 DNA binding activity was analyzed by electrophoretic mobility
shift assay (EMSA) using the commercially available Gel Shift Assay Systems Kit
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(Promega) and manufacturer’s instructions followed. The consensus oligo
nucleotide sequence of AP-1 (c-Jun) was 5’-CGCTTGATGAGTCAGCCGGAA-3’
and Oct-1 (a nonspecific competitor) was 5’-TGTCGAATGCAAATCACTAGAA-3’.
Briefly, the consensus oligonucleotides were first labeled with T4 polynucleotide
kinase and [y-32P]ATP (3000 Ci/mmol, Amersham Biosciences) at 37 °C for 10
min. The mixture was incubated with 20 pg nuclear extract at room temperature
for an additional 20 min. In the competition assay a 100-fold molar excess of
unlabeled AP-1 or Oct-1 consensus oligonucleotides was used. The DNA-protein
complexes were separated on a 4 % polyacrylmide gel in 0.5x Tris-Borate-EDTA
(TBE) buffer (44.5 mM Tris-base, 55 mM boric acid, 1 mM EDTA, pH 8.3) and
then exposed to a phosphorimager screen and/or subjected to autoradiography
at -70°C with Kodak X-OMAT film and intensifying screens. The bands were
quantitated using scanning densitometry, STORM 860 imager (Molecular
Dynamics). The results are presented as the mean ± S.E.M. of N number of
animals used for each experiment. The comparisons between groups were
performed by one-way analysis of variance (ANOVA) followed by StudentNewman-Keuls test. Statistical significance was tested at p < 0.05.

Affymetrix Microarray Experiment

RNA from primary hepatocytes in culture was isolated from cells of four
individual rats and four independent experiments (four chips for no addition
control and four chips for 4 pM CdCI2 3hrs) were conducted. Affymetrix rat RAE
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230A arrays, containing 15,923 transcripts (genes and expressed sequence tags/
EST) from the rat UniGene database, are used for transcript profiling and the
manufacturer’s protocols (Affymetrix GeneChip Expression Analysis Technical
Manual, 701022 Rev. 2) were followed. The major steps included (1) double
stranded cDNA synthesis and cleanup (2) in vitro transcription of biotin-labeled
cRNA, cleanup, and cRNA fragmentation (3) hybridization of sample onto
microarray (4) probing with biotinylated antibody, washing, staining, scanning
and generating signal intensity for data analysis.

Double-Stranded cDNA Synthesis and Cleanup

8 pg total RNA was converted to first-strand cDNA using the Superscript
Choice System (Invitrogen Life Technologies) with a HPLC purified oligo-dT
primer containing a T7 RNA polymerase promoter (Geneset Corp, La Jolla, CA).
Primer hybridization was completed in a total volume of 20 pi containing a final
concentration of 10mM dithiothreitol (DTT), 1mM dNTP mix and 5x first strand
reaction mix buffer. The reaction was incubated at 42 °C for 2 minutes followed
by the addition of 200 U Superscript II reverse transcriptase for 1 hr incubation at
42 °C. The second-strand cDNA was carried out by adding 200 pM dNTP, 10 U
E.Coli DNA ligase, 40 U E.Coli DNA polymerase I, 2 U RNase H, and 5x second
strand reaction mix buffer to a final reaction volume of 150 pi and incubated at 16
°C for 2 hours. T4 DNA polymerase was added at the end of the reaction for an
additional 5 minutes and the reaction was stopped by adding 10 pi 0.5 M EDTA.
The synthesized double-stranded cDNA was then purified and recovered by
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using GeneChip Sample Cleanup Module (Affymetrix) and manufacturer’s
instructions followed. Briefly, the sample was bound to a special membrane on
the spin column, washed, and eluted the cDNA with cDNA elution buffer
(average volume of eluate is 12 pi) by centrifugation.

Biotin-Labeled cRNA Preparation. Cleanup and Fragmentation

After cleanup, the purified cDNA was transferred into a RNase-free
microfuge tube for an in vitro transcription (IVT) reaction with the presence of a
mixture of biotin-labeled ribonucleotides to generate cRNA by GeneChip IVT
Labeling Kit (Affymetrix). In each micofuge tube, 4 pi of 10x IVT labeling buffer,
12 pi of IVT labeling NTP mix, 4 pi of IVT labeling enzyme mix was added to final
total volume equal to 40 pi. After incubation for 16 hours at 37 °C, the biotinlabeled cRNA was purified using GeneChip Sample Cleanup Module (Affymetrix)
described as above. Purified cRNA was quantified by measuring absorbance at
260 nm of UV spectrometry and 20 pg cRNA was fragmented to 35-200 bp with 8
pi of 5x fragmentation buffer (200 mM Tris-acetate pH 8.1, 500 mM potassium
acetate and 150 mM magnesium acetate) in a total volume of 40 pi for 35
minutes at 94 °C. Before hybridization onto RAE 230A arrays, the quality of
labeling and fragmentation was first checked on an agarose gel.
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Hybridization of Sample to Microarrav

Final volume of 15 pg fragmented cRNA was mixed with hybridization
cocktail (0.05 pg/pl cRNA, 50 pM control oligonucleotide B2, 1.5 pM bioB, 5 pM
bioC, 25 pM bioD, 100 pM ere, 0.1 mg/ml herring sperm DNA, 0.5 mg/ml acetyl
acetylated BSA, 100 mM MES, 1 M NaCI, 20 mM EDTA, 0.01 % Tween-20, 10 %
DMSO). Prior to sample hybridization, the chips was pre-hybridized with 1x
hybridization buffer (100 mM MES, 1 M [Na+], 20 mM EDTA, 0.01 % Tween-20)
for at least 10 minutes at 45 °C and 60 rmp in a GeneChip® Hybridization oven
640 (Affymetrix). Hybridization was performed by incubating 200 pi of the sample
with the Rat Genome 230A array at 45 °C and 60 rmp in the oven for 16 hours.

Washing. Staining and Scanning

After hybridization, the washing and staining procedures were carried out
on a GeneChip® Fluidics Station 450 (Affymetrix) in conjunction with Affymetrix
Microarray Suite 5.0 software (MAS 5.0, Affymetrix). The whole procedure of
wash and stain takes approximately 90 minutes to complete. The steps were as
follows: (1) Post hybridization wash 1 at 25 °C (10 cycles of 2 mixes/cycle with
wash buffer A: 6x SSPE, 0.01 % Tween-20). (2) Post hybridization wash 2 at 50
°C (4 cycles of 15 mixes/cycle with wash buffer B: 100 mM MES, 0.1 M [Na+],
0.01 % Tween-20). (3) First stain: stain the probe array for 10 minutes at 25 °C in
a 600 pi streptavidin phycoerythrin (SAPE) solution mix: 100 mM MES, 1 M [Na+],
0.05 % Tween-20, 2 mg/ml BSA, 10 pg/ml SAPE (Molecular Probes, Eugene,
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OR). (4) Post stain: wash at 25 °C (10 cycles of 4 mixes/cycle with wash buffer A).
(5) Second stain: stain the probe array for 10 minutes at 25 °C in a 600 pi
antibody solution mix: 100 mM MES, 1 M [Na+], 0.05 % Tween-20, 2 mg/ml BSA,
0.1

mg/ml goat IgG stock, 3 pg/ml biotinylated goat anti-streptavidin antibody

(Vector Laboratories, Burlingame, CA). (6) Third stain: stain the probe array for
10 minutes at 25 °C in a 600 pi SAPE solution mix. (7) Final wash at 30 °C (15
cycles of 4 mixes/cycle with wash buffer A). After the washing and staining
procedures are all completed, each individual array was then scanned using HP
GeneArray Scanner G2500A (Hewlett-Packard/Affymetrix). After scanning, each
image was inspected for major chip defects or abnormalities in hybridization
signal as a quality control. The scanner generates an image of the array by
detecting the intensity of fluorescent labeled RNA that has hybridized to the
specific probes on the array and the signal intensity files (.CEL) were generated
by MAS 5.0 software and ready for further analysis.

Affymetrix Microarray Data Analysis

Detailed protocol and documentation with regard to sensitivity and
statistical analysis of the method are described in the MAS 5.0 User’s Guide and
GeneChip® Expression Analysis Data Analysis Fundamentals from Affymetrix
website. Briefly, each gene is represented by the use of ~11 perfectly matched
(PM) and mismatched (MM) control probes. The MM probes serve as controls for
background and cross hybridization signals. The overall intensity of an individual
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transcript was obtained by the difference between the PM and MM probes, that
was generated by the Gene Array Scanner software. For single array analysis,
the One-Sided Wilcoxon’s Signed Rank test was performed to generate the
Detection p-value. The p-value less than 0.04 will generate a Present Call and
the p-value greater than 0.06 will generate an Absent Call. For comparison array
analysis, the Cd-treated experimental array was normalized to baseline control
array and the Wilcoxon’s Signed Rank test was used to generate the Change pvalue. The p-value ranges in scale from 0.0 to 1.0 and provides a measure of
change and direction. Values close to 0.0 indicate an increase in expression and
the p-value less than 0.0025 generates an Increase Call. Values close to 1
indicate a decrease in expression and the p-value greater than 1 minus 0.0025 (p
> 0.9975) generates a Decrease Call. The second algorithm gave a quantitative
estimate of the change in gene expression in the form of Signal Log Ratio. The
log scale used is base 2 and a Signal Log Ratio of 1.0 indicates an increase of
the transcript level by two fold and -1.0 indicates a decrease by two fold.
After data was generated from MAS 5.0 it was imported into Spotfire©
DecisionSite for Functional Genomics 8.2 (Spotfire) for further analysis. To see
the most robust increases in our study, three metrics were followed: (i) eliminate
probe sets in the Cd-treated sample called “Absent” in each individual array (ii)
select for probe sets called “Increase” in each comparison array (iii) eliminate
probe set with a Signal Log Ratio below 0.585 (1.5 fold change) in each
comparison array. For the most robust decreases, three metrics were followed: (i)
eliminate probe sets in the baseline control sample called ’’Absent” in each
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individual array (ii) select for probe sets called “Decrease” in each comparison
array (iii) eliminate probe sets with a Signal Log Ratio of above -0.585 (1.5 fold
change) in each comparison array. The final set of filtered gene changes (109
increase and 33 decrease) was further analyzed through several bioinformatics
websites such as the Affymetrix NetAffx™ Analysis Center, National Center
Biotechnology Information (NCBI/Pubmed), Rat Genome Database (RGD), Gene
Ontology (GO) and Swiss-Prot (Protein knowledgebase).

Quantitative Real Time PCR (qRT-PCR) Experiment

The levels of expression of the selected genes were quantified using
quantitative real time PCR TaqMan® analysis using the ABI Prism 7700
Sequence Detector System® (SDS) with version 1.9.1 software (Perkin Elmer
Corp./Applied Biosystems). To begin with, primary rat hepatocytes were treated
with 4 pM Cd for 3 hrs to verify microarray data. In order to investigate the role of
GSH in the change in gene expression induced by Cd, cells were treated with 0.4
mM BSO (3, 6, 12hrs) or 1 mM BSO (12 hrs) alone as well as 1 mM BSO (12 hrs)
plus 4 pM Cd for 1 hr (13 hrs total). To investigate whether or not the changes in
gene expression observed in the presence of Cd were due to oxidative changes,
the antioxidant NAC was used. 10 mM NAC was pre-incubated for 1 hr, media
was changed and then Cd was added for either 1 hr or 3 hrs of incubation.
Another set of NAC experiments was performed with BSO plus Cd: primary
hepatocytes were incubated with 1 mM BSO for 12 hrs, NAC was added in the
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last hour, fresh media was changed and treated with Cd for an additional 1 hr (13
hrs total). All the reagents, kits and target gene probes for qRT-PCR were
purchased from Applied Biosystems (ABI) and followed manufacture’s instruction.
Two step RT-PCR was performed starting with converting 500 ng total
RNA into cDNA using a TaqMan® Reverse Transcription Reagents Kit containing
Taqman buffer, magnesium chloride, random hexamers dNTPs, RNase inhibitor
and reverse transcriptase (product # N8080234, ABI). The quality of cDNA was
checked by gel electrophoresis before the second steps of PCR amplification.
Real time PCR reaction was then carried out in a 96-well plate containing 12.5 pi
of 2x TagMan® Universal PCR Master Mix, 1.25 pi of 20x TagMan® Gene
Expression Assays-containing specific PCR primers and FAM™ dye-labeled
probes, cDNA obtained from the first-strand synthesis reaction and water to a
final reaction volume of 25 pi. After an initial incubation step for 2 minutes at 50
°C and denaturation for 10 minutes at 95 °C, qRT-PCR was carried out using 40
cycles of PCR (95 °C for 15s, 60 °C for 60s).
Several reference genes (B-actin, ribosomal protein 19/rPL19, cyclophilin
A/Cypa, and glyceraldehydes-3-phosphate dehydrogenase/GAPDH) were initially
tested and GAPDH was chosen for the most equally expressed among all the
experimental conditions. Data were acquired from cells from four rats (4
independent experiments of primary hepatocyte in culture with different treatment
conditions) and samples were analyzed in duplicate with both the target gene
and the reference gene, GAPDH, on each plate. Real time PCR reactions were
quantified based on the point in time during cycling when amplification of a target
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is first detected. The higher the initial amount, the sooner the target is detected
(equal to obtain a lower amplifying Ct value).

Quantitative Real Time PCR (qRT-PCR) Data Analysis

Two different analysis software programs, DART-PCR version 1.0 and
Relative Expression Software Tool (REST©), were obtained from genequantification websites (www.qene-guantification.de). DART-PCR provides a
simple means to analyze real time PCR data from raw fluorescence data. Initially
six amplification plots (duplicates times 3 experiments) generated from ABI prism
7700 SDS platform were imported into DART-PCR for preliminary efficiency
check. The results generated equal efficiency from 1.999 to 2.0 among all the
target genes (data not shown) therefore the default efficiency (2.0) was used in
the REST program for further relative expression analysis. Expression ratios
were calculated according to Pfaffl et al. (2002) where the relative expression
ratio (R) of a target gene was calculated using PCR efficiency and the CP
(crossing point) deviation of an unknown sample versus a control was expressed
to a reference gene. The target gene expression levels were adjusted to GAPDH
and results were then expressed as a fold difference in control group and
.
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Statistical significance was

tested by PairWise Fixed Reallocation Randomization Test© included in REST
and a p value less than 0.05 was considered significant (Pfaffl et al., 2002).
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RESULTS AND DISCUSSION

Establishing Signal Transduction and Gene Expression Changes upon
Cadmium Exposure

Previous work from the Stapleton laboratory has shown that incubation of
primary rat hepatocytes with Cd increases cytotoxicity as measured by an
increase in both lactate dehydrogenase leakage (LDH) and lipid peroxidation at
various concentrations and exposure times (Xu et al., 2003). Prior to significant
increases in these cytotoxic parameters, decreases in reduced GSH and
increases in the mRNA levels of glucose-6-phosphate dehydrogenase (G6PDH),
a redox sensitive antioxidant enzyme, were observed (Xu et al., 2003). Activation
of signal proteins in the cytoplasm provides a critical link between extracellular
stimuli and regulation of nuclear gene expression. It was also shown that p44/42
MAPK (also known as ERK) activity was enhanced by Cd and when blocked by
use of either PD098059, an inhibitor of MEK (the upstream signal protein of
p44/42 MAPK) or the antioxidants NAC, GSH or Trolox, the Cd induction of
G6PDH decreased. Thus, activation of p44/42 MAPK appears to be necessary
for activation of G6PDH and ROS plays a role in this induction. As a continuation
to better understand cadmium’s effect on the cell, we investigated whether or not
Cd, through the generation of ROS, would activate JNK, another signal protein of
the MAPK family that is more often associated with cellular stress. JNK in turn
regulates c-jun expression and promotes the binding of redox sensitive
transcription factor AP-1 with transcriptional activation of related target genes.
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Cadmium Increases Signal Protein JNK Activity, c-iun Gene Expression
and AP-1 DNA Binding Activity in a Time Dependent Manner

Our previous work investigated

both the time and concentration

dependent activation of p44/42 MAPK. We found 4 pM CdCl2 induced MAPK
activity about 8 fold after 6 hrs of treatment. Thus, in these experiments we used
4 pM CdCI2 for various times and found that JNK activity was significantly
increased by 1 hr and remained increased about 3-fold for 6 hrs (Figure 5A and
5B), as measured by western blot analysis. Thus, activation of JNK activity
appears to be an earlier event than activation of p44/42 MAPK activity in our
hepatocyte model. Since c-Jun is one substrate of the active form of JNK, we
next investigated the effect of Cd on c-jun gene expression. Using northern blot
analysis, c-jun mRNA levels were significantly increased within 1 to 3 hrs and
returned to a basal level at 6 hrs (Figure 6A and 6B). Therefore, the time frame of
activation for c-jun corresponded to the increased JNK activity observed with 4
pM of CdCI2treatment. Furthermore, since c-Jun is the main component of AP-1,
it was also of interest to explore the Cd effect on AP-1 activity. Using an
electrophoretic mobility shift assay, AP-1 DNA binding activity was shown to be
significantly enhanced after 3 hrs and 6 hrs of 4 pM CdCI2 treatment (Figure 7A
and 7B). Using excess amounts of specific (AP-1, c-Jun, c-fos) and nonspecific
(Oct-1) competitors in an electrophoretic mobility competition assay, the
specificity of the binding was shown (Figure 7A). In summary, we provide
evidence to support that Cd induces the activity of the signal protein JNK, which
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may in turn drive c-jun gene expression and promote transcription factor AP-1
DNA binding activity.
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Figure 5. Effect of 4 pM CdCI2 at different incubation times on JNK activity in
primary rat hepatocytes in culture.
A. A representative western blot of JNK activity in hepatocytes is shown.
B. Quantitative results of the blots are expressed as the mean ± SEM of the
percent of the control (NA = no addition). In all data sets, the significant
difference (*) compared to NA was tested at p < 0.05 and is reported in the
results (n=5).
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Figure 6. Effect of 4 pM CdCI2 at different incubation times on the c-Jun mRNA
levels in primary rat hepatocytes in culture.
A. A representative northern blot of c-jun mRNA levels in hepatocytes is shown.
The bottom figure shows the same blot probed for the control P-actin.
B. Quantitative results of the blots are expressed as the mean ± SEM of the
percent of the control (NA = no addition). In all data sets, the significant
difference (*) compared to NA was tested at p < 0.05 and is reported in the
results (n=4).
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Figure 7. Effect of 4 pM CdCI2 at different incubation times of AP-1 DNA binding
in primary rat hepatocytes in culture.
A. A representative gel shift assay of AP-1 DNA binding in hepatocytes is shown.
1 kilobase DNA ladder is incorporated in the picture. The first darker band in the
bottom is 100 bp and the middle darker band is 500 bp. For competition assays,
the non-competitor was Oct-1 and competitors were AP-1, c-jun and c-fos.
B. Quantitative results of the binding assay are expressed as the mean ± SEM of
the percent of the control (NA = no addition). In all data sets, the significant
difference (*) compared to NA was tested at p < 0.05 and is reported in the
results (n=4).
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ROS as the Second Messenger in the Cadmium-Induced Signaling Pathway

Cd may mediate these cellular events by disrupting the cellular redox
states, possibly via binding sulfhydryl groups of proteins and/or causing an
increase of ROS in the environment. Fortunately, cellular antioxidant enzymes
can work together to neutralize ROS. In addition to antioxidant enzymes, various
non-enzymatic antioxidant compounds also assist in balancing the redox state of
a cell. Here, we investigate the role of ROS in the activation of JNK and AP-1
activity by pretreating the cell with two antioxidant compounds (NAC and CAR)
before the administration of Cd. We have found these two antioxiants to be the
most effective ones among many other antixodiants tested in both primary rat
hepaocytes in culture and in stable liver cells in culture (Xu, 1999; Maki, 2000;
Goel, 2005). We show that the increased JNK activity, with 4 pM Cd for 3 hrs of
incubation, was reduced by the antioxidants tested (Figure 8A and 8B).
Increased c-jun mRNA level, with 4 pM Cd for 3 hrs of incubation, was also
significantly reduced by antioxidants (Figure 9A and 9B). Enhanced AP-1 DNA
binding activity, with 4 pM Cd for 3 hrs of incubation, was significantly reduced by
NAC (Figure 10A and 10B). Thus, from the antioxidant data, it appears that ROS
serves as a second messenger that engages JNK to turn on the subsequent
downstream events including c-Jun gene expression and transcription factor AP1 DNA binding activity. The involvement of ROS in the induction of c-Jun
parallels our earlier findings with the induction of G6PDH by Cd.
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The Relationship of JNK. c-iun and AP-1 in the Cadmium-Induced Signaling
Pathway

Phosphorylation at theronine (183) and tyrosine (185) residues of JNK
increases its activity to bind the nuclear substrate, c-Jun, and phosphorylation at
serine residues (63 and 73) of c-Jun promotes dimerization of AP-1 to increase
its binding activity. In order to determine if JNK is the upstream signal for
increased c-Jun expression in the presence of Cd, we used three different
MAPKs inhibitors: SP600125 an inhibitor of JNK, PD098059 an inhibitor of MEK1
which is the upstream signal protein of ERK (p44/42 MAPK), and SB203580 an
inhibitor of p38 MAPK to test. SP600125 is an ATP competitive inhibitor and
specifically inhibits JNK1/2/3 activiation and exhibits a greater than 300-fold
selectivity against related MAPKs, ERK1 and p38(3 (Bennett et al., 2001).
PD098059 acts by binding to the inactivated form of MEK1/2, thereby preventing
its phosphorylation by MEKs or by an upstream signal protein, c-Raf (Alessi et al.,
1995). SB203580 inhibits the catalytic activity of p38a and p38(3 MAPK kinases
by competitively binding in the ATP binding pocket (Lee et al., 2000). In the
beginning of our experiments, we also included another ATP competitive inhibitor,
LY294002, which inhibits phosphatidylinositol 3-kinase (PI3 Kinase) as our
positive control. Our data consistently show no significant difference in the
activity of JNK protein between Cd treatment and 1hr preincubation of 25 pM
LY294002 prior to Cd exposure.
As to three MAPK inhibitors tested, both the JNK inhibitor and p38
inhibitor were able to decrease the Cd induced JNK activity (Figure 8A and 8B)
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and c-jun mRNA expression (Figure 9A and 9B). These results suggest that JNK
plays a role in the activation of c-jun in primary rat hepatocytes exposed to Cd,
and that there may be some cross talk between JNK and p38. Surprisingly, only
SB203580 (p38 inhibitor) but not SP600125 (JNK inhibitor) was able to attenuate
the Cd induced AP-1 DNA binding activity with 4 pM Cd for 3 hrs of incubation
(Figure 10A and 10B) which may imply the possibility that p38 plays a role in the
Cd activation of AP-1.

Discussion of Signal Transduction and Gene Expression Changes upon
Cadmium Exposure

The first part of this project was to establish that under short time
exposure, as noted (1, 3, 6 hrs), to low dose of Cd (4 pM), cells indded activate
stress response. The results presented in this section clearly show that upon Cd
insult, through the generation of ROS and/or disturbance of the redox
environment as determined through the use of antioxidants, the cellular
molecular cascades involving the signaling protein JNK, immediate early gene cJun and the transcription factor AP-1 DNA binding are actively engaged. In fact,
the regulation of these events is dependent on ROS. Under minor oxidative
challenge, ROS can also serve as a second messenger to activate signaling and
cellular activities. Only when ROS overwhelms a cell will the long-term
consequences of oxidative stress bring detrimental consequences such as
toxicities and chronic diseases.
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Figure 8. Effect of antioxidants and inhibitors on CdCI2-induced JNK activity in
primary rat hepatocytes in culture.
A. A representative western blot of JNK activity in hepatocytes is shown.
B. Quantitative results of the blots are expressed as the mean ± SEM of the
percent of the control (NA = no addition). In all data sets, the significance from
the control (*) and CdCI2 (#) were tested at p < 0.05 and is reported in the results
(n=5). Antioxidants: NAC, N-acetylcysteine; CAR, carnosol. Inhibitors: SP600125
(JNK inhibitor), PD098059 (MEK inhibitor); SB203580 (p38MAPK inhibitor).
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Figure 9. Effect of antioxidants and inhibitors on CdCI2-induced c-jun expression
in primary rat hepatocytes in culture.
A. A representative northern blot of c-jun mRNA levels in hepatocytes is shown.
The bottom figure shows the same blot probed for the control p-actin.
B. Quantitative results of the blots are expressed as the mean ± SEM of the
percent of the control (NA = no addition). In all data sets, the significance from
the control (*) and CdCI2 (#) were tested at p < 0.05 and is reported in the results
(n=5-6). Antioxidants: NAC, N-acetylcysteine; CAR, carnosol. Inhibitors:
SP600125 (JNK inhibitor), PD098059 (MEK inhibitor); SB203580 (p38MAPK
inhibitor).
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Figure 10. Effect of antioxidants and inhibitors on CdCI2-induced AP-1 DNA
binding in primary rat hepatocytes in culture.
A. A representative gel shift assay of AP-1 DNA binding in hepatocytes is shown.
B. Quantitative results of the binding assays are expressed as the mean ± SEM
of the percent of the control (NA = no addition). In all data sets, the significance
from the control (*) and CdCI2 (#) were tested at p < 0.05 and is reported in the
results (n=6). Antioxidants: NAC, N-acetylcysteine; CAR, carnosol. Inhibitors:
SP600125 (JNK inhibitor), PD098059 (MEK inhibitor); SB203580 (p38MAPK
inhibitor).
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Since the MAPK cascades play an important regulatory role in various
cellular programs such as cell proliferation, differentiation, movement and cell
death and accumulating evidence shows different MAPK subfamily members can
activate AP-1 under different stimuli in various cell types including hepatocytes
(Czaja et al., 2003), studies were put forward to determine whether or not Cd can
increase AP-1 DNA binding activity. These studies also were designed to elicit
whether or not ROS was involved. First we looked at the effect of Cd on JNK
activity, c-jun mRNA expression and AP-1 DNA binding activity in the presence
or absence of antioxidants. We showed a 3-fold increase in JNK activity within 1
hr, a 2 to 4-fold increase in mRNA level of c-jun within 1 to 3 hrs and a 3-fold
increase of AP-1 DNA binding activity within 3 to 6 hrs. The increase we
observed in JNK activity correlated well to the results by Vernhet et al. (2001) in
that they detected an increase in phosphorylated JNK1 and JNK2 under 1 pM of
cadmium for 2 hrs and 4 hrs of exposure in primary rat hepatocytes. Our data
clearly show that Cd increases JNK activity, elevates c-jun mRNA level and
enhances transcription factor AP-1

DNA binding activity in primary rat

hepatocytes. NAC, a broadly used antioxidant compound, can either directly
scavenge certain oxidant species such as hydroxyl radicals and H20 2 (Aruoma et
al., 1989) or increase cysteine for enhanced production of GSH. Carnosol, a
natural phenolic antioxidant compound extracted from rosemary, has been
shown to have anti-carcinogenic properties and to induce the antioxidant enzyme
glutathione S-transferase (Debersac etal., 2001; Offord eta!., 1997). In our study,
treating the cells with antioxidants, especially NAC, decreases the Cd-induced
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JNK activity, c-jun expression and AP-1 DNA binding activity. These results
support the hypothesis that ROS as a second messenger is involved in Cdinduced signaling and gene expression.
In order to establish that Cd-induced the JNK/AP-1 signaling pathway and
that this was necessary to mediate the downstream events, different inhibitors of
the MAPKs were used. Studies using various cell types have shown a link
between activated JNK and increased AP-1 binding. For example, in human
umbilical vein endothelial cells (Wang et al., 2003) and human OVCAR-3 cell line
(Shin et al., 2002), JNK inhibitor SP600125 is able to attenuate the
phosphorylated JNK and phosphorylated c-Jun as well as AP-1 DNA binding
activity. Similarly in our study, SP600125 decreases JNK activity and c-jun
mRNA expression but surprisingly does not diminish AP-1 DNA activity. A
possible explanation for this conflicting result may be drawn from recent
references that suggest that the composition of the AP-1 dimer may affect its
binding affinity and activity. In a murine IL-7-dependent cell line, JunD is a
prominent component of AP-1 with and without the presence of IL-7, however,
following IL-7 withdrawal, c-Fos also becomes the major component (Rajnavolgyi
etal., 2002). In human KB-3 cells treated with vinblastine, a microtubule inhibitor,
highly selective alterations in specific members of the Jun and Fos family are
revealed (Berry et al., 2001). Treating with microphage deactivating factors
results in a marked change in the composition of the AP-1 complexes from cJun/c-Fos to JunB/c-Fos (Delgado and Ganea, 2000) and this result is consistent
with the literature that suggests c-Jun and JunB have a compensative regulatory
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effect. Additionally, if we recall in the introduction chapter for AP-1 transcriptional
regulation, we realize that there exist many AP-1 members to combine in various
dimerization possibilities. Therefore in our hepatocyte model, changes in the
composition of AP-1 members with Cd compared to nothing added (NA/control)
may provide one possible explanation to our observation but these would need to
be confirmed by identifying the components of AP-1. An additional explanation
for why SP600125 failed to attenuate AP-1 might be summarized by a recent
report addressing the possibility that for liver development and hepatocyte
proliferation after partial hepatectomy c-Jun could have functions independent of
its N-terminal phosphorylation (Schwabe et al., 2003).
Another unexpected result was that the p38 inhibitor SB203580 not only
decreases JNK activity and c-jun mRNA but also inhibits AP-1 DNA binding
activity in our study. These results suggest either a critical role for p38 MAPK in
Cd induced signal transduction or potential cross talk between p38 MAPK and
JNK. Evidence in support of cross talk between the pathways can be found in the
report that in a mouse pancreatic (3-cell line, SP600125 inhibits phosphorylated
JNK and phosphorylated c-Jun but also activates the phosphorylation of p38
MAPK (Vaishnav et al., 2003). Several reviews also suggest possibility for cross
talk since p38 MAPK and JNK have several shared upstream cascade members
and downstream substrates (Mielke and Herdegen, 2000; Vasilevskaya and
O'Dwyer, 2003). Additionally, others have shown p38 MAPK pathway to be
activated in various cell types in the presence of Cd (Chuang et al., 2000; Galan
et al., 2000; Misra et al., 2003). The attenuation of AP-1 DNA binding activity by
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SB203580 has also been observed (Becuwe et al., 2003; Hua et al., 2002; Ishii
and Takada, 2002; Jung et al., 2002). Therefore, combined evidence suggests
that it is highly possible that p38 MAPK plays a role in AP-1 activation in
response to Cd in rat hepatocytes in culture.
In summary we have shown Cd, through the generation of ROS and/or
disturbance of redox environment, activates the stress-related signal protein JNK,
increases c-jun expression and promotes the binding of the transcription factor
AP-1 to DNA in primary rat hepatocytes. While the JNK inhibitor SP600125
blocks the Cd-induced increase in JNK activity and c-jun expression, it does not
attenuate AP-1 DNA binding activity. This may be due in part to the change in
composition of Jun/AP-1 members or compensatively activating p38 MAPK.
These early events happen prior to the cytotoxic events (increased LDH leakage
and lipid peroxidation) and therefore may be part of the trigger for activating
protective mechanisms within the cell. Results presented here have been
published (Hsiao and Stapleton, 2004) and permission to include the published
data in this dissertation has been obtained from the publisher (Appendix F).

Global Transcript Profiling Using the Microarray Approach to Identify
Cadmium Responsive Genes

The next phase of this project is to determine whether or not cells can
sense and increase potential protection mechanisms under low dose/short times
of Cd exposure. In order to do so, we must first identify genes that are sensitive
to the early presense of Cd before we can dissect the potentially diverse
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molecular activities engaged in by these genes. The results in the previous
section show that with 3 hrs of exposure cellular changes are occurring, thus this
presents a promising condition to use for global transcript profiling of possible
protective responses. Previous studies carried out in our laboratory also
established that incubation of primary hepatocytes with 4 pM Cd for 3 hrs yielded
no significant increase in the typically measured cytotoxic parameters, lipid
peroxidation and LDH leakage. Additionally, no decrease in GSH, the liver’s
natural antioxidant, could be measured. However, to be extremely cautious, a
series of pilot experiments examining gene expression changes for a number of
different molecular events under various times of Cd exposure were conducted
by quantitative real time polymerase chain reaction (qRT-PCR). Analysis of the
results aided our final choice of exposure time for microarry global transcript
profiling.
The first series of pilot experiments were carried out to investigate the
expression of classical antioxidant genes (CuZn-SOD, CAT, GPx) under either 4
pM Cd for 1, 3 or 6 hrs or 1 pM Cd for 1, 3, 6, 12 or 24 hrs (data not shown). To
our surprise, the gene expression pattern of these classical antioxidant genes did
not show significant changes upon Cd exposure at any of the time points studied.
It is possible that these classical antioxidant enzymes could participate in cellular
activities without transcriptional regulation or that Cd temporary interferes with
their structure or activity which does not result in sequential gene activation.
While we did not measure the activity of these antioxidant enzymes, there are
reports to substantiate that Cd can impair the cellular antioxidant defense system
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due to the disturbance in antioxidant enzyme activity (Casalino et al., 2002;
Waisberg et al., 2003). In a study to investigate the acute exposure of Cdinduced oxidative stress after 4 to 8 hrs, the activities of catalase and glutathione
reductase were shown to be reduced while the activity of superoxide dismutase
(SOD) and glutathione peroxidase initially decreased at 4 hrs but then increased
at 8 hrs (Ikediobi et al., 2004). Another study shows that Cd interacts with
catalase at Histidine-74, which is essential for its catalytic activity to decompose
hydrogen peroxide into water and oxygen. Cd inhibition of mitrochoidrial Mn-SOD
takes place as early as 6 hrs and is reversed by incubating the mitochondrial with
Cd plus Mn2+, suggesting that cadmium displaces the manganese. Intriguingly,
the activity of the cytosolic CuZn-SOD decreases at 24 hrs and recovers at 48
hrs. The authors speculate that this transient perturbation of activity is due to a
temporary conformational change induced by Cd (Casalino et al., 2002).
In our primary hepatocyte in culture model, since no change was observed
with these classical antioxidant genes, another series of pilot experiments were
conducted using genes potentially sensitive to Cd-induced stress. These genes
and associated molecular activities included MT-1 and HO-1 involved in
detoxification

and

an

antioxidant

response

respectively,

another

AP-1

transcription factor member fos-like antigen 1 (fosll) involved in transcriptional
regulation, and ubiquitin B (ubB) involved in protein degradation. The expression
of these genes changed when treated with 4 pM Cd for 1, 3 or 6 hrs as measured
by qRT-PCR. Results are provided in the following table (Table 3).
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Table 3
Relative change in gene expression of HO-1, MT-1 and ubB
Fold Change
HO-1
MT-1
ubB

NA
1
1
1

1hr
15.03 ± 1.48 (#)
34.64 ±9.11 (#)
1.31 ±0.14

3hr
99.41 ±21.56 (#)
14.00 ±7.03
3.61 ± 0.48 (#)

6hr
127.29 ±42.28
5.25 ± 4.43
4.40 ± 0.43 (#)

These pilot experiments were performed by using the standard curve method for
relative change and quantlifation of the amount of RNA presented in real time
without normalization to a reference gene. (#) indiciates a significant difference
compared to control (NA) by Student t-test (n=4).

The results from these additional pilot experiments using qRT-PCR as well
as our earlier studies confirmed that 3 hrs is the earliest and the best time point
to see an array of potential changes upon Cd exposure without damage to the
cell. Thus, with confidence we moved on to global profiling to investigate the
changes of gene expression using Affymetrix Rat RAE 230A arrarys which
presents 15,923 genes and expression sequences tag (EST) on each individual
chip. Four independent experiments using primary rat hepatocytes isolated from
different animals were conducted. RNA was isolated and the quality control steps
for microarray experiments were carried out according to the manufacture’s
instruction (result shown in Appendix B). Following robust data analysis as
indicated in materials and methods, 109 genes + ESTs were found to be
significantly up-regulated and 33 genes + ESTs were found to be significantly
down-regulated in response to Cd exposure. These genes are clustered
according to functional groups and summarized in Table 4. Additional information
regarding quality control for the microarry experiments is provided in Appendix

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

71
B1, B2 and B3. Changes in target genes from different categories (Egr1, Atf3,
FosH and Zfp36 for transcriptional regulation, HO-1, Gclm and TrxR for
antioxidant response; HSP70 and HSP40 for protein integrity control) were
further verified by qRT-PCR (Figure 11). The majority of the genes found to have
significant changes in expression in response to Cd exposure are for proteins
involved in transcriptional regulation and/or binding activities (protein-protein,
protein-nucleic acids and ions binding).

Table 4
List of genes that were significantly regulated by CdCI2 using microarray global
transcript profiling approach

4A. Summary chart by functional category for the up-regulated genes (presented
as functional group, number of genes, and percentage of total genes)

Signaling, 10 (9%)
Uncharacterized, 23
(21%)

Transcriptional
Regulation, 30 (27%)
Cellular
Physiological
Response, 17 (16%)

Antioxidant
Response and
Metabolism,

Protein Integrity
Control, 18 (17%)

11 (10%)
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4B. Genes significantly regulated by CdCl2
Gene Bank/
Gene
Accession No. Symbol
(1) Regulation of Transcription
Transcription factor
NM_012551
Egr1
NM 012912
Atf3
BF415939
Fos
NM 012953
Fosll
NM 021835
Jun
NM 021836
Junb
Mafg
AB050011
BI284461

Mafk

AW917124
Gtf2h1 predicted
Tcf8
BM391853
Transcriptional regulation
NM_024388
Nr4a1
NM 031642
KlfB
Ccnll
NM 053662
BE113667
Hmgn2
BE 118720
Jmjd3_predicted
BE102096
Jm jdlc
BE098745
Ctdp1_predicted
BG374299
Cpeb4_predicted
BE107459
Tardbp
AB020967
Trib3
BI290979
Sfrs10
NM 021754
Nol5
Zinc finger proteins
AI406908
Zfand2a
AW529183
Zbtb2 predicted
AB025017
Zfp36
Al 172425
Zfp216_predicted
AA892238
Chordc1_predicted
AI009613
Bl303933
BE120443

Zfp655
Zswim6
Prdm2

Gene
Description

Fold
Change

early growth response 1
activating transcription factor 3
FBJ murine osteosarcoma viral oncogene homolog
fos-like antigen 1
Jun oncogene
Jun-B oncogene
v-maf musculoaponeurotic fibrosarcoma oncogene
family, protein G
v-maf musculoaponeurotic fibrosarcoma oncogene
family, protein K
general transcription factor II H, polypeptide 1
transcription factor 8
nuclear receptor subfamily 4, group A, member 1
Kruppel-like factor 6
cyclin L1
high mobility group nucleosomal binding domain 2
jumonji domain containing 3
jumonji domain containing 1C
CTD (carboxy-terminal domain, RNA polymerase II,
polypeptide A) phosphatase, subunit 1
cytoplasmic polyadenylation element binding protein 4
TAR DNA binding protein
tribbles homolog 3
splicing factor, arginine/serine-rich 10
nucleolar protein 5
zinc finger, AN 1-type domain 2A
zinc finger and BTB domain containing 2 (predicted)
zinc finger protein 36
zinc finger protein 216
cysteine and histidine-rich domain (CHORD)containing, zinc-binding protein 1
zinc finger protein 655
zinc finger, SWIM domain containing 6
PR domain containing 2, with ZNF domain

50.5
14.0
7.9
6.4
4.3
2.6
3.4
2.4
2.3
2.0
4.1
3.6
3.5
2.7
2.6
1.7
2.4
2.3
2.1
2.0
1.6
1.6
15.4
6.4
4.1
3.0
2.8
2.1
2.9
2.3

(2) Antioxidant Response and Metabolism
NM 012580
Hmoxl (HO-1)
heme oxygenase (decycling) 1
Homerl
AB003726
homer homolog 1
BI301532
RGD1563902_predicted similar to Ferritin light chain (Ferritin L subunit)
Al 172302
Srxnl
sulfiredoxin 1 homolog
NM 031614
Txnrdl (TrxR)
thioredoxin reductase 1
Gclm
NM 017305
glutamate cysteine ligase, modifier subunit
BI284218
Slc2a1
solute carrier family 2, member 1
AM 77358
Slc25a25
solute carrier family 25, member 25
AM 70665
C h a d predicted
ChaC, cation transport regulator-like 1
NM 022392
LOC683385/LOC688922I similar to insulin-induced gene 1 protein (Insigl)
BM390399
Hmgcr
3-hydroxy-3-methylglutaryl-Coenzyme A reductase

29.7
5.5
2.1
2.5
1.9
2.0
2.3
7.4
3.6
2.4
2.2

(3) Heat Shock Protein
BI278231
Hspalb

59.5

heat shock 70kD protein 1B
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NM 031971
BM384926
AM 04324
NM 022934
NM 012699
AI236601
BG671521
NM 031970
NM_012935

Hspa1a/Hspa1b
Dnajbl predicted
Dnaja4/LOC498996
Dnajal
Dnajb9
Hsphl
Hspca
Hspbl
Cryab

(4) Ubiquitin and Degradation
BI289529
Fbxo30
BM388946
Wsb1
AI712911
Peli1/RGD1564594
AM 70410
MGC95208
AI235912
NM 017314
AM 75452
BM392295

Ubc
March7
Rnf12

heat shock 70kD protein 1A/1 B
DnaJ (Hsp40) homolog, subfamily B, member 1
DnaJ (Hsp40) homolog, subfamily A, member 4
DnaJ (Hsp40) homolog, subfamily A, member 1
DnaJ (Hsp40) homolog, subfamily B, member 9
heat shock 105kDa/110kDa protein 1
heat shock protein 1, alpha (Hsp86/90)
heat shock 27kDa protein 1
crystallin, alpha B

40.6
23.1
6.2
3.3
2.0
7.7
1.8
3.3
2.7

F-box protein 30
WD repeat and SOCS box-containing 1
similar to pellino protein (predicted)
similar to 4930453N24Rik protein
involved in ubiquitin-dependent protein catabolism;
ubiquitin-thiolesterase activity
ubiquitin C
Membrane-associated ring finger (C3HC4) 7
ring finger protein 12

(5) Signaling (Receptor/Phosphatase/Kinase)
Errfil
Al 169756
ERBB receptor feedback inhibitor 1 (mitogen-inducible
gene 6 protein homolog)
Al602491
Epha2_predicted
Eph receptor A2 (predicted)
Al 172313
Rapgef6_predicted
Rap guanine nucleotide exchange factor (GEF) 6
AI409218
Spred2_predicted
similar to Sprouty-related, EVH1 domain containing 2
NM 133578
Dusp5
dual specificity phosphatase 5
NM 022951
Ppp1r10
protein phosphatase 1, regulatory subunit 10
Clk1
Al 177513
CDC-like kinase 1
Clk4
BF404428
CDC-like kinase 4
PVR
Al548856
poliovirus receptor
BI303379
T nfrsf 12a
tumor necrosis factor receptor superfamily, member12a
(6) Cellular Physiological Response
Stress and inflammation response
Ier2
BF420059
immediate early response 2
AW251534
RGD1303142
oxidative stress responsive gene
NM 053647
Cxcl2
chemokine (C-X-C motif) ligand 2
D87927
Gm1960
gene model 1960
NM 019242
Ifrd 1
interferon-related developmental regulator 1
NM 057138
Cflar
CASP8 and FADD-like apoptosis regulator
Al 100783
LOC687118
similar to death effector domain-containing DNA
binding protein 2
NM 024127
Gadd45a
growth arrest and DNA-damage-inducible 45 alpha
Al599423
Gadd45g
growth arrest and DNA-damage-inducible 45 gamma
Promoting survival and growth response
Gdf15
NM 019216
growth differentiation factor 15
BI284349
Myd116
myeloid differentiation primary response gene 116
Adm
NM 012715
adrenomedullin
AA799330
Pelo
pelota homolog
Azi2
AM 77093
5-azacytidine induced gene 2
AI231792
Bag3
Bcl2-associated athanogene 3
Okl38
AY081218
pregnancy-induced growth inhibitor
BI286041
Bcar3_predicted
breast cancer anti-estrogen resistance 3
(7) Uncharacterized/Miscellaneous
BI275261
RGD1561927_predicted similar to Ab2-143
BE096387
LOC288526
similar to DNA segment on chromosome X and Y

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

3.4
2.3
3.7
2.7
4.0
1.8
1.7
1.6

2.5
2.0
2.1
1.6
2.9
3.4
2.4
1.8
2.1
1.7

4.9
2.2
2.4
2.4
2.2
3.8
3.0
2.0
3.0
7.6
3.5
8.5
1.9
3.1
7.5
3.3
2.4

18.1
3.6
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BG671589
Al013468
BM389685
AI599284
Al 168986
AI230318
AI408713
AJ225654
AA860044
AH 78043
AW917092
AI409983

Cdr2
RGD1560454_predicted
RGD1565927_predicted
RGD1305572
LOC360807
Tmem39a
Impact
RGD1559728_predicted
LOC498404
Kbtbd2_predicted
Bxdc2
LOC680485/LOC684012

(unique) 155 expressed sequence isoform 1
cerebellar degeneration-related 2
similar to RIKEN cDNA 5830435K17
similar to 4631422O05Rik protein
similar to hypothetical protein MGC30618
LOC36807
transmembrane protein 39a
imprinted and ancient
hypothetical protein XP_580217
similar to cDNA sequence BC018601
Kelch repeat and BTB (POZ) domaincontaining 2
brix domain containing 2
hypothetical protein LOC680485/LOC684012

2.9
2.8
2.7
2.3
2.2
2.2
2.0
1.9
1.9
1.7
1.7
1.6

Down-Regulated Gene by Cd
BM384301
BI299621
AI408443
BE114972
BF386742
BF402385
AA848306
AW672589
M64780
NM 053322
M60103
BF282174
NM 012743
BE113111
BM385463
BM391283
BF285187
AH77866
AI410301
AI556235
AA943740
BF284058
BE117126
AI012869

Pola2
Igf2r
Psrc2
Rnpc2
Catnal
Magee1_predicited
H n rpa2b 1_predicted
Nfkbia

Polymerase (DNA directed), alpha 2
-9.0
Insulin-like growth factor 2 receptor
-5.4
proline/serine-rich coiled-coil 2
-4.0
RNA-binding region (RNP1, RRM) containing 2
-3.1
Catenin (cadherin-associated protein), alpha 1
-3.0
melanoma antigen, family E, 1
-2.7
heterogeneous nuclear ribonucleoprotein A2/B1
-2.6
nuclear factor of kappa light chain gene enhancer in -2.5
B-cells inhibitor, alpha (NF-kB inhibitor alpha/lkB alpha)
Agrn
agrin
-2.3
nuclear pore membrane glycoprotein 210
-2.1
Pom210
Ptprf
protein tyrosine phosphatase, receptor type, F
-1.9
Kif16b_predicted
Kinesin family member 16B
-1.9
Foxa2
forkhead box A2
-1.8
LOC680451/LOC684607 similar to nuclear receptor binding protein
-1.7
Tmem43
transmembrane protein 43
-1.7
Etnk1_predicted
Ethanolamine kinase 1
-1.7
immediate early response 5
-1.5
Ier5
LOC362264
similar to dJ862K6.2.2 (splicing factor, arginine/
-1.6
serine-rich 6 (SRP55-2) (isoform2))
RGD1307981_predicted similar to cisplatin resistance-associated overexpressed -1.8
protein
RGD1310061
similar to hypothetical protein FLJ10154
-1.8
RGD1564263 predicted similar to Opa-interacting protein 5
-1.9
RGD1310553
similar to expressed sequence AI597479
-1.9
RGD1309105 predicted similar to RIKEN cDNA 2310005N03 gene
-3.7
LOC310926
similar to RIKEN cDNA 4833436C18 gene
-8.1

Abbreviations in the order they appear in Figure 11:
(1) HO-1 (HmoxD: heme oxygenase 1, Eqr1: early growth response 1, and
HSP70 (Hspala): heat shock protein 70
(2) Atf3: activating transcription factor 3, Fosl1: fols-like antigen 1, and Zfp36:
zinc finger protein 36
(3) HSP40 (DnaiaP: heat shock protein 40, Gclm: glutamate cysteine ligase,
modifier subunit, and TrxR (TxnrdD: thioredoxin reductase 1
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Figure 11. Validation of CdCI2-induced gene expression in microarray data by
qRT-PCR.
Primary rat hepatocytes were treated with 4pM Cd for 3h. The data is presented
as the fold change induced by Cd compared to control/no addition (NA sets to be
1, not shown). Both microarray and qRT-PCR data show significant increased
response to Cd (n=4). qRT-PCR statistical analysis were performed using REST
program described in materials and methods.
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Transcriptional Regulation

A substantial number of transcripts identified as significantly increased
encode for proteins involved in transcriptional regulation, including a host of
transcription factors, transcription assisting proteins and zinc finger proteins. In
this group, we observed some large fold increases such as for Egr1 (known as
Zif268, 50 fold), Atf3 (known as liver regenerating factor, 14 fold), Fos (8 fold)
and Zfand2a (15 fold). Several of the fold changes in this group (Egr1, Atf3,
FosM and Zfp36) were verified by qRT-PCR (Figure 11). Interestingly, many of
these transcription factors are categorized as immediate early genes and/or
belong to the basic-region leucine zipper (bZIP) family (Egr1, Jun, Junb, Fos,
FosM, Atf3, Mafg and Mafk). Generally this group of proteins have been found to
be up-regulated under numerous stress inducing conditions such as exposure to
UV light, H2 O2 or metals (e.g. Pb, Fe, Cd) under both acute or chronic exposure
(Fan et al., 2002; Frippiat et al., 2002; Garrett et al., 2002; Katsuoka, et al., 2005;
Liu et al., 2006). As a result of their up-regulation, the expression of other genes
involved in either growth regulation, differentiation, transformation, inflammation,
antioxidant protection or cell death are also modulated in either a positive or
negative fashion depending on what they associate with or bind. For example,
evidence suggests that the Atf3 homodimer is a transcription repressor (Chen et
al., 1994; Fan et al., 2002) where the Atf3 heterodimer with other bZIP members
can serve as a transcription activator (Allan et al., 2001; Hai et al., 1999). More
intriguingly, it is reported that classical AP-1 members (Fos, FosM, Jun, Junb and
Atf3 all upregulated in our data) can not only interact with each other to form an

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

77
active dimer of the AP-1 transcription factor but also can dimerize with other bZIP
transcription factors including NF-E2 (Nrf2) and small Mafs (Mafg 3.4 fold; Mafk
2.4 fold), thereby influencing the activation and/or regulation of a broad range of
antioxidant genes and phase II detoxifying enzymes (Katsuoka et al., 2005;
Motohashi et al., 2002; Rahman, 2005; Sakurai et al., 2005; Sun et al., 2004).
Remember in our first study we also found AP-1 activated at this time point by Cd
and that some of the anomalies in the inhibitor data may have been due to
different family members contributing to this dimer. These data suggest a broad
range of family members expressed at this time.
Work done by Alam et al. (2003) has shown that treating rat renal
epithelial cells with 10 pM Heme for 3 hrs increases the DNA binding activity of
the following transcription factors (Nrf2, Mafg, Atf3, Fos and Jun) that turn on
HO-1 gene expression. Furthermore, the same laboratory has also shown that
treatment of mouse hepatoma cells with 50 pM Cd for various times (0-6 hrs)
increases HO-1 gene expression through Nrf2 activity. The Nrf2 activity is
increased post-translationally by increasing its half-life and stability, without any
significant induction of Nrf2 mRNA level (Stewart et al., 2003). Similarly we found
induction of several bZIP transcription factors and HO-1, but not Nrf2, in our
microarray data. Future studies are needed to investigate potential interaction
among these AP-1/bZIP members and small Mafs under Cd exposure.
Another major group of genes that we observed upregulated in response
to Cd includes the Zinc finger proteins and

proteins associated with

transcriptional regulation. Zinc finger proteins (Zfps) are evolutionary conserved
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among species and a general function of this family is involved in nucleic acid
binding and/or protein-protein/protein-DNA interaction. While the specific function
of individual Zfps are not thoroughly characterized, a well recognized function lies
in transcriptional regulation. Zfp36 (known as tristetraprolin) was upregulated
approximately 4 fold and controls, for example, gene expression by promoting
degradation of TNFa mRNA and by decreasing the secretion of the protein in a
bone marrow derived macrophage model (Blackshear, 2002; Carballo et al.,
1998). Proteins such as those in the jumonji family (Jmjdlc upregulated
approximately 2 fold) are recognized as transcriptional repressors involved in
transcription and chromatin regulation (Takeuchi et al., 2006; Toyoda et al.,
2000). We also observed increases in genes whose gene products are involved
in rRNA modification (Nucleolar protein 5/Nol5 approximately 2 fold) and RNA
splicing (Cyclin L1/Ccnl1 with 3.5 fold; splicing factor, arginine/serine-rich
10/Sfrs10 with 1.6 fold). Several of the genes we observe to be upregulated,
such as Sfrs10, have been shown to be upregulated by ROS (Matsuo etal., 1995)
or other stress inducing conditions. For example, the nuclear receptor subfamily
4, group A, member 1 (Nr4a1) that is induced under liver regeneration (White et
al., 2005) and the Kruppel-like factor 6 (Klf6, known as core promoter elementbinding protein) that is activated under acute hepatic injury (Ratziu et al., 1998)
are also induced by Cd in our model. Thus it is interesting to find that these
stress sensitive genes involved in transcriptional regulation are also up-regulated
under low concentration and early exposure time of Cd when no apparent
damage to the cell can be detected.
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Antioxidant Regulation

Another significant number of genes associated with a common function
that are induced by Cd include those involved in antioxidant regulation however,
not those that are considered classical antioxidant genes for proteins such as
SOD or catalase. Hmoxl (heme oxygenase 1/HO-1), a rate limiting enzyme in
heme degradation, was induced approximately 30 fold and verified by qRT-PCR
(Figure 11). HO-1/Hmoxl is the inducible form of the family and its induction has
been shown to protect cells against a diversity of stresses such as exposure to
UV and ROS, as well as toxic chemicals including heavy metals under either
acute or chronic conditions (Alam et al., 2003; Carmel et al., 2004; Farombi and
Surh, 2006; Numazawa etal., 1997; Suzuki et al., 2003). Interestingly this protein
is known to be regulated by the small Maf proteins and Atf3 (possibly other AP-1
members too) which we also observe to be up-regulated. Furthermore, another
gene product, RGD1563902 that is similar to Ferritin light chain, likely is activated
to sequester and store free iron inside a cell due to the fact that either Cd
potentially displaces iron or another gene induced under our conditions, HO-1,
catabolizes the degradation of heme and thereby releases iron. Thus, it is
attractive to speculate that the upregulation of Hmoxl/HO-1 and subsequent
derivatives of heme degradation, such as carbon monoxide, biliverdin/bilirubin
and ferritin, with their recognized roles in antioxidant response and cytoprotection,
are to provide another degree of protection against future Cd insult.
Since glutathione plays a critical role in the antioxidant defense
mechanism of a cell, in particular in liver, it makes sense that we also observe a
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host of genes up-regulated by Cd that are involved in the synthesis of GSH,
suggesting that this battery of enzymes is involved in sensing the potential
disturbance of the redox state or the change in concentration of reduced
sulfhydryls. A regulatory modifying light subunit (Gclm) of glutamylcysteine ligase
(GCL, formerly called y-glutamylcysteine synthetase) is required for holoenzyme
activity (Lee et al., 2006) and GCL is also the rate limiting enzyme of GSH
synthesis. Our results show Gclm is significantly increased by 2 fold and this was
further verified by qRT-PCR (Figure 11). Additionally, the expression of Homerl
(5.5 fold), a protein involved in the glutamate receptor pathway, and proteins in
the solute carrier family (Slc2a1 2.3 fold; Slc25a25 7.4 fold) are also up-regulated.
These proteins have been shown to be involved in transporting metabolites
including GSH (Lee et al., 2003). Given these results, it is attractive to speculate
that regulation of GSH concentration in the cell is an important first step in the
response to the potential damaging effects of Cd. There is literature that also
supports this notion including our previous findings (Rikans and Yamano, 2000;
Xu et al., 2003).
In this same regard, other proteins involved in redox homeostasis through
participation in reducing thiols are also induced. Sulfiredoxin (Srxn, 2.5 fold) and
thioredoxin reductase (TrxR/Txnrd1, 1.9 fold; verified by qRT-PCR in Figure 11)
participate in reducing disulfide bonds and oxidized sulfers within proteins.
Thioredoxin (Trx) can easily reduce an oxidized cysteine residue (R-SOH) of a
protein back to its reduced form (R-SH) and TrxR helps reduce oxidized Trx
disulfides. Further oxidation of cysteine residues as sulfenic acid (R-SOH) will
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generate sulfinic acid (R-S02H), which was thought to be an irreversible step
until the recent discovery of Srxn (Findlay et al., 2005; Rhee et al., 2005). In
addition, Srxn is suggested to participate in reducing glutathionylated proteins
(Findlay et al., 2006). Therefore two distinct but intimately linked major redox
antioxidant systems, thioredoxin (red-Trx/oxi-Trx) and glutathione (2GSH/GSSG)
are induced under our experimental condition and may jointly play a critical role
in sensing the presence of Cd.

Protein Integrity Control

Heat shock proteins are another important group of molecules that aid in
cellular protection. They can function as chaperone proteins to prevent
aggregation, as well as maintain the integrity of de novo synthesized proteins by
assisting in their proper folding. Our results show HSP70 gene expression
increases substantially (HSP70 1B with 60 fold; HSP70 1A/1B with 41 fold; the
latter was verified by qRT-PCR in Figure 11) in the presence of Cd. Although
increases in HSP70 expression are well established under stress inducing
conditions (Salminen et al., 1996; Somji et al., 1999; Souza et al., 2004), our
result also suggests that under short term of Cd incubation when no increases in
cytotoxic parameters are measurable, the cell senses potential insults and
responds to it through the induction of an array of HSP family members. Under
this early Cd incubation in addition to HSP70, there are several HSP40 (known
as DnaJ in Yeast) family members increased. Two type l/subfamily A of HSP40s
which have a unique zinc finger binding domain (Banecki et al., 1996; Fan et al.,
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2003), Dnaja4 (6.2 fold) and Dnajal (3.3 fold; verified by qRT-PCR in Figure 11),
are increased. Changes in the redox environment and/or increased ROS may, in
part, play a role to increase the expression of HSP70 and HSP40 upon Cd
exposure. Work done by Kim et al. (2005) has shown that arsenic increased
HSP70 expression through the generation of ROS whereas the antioxidant NAC
was able to reverse this induction of HSP70. Another study demonstrated that
the activity of human DnaJ homolog Hdj2 (HSP40), that also contains a cysteinerich zinc finger domain like our Dnajal (HSP40), was influenced by changes in
the redox state of the cell (Choi et al., 2006). Moreover, the transcripts of two
small HSPs (Hspb1/HSP27 and Cryab) and two large HSPs (hsph1/HSP105/110
and hspca/HSP86/90) were also increased in our experiments. It is tempting to
speculate that these gene products work in conjunction with the HSP40/HSP70
system to monitor protein quality and enhance protective capacity of a cell.
Besides the well established interactions of HSP90 with HSP70, HSP110 has
also been shown to interact with and to assist HSP70 for both de novo protein
folding and stress-denatured protein refolding (Dragovic et al., 2006). HSP27,
HSP70 and HSP90 all have also been suggested to interfere with key effectors of
the apoptosis pathways to initiate anti-apoptosis mechanisms (Beere, 2005; Paul
et al., 2002), which correlate to the early sensing and protective pathways
suggested in our model. Additionally aB-crystallin (Cryab), HSP27, HSP70 and
HSP90 are believed to be connected to protein degradation through the ubiquitinproteasome machinery (Imai et al., 2003; Parcellier et al., 2003), providing
another degree of protection to maintain cellular homeostasis.
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Recent reports have linked the chaperone and ubiquitin-proteasome
machinery (Esser et al., 2004). Under normal conditions it is estimated that
approximately 30% of newly synthesized proteins are undergoing degradation
(Goldberg, 2003). However, under stressful or oxidative challenge, oxidized
proteins are degraded more rapidly. Interestingly, a group of genes, whose
products likely will participate in the ubiquitin-proteasome machinery, were also
shown to be increased in our study. The ubiquitin system contains three
cascades, E1 ubiquitin-activating enzymes, E2 ubiquitin-conjugating enzymes
and E3 ubiqutin-ligase enzymes, in a hierarchical order with a complex cross-talk
network. In most eukaryotes, there is only one E1 with a limited number of E2s
(about 60 in mammals) and a much larger number of E3s that can be further
divided into 2 classes: HECT domain type and RING-finger domain type (Gao
and Karin, 2005). The ring-finger type E3 is of interest due to the fact that many
ring fingers also contain a zinc finger structure. Recent work done by
Schauvliege et al. (2006) has shown that pellino protein with a RING-like motif
(pelil, 3.7 fold in ours) functions as an E3 enzyme participating in the process of
polyubiquitination of target proteins. We also observed an increase in one
transcript (ID: AI235912, 4.0 fold) that has ubiquitin thiolesterase activity and can
potentially serve as an E1 enzyme and another gene, the Ubc (approximately 2
fold), has been recognized as E2 enzyme (Zhen et al., 1993). Furthermore, there
are several potential E3 enzymes (Fbxo30, Wsb1, Pelil, March7, Rnf12)
upregulated approximately 2-4 fold in our study. In addition to the above
observations, emerging evidence has suggested that ubiquitin participates in
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non-proteolytic signaling and regulates diverse cellular activities besides working
in conjunction with the HSP system (Welchman et al., 2005; Wolf and Hilt, 2004).
It is attractive to propose that at this early stage of Cd exposure with no
significant sign of cellular damage, the ubiquitin system serves to selectively
target proteins in an attempt to protect the cell from later insult.

Cellular Physiological Responses

One unexpected set of genes upregulated fell into the category of
stress/inflammation response and the responses promoting cell survival with
growth/proliferation/cell cycle/apoptosis regulations, revealing a strong attempt
by a cell to protect itself against Cd even with no sign of cellular damage
occurring. We observed an array of gene transcripts whose products can
potentially participate in inflammatory regulation as a beneficial response. The
cytokine receptors such as poliovirus receptor (PVR, 2.1 fold) and tumor necrosis
factor receptors superfamily member 12a (Tnfrsf12a, 1.7 fold), as well as the
cytokine/chemokine regulators such as chemokine ligand 2 (Cxcl2, 2.4 fold),
gene model 1960 (Gm1960, 2.4 fold) and interferon-related developmental
regulator 1 (Ifrdl, 2.2 fold) are likely transmitting pro-inflammatory signals to
downstream regulators in order to promote survival and growth response. Indeed,
recent studies have revealed that the activation of several genes that we
observed

has

been

associated

with

stress or inflammatory conditions.

Adrenomedullin (Adm, 8.5 fold), a promising upstream regulator involving
proliferation and anti-apoptosis, has been reported to provide protection in
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response to wounding, cardiac damage, renal damage and inflammation (Uzan
et al., 2006). Growth differentiation factor 15 (Gdf15, 7.6 fold) has been reported
to have cytokine and growth factor activity and is activated under various toxic
chemical insults (Hsiao et al., 2000; Zimmers et al., 2005). It is highly possible
that both Adm and Gdf15 are activated and synchronized with pro-inflammation
responses to assist in protection against Cd.
Intriguingly, a few genes associated with the death receptor which is
intimately associated with tumor necrosis factor (TNF)/inflammation signaling
cascades for diverse cellular processes, including inflammation, survival and
death, are also upregulated in our data. We observed that the CASP8 and
FADD-like apoptosis regulator (cflar, 3.8 fold) and the LOC687118 (similar to
death effector domain-containing DNA binding protein 2, 3.0 fold) may potentially
work with tumor necrosis factor receptors (Tnfrsf12a, described above) and drive
cellular processes toward cell survival under this early sensing and low dose of
Cd exposure. Because these genes sit in the very beginning of signaling
cascades, their gene products influence cellular decisions regarding protection or
damage and this is dependent on what downstream regulators participate at any
given moment. Only when the oxidative challenge and accumulated stress
overwhelms the cellular protection capacity, especially under acute or chronic
exposure, will genes participating in death signaling cascade lead to cell death
and damage (Galun and Axelrod, 2002; Wullaert et al., 2006). Other evidence to
support this notion of an early protective response comes from the increased
expression of Bcl-2 associated athanogene 3 (Bag3, 7.5 fold) with its anti-
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apoptosis role. Bag3 has been shown to interact with HSP70 and provide an antiapoptosis response under Cd, Zn and heat shock exposure (Pagliuca et al.,
2003). Interestingly, two growth promoting genes Adm and Gdf15 induced under
our condition have been suggested to have anti-apoptosis properties in response
to chemicals and stress (Uzan et al., 2006). It is also interesting to observe that
the potent cell cycle check point genes like the growth arrest and DNA damageinducible 45 genes (Gadd45a, 2 fold; Gadd45g, 3 fold) were activated to sense a
disturbance by Cd and provide another degree of protection. A recent paper has
shown that in myeloid cells under UV exposure, Gadd45a and Gadd45b work in
concert to protect a cell (Gupta et al., 2006). In that study, Gadd45a promotes
survival through activation of p38MAPK-NFkB pathway while Gadd45b reduces
apoptosis through inhibition of MKK4-JNK pathway. It is attractive to speculate
that these genes were upregulated by Cd to also promote cell survival.

Down-Regulated Genes

Surprisingly at this early time of exposure to Cd, we did not find a lot of
significantly down-regulated gene transcripts. With a limited number of affected
genes it is hard to group them into a comprehensive picture, yet we will draw out
three interesting observations with respect to those down-regulated (1) the
cytoskeleton related genes, (2) NFkB inhibitor (Nfkbia), and (3) forkhead box A2
(Foxa2). First, we observed a few down-regulated genes that are linked to
maintaining structural integrity such as catenin alphal (Catnal, -3.0 fold) for actin
filament binding, agrin (Arg, -2.3 fold) for cytoskeleton structure and nuclear pore
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membrane glycoprotein 210 (Pom210, -2.1 fold) for nuclear pore structure. It is
possible that Cd, a non-essential toxic metal, interferes with cellular integrity in
this early time. A study done by Zimmerhackl et al. (1998) has shown that, under
higher concentration and a longer exposure time, compared to our study, Cd
caused ATP depletion and interfered with the cadherin-catenin complex in renal
cells. Evidence from another study also suggests that under ATP depletion, the
association of HSP27 with F-actin was observed to provide protection by
preventing actin disruption (Van Why et al., 2003). While most of the studies
focus on investigating cytoskeleton disruptions under toxic or injury conditions,
our study on low dose and short exposure time of Cd provides new insights. It is
highly feasible that the initial disturbance of cytoskeleton structure serves as a
sensor to influence molecular activities and recruit protective regulators such as
small heat shock proteins like HSP27/Hspb1 and aB-crystallin/Cryab which we
also found to increase in expression.
Secondly, while we did not observe an increase in the expression of NFkB,
a multifunctional transcription factor that participates in stress and inflammatory
responses, we did observe the decreased expression of NFkB inhibitor alpha
(Nfkbia/lkba, -2.5 fold; that encodes for IkB), which binds NFkB and retains the
inactive complex in the cytoplasm. The down-regulation of Nfkbia may increase
the translocation of active functional NFkB into the nucleus to allow it to
participate in target gene transcription in response to early Cd exposure. Lastly,
the decreased expression of forkhead box A2 (Foxa2, -1.8 fold), one family
member among the subfamily A in the forkhead transcription factor superfamily
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(over 100 Fox genes have been identified), is also of interest. Foxa2 is highly
expressed in the liver and is also known as hepatocyte nuclear factor 3 beta
(HNF3(3). It plays a potent role in both transcription regulation for liver
development (Mizuguchi et at., 1998) and in metabolism as a coactivator for
many genes especially those in regulation of glucose and lipid homeostasis such
as insulin-like growth factor-binding protein (IGFBP) and phosphoenolpyruvate
carboxykinase (PEPCK) (Friedman and Kaestner, 2006). A study done by
O'Brien et at. (1995) has shown Foxa2/HNF3|3 is an accessory factor required to
facilitate the transcriptional regulation of insulin-like growth factor-binding protein
1 (IGFBP-1) and PEPCK. The down-regulation of both Foxa2 and insulin-like
growth factor 2 receptor (Igf2r, -5.4 fold), that we observe, may imply a potential
disturbance in energy metabolism similarly to the studies described above and
that Cd eventually can cause ATP depletion and disrupt cytoskeleton structure if
exposure is long enough.

Further Investigation of Gene Expression under Changes in Redox State

Identifying responsive genes under the initial stages of Cd exposure by a
global transcript profiling approach provided us with insight into the early
physiological responses of the cell that allow us to further explore the potential
mechanisms involved. Various reports on the mechanism(s) behind the induction
of toxicity or damage by Cd to a cell suggest that either generation of ROS or the
ability of the metals to deplete sulfhydryls play critical roles in a cell’s response.
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Thus, we investigated the role of these potential mechanisms of toxicity in the
early Cd physiological responses by providing antioxidants (NAC) to reduce free
radicials and possible oxidative stress and also by depleting GSH, a major
sulfhydryl containing molecule, by using BSO to block GSH synthesis. The
experimental design utilized is summarized in Table 5, the results are presented
in Figure 12-14, and the additional information regarding quality control for qRTPCR experiments is provided in Appendix C1, C2 and C3.
Besides the nine representative genes from transcription regulation (Egr1,
Atf3, FosM, Zfp36), antioxidant response (HO-1, Gclm, TrxR) and protein
integrity control (HSP70, HSP40) shown on our microarry data, we also include
one more important metal detoxifying gene, metallothionein 1 (MT-1), to
investigate potential mechanism. MT-1 is a highly inducible gene under diverse
stress conditions including Cd exposure in various models (Carmel et al., 2004;
Liu et al., 2002; Miles et at., 2000; Wimmer et al., 2005). We were unable to see
a significant MT-1 induction using the global transcript profiling approach
because it did not pass the strict analysis that requires all data from four
individual experiments to have a statistically significant change (the “Increased”
call) under Cd exposure compared to control. In our microarray data, the MT-1
gene (Affymetrix RAE 230A array, probe ID 1371237_a_at; Mt1a) has three
“Increased” calls but one “No Change” call in these four experiments, with an
average of 1.52-fold change. If a lower stringent analysis was utilized and since
MT-1 has been shown to be induced by Cd in other systems, we re-evaluated the
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effect of Cd on MT-1 expression using qRT-PCR and included it in our
experiments to address mechanism.

Table 5
Overview of qRT-PCR experimental design
Results

p rim ary hepatocytes in culture

f

E xp 1A:
Exp 1B:
N
1
NA (control)
NA (control)
4 pM Cd 3hr
4 pM Cd 1 hr
10mM NAC 1h+C d3h,
10m M NAC 1h+Cd1h.
Exp 2:
NA (control)
0.4m M BSO
Q.4mM BSO
0.4m M BSO
1mM BSO

3hr
6hr
12hr
12hr

>=>

HSP:
HSP70
HSP40

A ntioxidan t (N A C ) data: Fig 13

BSO pro-oxidant (GSH depletion) data:
Fig 12, m iddle

Exp 3:
N A (control)
Cd 1 hr
1mM BSO 12hr + Cd 1 hr
1 mM BSO 12 h r + NAC 1 hr + Cd 1 hr

TF:
E gr1, Atf3,
Fosl1, Zfp36

Cd data: Fig 12, top

(BSO + C d) data: Fig 12, bottom
A ntioxidan t (N A C ) data: Fig 14

A ntioxidant:
HO-1, MT-1,
G clm , TrxR

A series of experiments were conducted to investigate the changes of gene
expression of three dominant groups (transcription factors, heat shock proteins
and antioxidant genes) that were sensitive to Cd exposure in our microarray data.
Several reference genes were initially tested and GAPDH was chosen due to the
low variance in all the treatments (in materials and methods). For each
experiment, target genes and GAPDH were performed in the same plate and the
final results were normalized to GAPDH. qRT-PCR statistical analysis were
performed using REST program described in materials and methods.
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Gene Expression in Response to Different Treatments of Cadmium
Exposure. Glutathione Depletion and Antixodiant N-acetvlcysteine
Exposure

In Figure 12 (top) one can see that at both 1 hr and 3 hrs of Cd exposure
the expression of ten selected genes increased significantly except for 1 hr of Cd
on HSP40, Gclm and TrxR. The change in expression over time increases as
one might expect. This suggests that these transcription factors, antioxidant and
metal detoxifying genes are very sensitive to Cd exposure even in low dose
condition. Gclm and TrxR, as the major cellular redox reducing system, and
HSP40, that transports damaged proteins to HSP70 for repair, are probably not
induced as early as they participate under more oxidized condition. Interestingly,
the induction of MT-1 is maximal at 1 hr and decreases at 3 hrs, differing from
other genes compared. This result in part supports the role of MT-1 as a metal
sensor and chelator in the intial stage of Cd exposure. This induction pattern of
MT-1 is also consistent with previous data in the pilot experiments of choosing
the best time point for the global transcript profiling shown in the Table 3.
For the depletion of GSH (Figure 12, middle), BSO treatment at several
different time points was used. The results show that Egr1 and HSP70 were
consistently not affected by BSO suggesting that the expression of Egr1 and
HSP70 are not sensitive to the availability of reduced GSH. Furthermore, if the
concentration of reduced GSH was essential to minimize the physiological
response to Cd in a cell, then BSO depletion should sensitize the cell to the
effect of Cd. To examine this, we used 1mM BSO for 12 hrs with 4 pM Cd for
additional 1 hr incubation (Figure 12, bottom). The results consistently show that
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the HSP group (HSP70 and HSP40) is not sensitive to the changes of GSH
inside the cell. Interestingly the response pattern for Egr1 is very unique. Recall
that it was not affected by depletion of GSH (Figure 12, middle) but under the
BSO + Cd treatment yielded the greatest fold change of all, indicating that GSH
depletion sensitizes it to Cd. Other studies have shown Egr1 to be activated
under various stress conditions (Fratelli et al., 2005) such as Cd exposure (Zhou
et al.,

2004),

partial

hepatectomy (White

et al.,

2005)

and

ischemic

preconditioning (Carmel et al., 2004). Egr1 can be a future candidate to
investigate in particular to understand how cells handle and respond to multiple
stress conditions and to identify potential down stream genes activated by this
immediate early transcription factor. Comparing the results of gene expression in
response to Cd, depletion of GSH by BSO, and BSO + Cd as shown in Figure 12,
we can conclude that HO-1 and FosM are Cd-responsive and GSH-sensitive
genes; Gclm and TrxR are GSH-dependent and affected by Cd at 3 hrs. HSP70,
HSP40, MT-1 and Zfp36 seem only to respond to Cd, not BSO, and therefore not
GSH depedent. Over all our data suggest different mechanisms of induction of
these genes.
If these genes are potentially affected by Cd-induced redox change, if
even only minimally, then providing antioxidants should be able to reduce or
delay the Cd-induced gene expression. Using NAC, as a potent antioxidant and
the most effective one shown in the first part of our data (JNK, c-Jun and AP-1),
we found that the induction of HO-1, HSP70, MT-1 and HSP40 was significantly
reduced under either 1 hr or 3 hrs of Cd addition if NAC was included (Figure 13).
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Very interestingly, the inclusion of NAC increased the gene expression of the
GSH-dependent genes over that observed with Cd alone. It is possible that NAC,
besides serving as a potent antioxidant to reduce free radicials, works differently
for Gclm and TrxR because NAC is also one of the precursors of GSH (Glu-CysGly). When NAC was used on cells where GSH was depleted prior to Cd
exposure, besides HO-1, the induction of three genes in transcription factor
category, Egr1, Atf3 and FosM, was also significantly reduced under the
BSO+Cd condition (Figure 14).
Taken together (Figure 12-14) it appears as though that HO-1, Atf3, Fosl1,
Gclm and TrxR are Cd-responsive and GSH-dependent/senstive genes. HSP70,
HSP40, Zfp36 and MT-1 are Cd-responsive and GSH-independent genes.
Therefore, by manipulating cellular antioxidant systems to increase or reduce the
oxidative stress of a cell, we show the possibility that more than one mechanism
is likely involved in the induction of these genes by Cd.

Abbreviations in order in Figure 12-14:
(1) HO-1 (HmoxD: heme oxygenase 1, Egrl: early growth response 1, HSP70
(Hspala): heat shcok protein 70, and MT-1: metallothionein 1,
(2) Atf3: activating transcription factor 3, FosM: fols-like antigen 1, and Zfp36:
zinc finger protein 36
(3) HSP40 (DnaiaP: heat shock protein 40, Gclm: glutamate cysteine ligase,
modifier subunit, and TrxR (TxnrdP: thioredoxin reductase 1
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Figure 12. Effect of CdCI2 and BSO on gene expression.
All the data in the figures are presented as fold changes compared to the control
(NA sets to be 1, not shown). Top figure represents gene expression after
exposure to 4pM Cd for 1h or 3h, and (#) indicates a significant increase
compared to NA. Middle figure represents gene expression with 0.4mM BSO (3h,
6h, 12h) or 1mM BSO 12h exposure; striped bar indicates a significant change
compared to NA. Bottom figure represents gene expression with 4pM Cd 1h or
1mM BSO 12h plus Cd 1h exposure. (#) indicates a significant increase
compared to NA and (&) indicates a significant increase compared to Cd (n=4).
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Figure 13. Effect of antioxidant NAC on CdC^-induced gene expression.
All the data in the figures are presented as fold changes compared to the control
(NA sets to be 1, not shown). Genes were grouped by similar fold change into 3
subfigures. (#) indicates a significant increase compared to NA and (*) indicates
a significant change compared to Cd (n=4).
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Figure 14. Effect of antioxidant NAC on BSO plus CdCh-induced gene
expression.
All the data in the figures are presented as fold changes compared to the control
(NA sets to be 1, not shown). Genes were grouped by similar fold change into 3
subfigures. (#) indicates a significant increase compared to NA, (&) indicates a
significant increase compared to Cd, and (*) indicates a significant decrease
compared to BSO+Cd (n=4).
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Potential Mechanisms Utilized in Cadmium Induction of Gene Expression

Cellular responses to Cd have been primarily characterized to be due to
either its ability to bind sulfhydryls such as GSH or to disturb the redox balance
by increasing ROS. If ROS or a shift to pro-oxidant status in the cell is critical to
the induction of gene expression by Cd then adding an antioxidant such as NAC
should block that induction. Similarly if the availability of GSH is important, then
blocking the synthesis of it should increase the expression of genes similarly.
Pretreatment of cells with antioxidant NAC prior to the addition of Cd for three
hours significantly reduced only HSP70 and HSP40, the two representative
genes associated with protein integrity control (Figure 13; Table 6).

Table 6
Relative change in gene expression in heat shock protein category
Fold Change
HSP70
HSP40
NA
1
1
4 pM Cd 3h
84.23 ± 28.2 (#)
2.38 ± 0.60 (#)
10mM NAC 1h + Cd 3h
47.84 ± 4.20 (&)
1.49 ±0.09 (&)
(#) significant difference compared to NA (n=4)
(&) significant difference compared to Cd 3h (n=4)

Our results imply that even at this early Cd exposure time, changes in the
redox environment are occurring and that HSP70 and HSP40 are the most
influenced by these changes. This finding is supported by a study that
demonstrates in arsenic treated cells, HSP70 mRNA is increased whereas
antioxidants catalase and NAC were able to diminish the arsenic-induced
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expression of HSP70 significantly (Han et al., 2005). In addition, the novel
concept of HSP functioning as redox sensor and/or redox switch has been
proposed recently. Under exposure to H20 2, the monomeric inactive HSP33 was
transformed into an active dimeric functional enzyme to protect cells from
damage (Hoffmann et al., 2004). Intriguingly however, H20 2 exposure inhibits the
activity of Hdj2 (DnaJ/HSP40), another proposed HSP as redox sensor, due to
the release of zinc that leads to inactive enzyme through intermolecular disulfide
formation (Choi et al., 2006).
We next investigated whether or not BSO alone at a concentration and
time where we have shown it to deplete GSH is able to have any effect on the
expression of any of the genes tested. BSO treatment alone increases the
expression of both Gclm and TrxR to nearly the same extent as Cd alone (Figure
12, top and middle; Table 7). Given their roles in maintaining availability of
reduced sulfhydryls in the cell this increase in expression is not surprising.

Table 7
Relative change in gene expression in antioxidant response category
Fold Change
Gclm
NA
1
4 pM Cd 3h
2.35 ± 0.61 (#)
0.4mM BSO 12h
2.14 ± 0.70 (#)
1mM BSO 12h
1.96 ±0.45 (#)
(#) significant difference compared to NA (n=4)

TrxR
1
1.96 ±0.27 (#)
1.79 ±0.49 (#)
1.83 ±0.35 (#)

Additionally, an approximate 2 fold increase in HO-1 is also observed
under BSO treatments (Figre 12, middle) however, the significance of the
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increase in relationship to Cd is unknown as the microarray data shows that Cd
induces expression by 30 fold. None of the other genes tested increased (or
decreased) significantly in the presence of BSO alone (in comparison with the
relative fold change of Cd alone, Figure 12). Thus as a group, it appears as only
those genes (HO-1, Gclm, TrxR) associated with an antioxidant function appear
to be most sensitive to the amount of GSH in the cell.

Table 8
Relative change in gene expression in transcription factor category
Fold Change
NA
4 pM Cd 1h
1mM BSO + Cd 1h
4 pM Cd 3h

Egr1
1
25.63 ± 8.85 (#)

F osii
1
4.23 ± 0.84 (#)

Atf3
1
3.74 ± 0.48 (#)

92.58 ± 6.90 (&)
68.77 ± 13.03 (§)

8.23 ± 0.98 (&)
11.49 ± 3 .8 5 (§)

5.13 ± 0.10 (&)
20.98 ± 3.22 (§)

(#) significant difference com pared to NA (n=4)
(&) significant difference com pared to Cd 1h (n=4)
(§) significant difference com pared to NA (n=4)

BSO treatment, however, did enhance the effect of Cd on the expression
of several genes, for example genes in the transcription factor category. In fact,
treatment of cells with Cd for 1 hr after BSO treatment significantly increased the
expression of both Egr1 and FosM to nearly the same amount observed after 3
hrs of cadmium treatment (Figrue 12; Table 8) suggesting that the glutathione
concentration in the cell is important in minimizing the effect of Cd on these
genes. Intriguingly another gene in transcription factor category, Atf3, shows a
different pattern. BSO plus 1 hr of Cd increased its expression over that
observed with 1hr of Cd treatment but did not reach the level observed with 3 hrs
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of Cd (Figure 12; Table 8). Thus, the depletion of GSH sensitizes the cell to the
effects of Cd and the genes (Egr1, FosM and Atf3) grouped under the
classification

of transcription

factors

are

most sensitive to this

effect.

Addidtionally, the other genes previously demonstrated to be sensitive to GSH
concentration in the cell (Gclm, TrxR and HO-1) are also increased in the BSO
plus 1hr of Cd treatment over 1 hr of Cd alone (Figure 12, bottom), reconfirming
their sensitivity to the changes of GSH level in the cells.
Genes deemed not sensitive to GSH level include those in the heat shock
and zinc finger categories. Similarly to what we have observed, BSO has been
shown to inhibit the activation of heat shock factor 1 (HSF1), which is required to
turn on the transcriptional regulation of HSPs (Galan et al., 2001). The authors
have demonstrated that HSP70 mRNA level was increased rapidly under Cd
exposure and reduced by NAC pretreatment, whereas treating cells with BSO
alone or BSO plus Cd failed to increase HSP70 expression due to the inhibition
of BSO on HSF1 activation.
In summary, our results suggest that at least two different mechanisms
may play a role in the Cd induction of gene expression under non-toxic
conditions. These mechanisms appear to be vital to the early sensing of Cd and
the subsequent physiological response generated. For the genes tested, clear
distinctions can be made as to whether or not the induction by Cd is sensitive to
changes in the redox state (HSP70 and HSP40) or to the availability of reduced
GSH (Gclm and TrxR).
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CONCLUSION

The ultimate goal of a living cell or individual is to survive through a wellbalanced regulated harmony of every stage of life before the final natural process
of aging and death arrives. Disturbing the cellular homeostasis, a synchronized
series of actions regulated by diverse biological processes in response to
external signals and internal programs, can bring detrimental consequences.
Hence, the ability to sense and adapt to environmental stimuli and cellular
demands is critical to a cell’s survival. The main goal of this project is to
investigate differential gene expression under low dose of Cd exposure with the
attempt to possibly identify markers of exposure and understand potential
sensing mechanisms and the related activities involved. One unusual feature of
Cd lies in its ability to generate ROS inside a cell (Elbekai and El-Kadi, 2005;
Lopez et al., 2006), and since Cd is not a Fenton redox active metal, several
indirect mechanisms have been proposed. Among these, the high affinity
between Cd and sulfhydryl groups appears to weigh considerably with regard to
subsequent outcomes. Using 4 pM Cd, GSH depletion was observed as early as
6 hrs of incubation, lipid peroxidation occurred at 12 hrs, and lactate
dehydrogenase leakage took place at 24 hrs in hepatocytes in culture (Xu et al.,
2003). From other studies, damage that has been found with longer cadmium
exposure includes the disturbance of antioxidant enzymes (Elbekai and El-Kadi,
2005; Lutzen et al., 2004) and the interference on DNA repair systems (Hartwig
et al., 2002; Jin et al., 2003; Waisberg et al., 2003). Taking into account what is
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known we proposed at 3 hrs of Cd exposure at low concentration, cells are
undergoing a sensing stage and at this stage, gene expression changes occur to
promote cell protection and survival. This is evident by observing a cascade of
events that includes induction of signal proteins followed by an increase in gene
expression.
The data presented in the first part of the study supported this notion for
the signal protein JNK, immediate early gene c-jun and stress

sensitive

transcription factor AP-1 all of which are activated in response to early Cd
exposure prior to any cytotoxic events. Thus, there appears to be a first line of
response by the cell in an effort to bypass the possible damaging effects of long
term Cd exposure by activating potential players that can assist the cell in
adapting quickly. After establishing the possibility that a cell can sense and
initiate protection for itself under early Cd exposure, the next series of
experiments were designed to identify potential Cd sensitive/responsive genes
using transcript profiling and present the possible mechanisms of induction
involved. In order

to gain insight into the function of each individual gene

identified through

this transcript profiling

approach, as well as

draw a

comprehensive global physiological response picture, several bioinformatics
databases were evaluated and compared (in materials and methods). Our final
transcript profiling data indicates that changes in expression of genes for
transcriptional regulation, antioxidant response, and protein integrity control
including heat shock proteins and the ubiquitin regulatory system, are the
dominant categories of genes affected in response to Cd. Changes to genes in
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categories associated with other cellular physiological responses such as
inflammation, growth and apoptosis, were also observed. Changes in these
major categories most likely work in concert to provide a dynamic and flexible
response to the early stage of Cd exposure. For example, induction of
stress/redox sensitive transcription factors can turn on diverse protective genes
and de novo protein synthesis, which then can undergo proper folding assisted
by the HSPs. Depending on the dimer formations of these transcription factors,
they can also influence gene expression as activators or repressors. On the other
hand, if Cd binds the sulfhydryl group of proteins and disturbs the redox
environment, there will be the possibility of increasing the demands of GSH
which could lead to more oxidation of proteins/enzymes and more accumulation
of ROS. All of the above events may account for the increased oxidative stress,
cellular damage and toxicity at a latter time point. From our data we note an array
of genes involving GSH synthesis (Gclm and others) and increasing reducing
capacity (TrxR and Srxn) and diminishing ROS (HO-1), and chelating Cd (MT-1)
that clearly particpate at this early time prior to cellular damage and toxicity.
Other damage prevention mechanisms are thoughtfully planted at this
early stage as well. For example, a host of HSPs, besides HSP70 and HSP40,
can work in conjunction to deliver and fix misfolded proteins caused by the direct
attack of Cd or by the consequences of Cd-induced oxidative challenges.
Increased expression of a series of ubiquitins can function to assist in redirecting
viable proteins back to their molecular function, or send the dysfunctional ones
into the degradation process. Thus in summary, results from this microarray
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global transcript profiling approach has given us an inside view of the early
events associated with Cd exposure and this view indicates action taken to
promote cell protection and survival. The microarry data reaffirmed the idea
proposed in the first section that activation of the signaling protein JNK, the gene
c-Jun and the transcription factor AP-1 is an early regulatory response and part
of the trigger for activating protective mechanisms within the cell. In addition, it
strengthens our notion that other MAPK proteins (like p38) and AP-1 members
(besides c-Jun) are involved and participate in these cellular responses.
Several recent outstanding reviews on Cd regarding its toxicity point out
that there are various mechanisms postulated for the detrimental chronic effects
(Martelli et al., 2006; Rikans and Yamano, 2000; Waalkes, 2003; Waisberg et al.,
2003). Changing the redox environment under various conditions early in our
study, either by providing the antioxidant NAC to reduce stress or by providing
BSO to block GSH synthesis suggests that Cd disturbs the redox environment
and generates ROS as an initial step towards toxicity at a later time. In addition
to the damaging effects associated with ROS, it can also serve as a second
messenger to participate in induced signaling and gene expression. The novel
concept of redox sensor and/or redox switch through either zinc-sulfur interaction
or cysteine/thiol chemistry may also be a possible mechanism to induce cellular
change due to Cd exposure. This hypothesis is attractive given our results where
proteins assoicated with the GSH/GSH-related enzyme system and Trx/TrxR
system, and MT-1 (a cysteine rich protein; one third residues are cysteines) are
upregulated under Cd exposure. Moreover, other gene products like the zinc
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finger protein family or genes with the zinc finger structure including (1)
Egr1/Zfp268, Tcf8 and Kif6/Zf9 in transcription group, (2) Dnaja1/HSP40 in heat
shock protein group, (3) Fbxo30, March7 and Rnf12 in ubiquitin group, (4)
Ppp1r10 in signaling group and (5) Cxcl2 in cellular response of cytokine group
are all induced upon Cd exposure. It is possible that diverse cysteine/thiol
biochemistry (e.g. metal binding, electron donation,

redox-actalysis) and

modifications (e.g. disulfide formation, glutathionlyation) work in concert with
other posttranslational modifications (e.g. phosphorylation, ubiquitination) to
contribute in signaling and enzyme regulation.
In conclusion, we provide solid evidence in this project that the early
sensing and regulatory mechanisms synchronized by a cell include signaling,
gene expression and molecular activities that orchestrate a fine-tuned cellular
regulatory symphony to protect cells against potential Cd damage (summarized
in Figure 15). The changing of the redox environment and the generation of ROS
under early Cd exposure serve as a cellular strategy where ROS participates in
signaling and influences biological processes. It is only when the signaling ROS
becomes overwhelming does it upset the fine balance of redox homeostasis.
Over time, the prolonged oxidative stress will eventually lead to unpleasant
chaotic discord and bring toxicity and disease as the final outcome.
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Figure 15. Proposed model for the early sensing mechanism under low dose of
cadmium exposure in primary rat hepatocytes.
Note: The dashed arrow and box represents the potential molecular events in a
later time point under CdCI2 exposure and (_l ) represents an inhibition effect.
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FUTURE DIRECTION

The results presented in this project are really just the beginning of more
exciting studies yet to be explored to fully examine and understand the cellular
consequences associated with short-term exposure to metals such as Cd.
Identifying target genes using a global profiling approach indeed gives us an
initial roadmap upon which to use for further expedition and an understanding of
the dynamic and complex molecular activities inside a cell. Without a doubt,
investigation of gene expression under a series of sequential exposure times, as
well as validation of protein levels through such things as enzyme activity and
changes through posttranslational modification, will add significant insights for
understanding sophisticated regulatory networks that maintain cellular harmony
after exposure.
There are many studies that can be planned right away. For example, one
could investigate gene changes at a longer exposure time of Cd to draw
connections between the early protective responses and the later responses
associated with cell damage.

Understanding various aspects of cellular

communication and regulation at different stages and identifying potential
genes/proteins serving as central controllers linking these sequential stages will
shorten the distance between gaining fundamental knowledge and application in
the practical prevention of diseases.
Another study that is of interest to carry out is to identify all the possible
members that contribute to an active AP-1 under Cd exposure. In the introduction,
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we presented a simplified overview of transcriptional regulation of AP-1 and
recognized that it is a complex and highly variable molecule that facilates
appropriate gene expression in regard to a biological response. For example,
there are currently 56 identified members of the bZIP/AP-1 family that can
potentially dimerize as homodimer or hetrodimer in humans (Newman and
Keating, 2003). These dimers can serve as activators or repressors to assist in
the transcriptional regulation of responsive gene expression. Based on our data
in the first section, we proposed that other AP-1 members (besides c-Jun) may
be involved in formation of the active protein. The data from our global gene
transcript profiling studies confirmed that several bZIP and/or AP-1 members are
indeed expressed under early Cd exposure. Therefore the next logicial step is to
identify whether or not these potential AP-1 members are part of the active AP-1
under Cd exposure in hepatocytes. It is also attractive to speculate that the
additional flexibility in AP-1 subunit interchange could serve as a molecular
switch to maintain and/or promote the regulation of genes for a fast adaptive
response of a cell. This switch could be driven by subtle alterations of the
signaling properties. For example, the interconnected cross-talk between signal
proteins provides another degree of flexibility. Our MAPK inhibitor data in the first
section also support this possibility, suggesting that p38 MAPK is involved in the
activation of AP-1 when the JNK pathway is inhibited by JNK inhibitor SP600125
under Cd exposure.
Another very interesting series of studies that could be initiated would
investigate the possibility of the displacement of essential metals by Cd as its
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mechanism of action. Recall from the introduction that this metal displacement
ability of Cd, due to its chemical property and ability to mimick the essential
divalent cations in a cell, is believed to be one of the main mechanisms behind
and reasons for the consequences of Cd. However, studies of this kind are not
easy as this interchange is very transient. It has been demonstrated that in cellfree models, the displacement of metal takes place within milliseconds (Rigby et
al., 2006). Some indirect methods using metal chelators however may be used
that can provide some clues contributing to the overall picture. Indeed a pilot
study was carried out to address this possibility. Among all the potential
candidates to possibly consider regarding metal interchange for this pilot study,
Zn was chosen for the following two reasons. First, the chemical property of the
two metals is similar and a number of transcripts that showed sensitively to Cd
included zinc finger proteins. Second, Zn is very important for the structure and
activity of a number of proteins;

therefore,

tight control

of moderate

concentrations of free Zn, as well as, the maintenance of Zn homeostasis of a
cell is very critical for survival.
If we use a specific Zn chelator to sequester Zn (assuming it was
displaced and released with Cd exposure) we could then identify the genes that
are sensitive to this change in Zn homeostasis. Among all the potential zinc
chelators such as desferrioxamine (DFO) (Karck et al., 2001), diethylenetriamine
penta-acetic acid (DTPA) (Kojima-Yuasa et al., 2003), and N,N,N',N'-Tetrakis(2pyridylmethyl)ethylenediamine (TPEN) (Chimienti et al., 2001; Chung et al.,
2006), TPEN was chosen because it is a membrane permeable zinc chelator and
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the one most applied to chelate Zn in various models including primary rat
hepatocytes (McNulty and Taylor, 1999). In addidtion, TPEN has the highest
relative affinity for zinc ions compared to other Zn chelators (Siemann et al., 2002)
and the greatest degree of specificity for Zn as compared to other metals such as
Ca2+ and Mg2+ (Arslan et al., 1985).
In our pilot experiments, after incubation with the various concentrations (5,
10, 20 pM) and incubation times (15 min, 1 hr, 3 hrs) of TPEN, the ten Cdresponsive genes, that were verified by qRT-PCR, were examined. Only MT-1,
Egr1 and Zfp36 were consistently shown to be significantly changed under the
Zn chelation condition with TPEN alone. The TPEN data suggests these three
genes are affected by intracellular concentrations of Zn. Moreover, these genes
indeed also demonstrated significant induction with 100 pM of ZnS0 4 in our
primary rat hepatocytes. Thus our results clearly suggest these three genes are
sensitive to not only Cd but also Zn (Figure 16B). Some of our results however,
are very intriguing and hard to explain, solely based on these pilot experiments.
For example, if TPEN alone is able to chelate intracellular Zn, then the decrease
in the expression of MT-1, as the major dynamic cellular device for zinc storage
and release, seems reasonable. On the contrary, we can not explain the opposite
observations on the induction of the transcription factors Egr1 and Zfp36 under
the same treatment of TPEN alone. Other results that provide no clear
explanation include no significant difference under TPEN+Zn coincubation
compared to Zn alone for these genes (Figure 16A). It is possible that the TPEN
concentration used is not sufficient to chelate the additional Zn. A series of well
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designed experiments utilizing various concentrations of TPEN along with a
series of different exposure times for both TPEN alone, Zn alone and in
combination are necessary before we can draw solid and convincing conclusions.
There is one promising result obtained from the pilot study. If as
hypothesized, the effect of TPEN is to chelate the free Zn released in the
presence of Cd, then the data regarding MT-1 and Egr1 expression, which shows
a significant decrease under TPEN+Cd compared to Cd alone (Figure 16A), may
suggest that it is truly the cpncentration of Zn that plays an important role in their
induction. Thus, it is attractive to speculate that Cd can displace Zn and this
displacement and release of Zn is the trigger, especially for the induction of MT-1.
In summary, these preliminary results generated more interesting
questions and provide information for future investigation. It is truly an exciting
era of functional genomics to be able to look into the regulation of many cellular
events with a prospective and systematic view. The voyage of this exciting and
non-stop expedition in understanding the effects of heavy metals such as
cadmium at the cellular and molecular level in primary hepatocytes is calling for
the hungry mind to explore it yet deeper and broader.
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A.
Fold Change
NA
10pMTPEN 15min
100pM Zn 1hr
4pM Cd 1hr
(TPEN 15min*+Zn) coincub. 1hr
(TPEN 15min*+Cd) coincub. 1hr

MT-1
1
0.17 ±0.06
17.03 ±5.34
18.60 ±3.64
17.34 ±5.39
0.09 ± 0.03

Egr1
1
6.84 ± 1.24
8.96 ±2.13
25.63 ± 8.85
10.45 ±2.17
5.50 ± 1.34

Zfp36
1
2.45 ± 0.46
1.58 ±0.28
2.28 ± 0.56
1.77 ±0.26
2.25 ± 0.45

B.
□ NA
TPEN15min
Zn1h
□ Cd1h

MT-1

Egr1

Zfp36

Fig 16. Effect of zinc chelator TPEN, zinc and cadmium on gene expression.
A. All the numbers in the table are significantly different compared to control (NA).
(*) indicates that 10pM TPEN was added 15 minute prior to the 1hr incubation of
zinc or cadmium for the co-incubation experiments.
B. All the data in the figure are presented as the fold change compared to NA. (#)
indicates a significant change compared to NA.
All statistical analysis were done using REST program and normalized to
GAPDH (n=4). MT-1: metallothionein 1, Eqr1: early growth response 1, and
Zfp36: zinc finger protein 36.
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List of the Frequently Used Abbreviations
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List of the Frequently Used Abbreviations
AP-1

activator protein-1

ATF

activating transcription factor

Atf3

activating transcription factor 3

ATP

adenosine 5'-triphosphate

bZIP

basic region leucine zipper

^BSO

DL-Buthionine-(S,R)-sulfoximine

Bag3

bcl-2 associated athanogene 3

Ca

calcium

CAT

catalase

Cd

cadmium

CRE

cyclic AMP-responsive element

CREB

cyclic AMP response element-binding protein

Egr1

early growth response protein 1

EST

expressed sequence tag

FosM

fos-like antigen 1

Foxa

forkhead box subfamily A transcription factor

G6PDH

glucose-6-phosphate dehydrogenase

Gadd45

growth arrest and DNA damage-inducible 45 genes

GAPDH

glyceraldehydes-3-phosphate dehydrogenase

JGCL
iglutamate-cysteine ligase
!(known as GCS) (also known as y-gultamylcysteine synthetase)
Gclm

glutamate cysteine ligase, modifier subunit

GPx

glutathione peroxidase

GS

GSH synthetase

GSH

glutathione (usually refer to the reduced form)

GST

glutathione S-transferase

H2 O2

hydrogen peroxide

HIF1

hypoxia-inducible factor 1

'HO-1 (Hmoxl)

heme oxygenase 1

HSP

heat shock protein

IE gene

immediate early gene

Ik B

inhibitor k B

JNK

c-Jun N-terminal kinase
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List of the Frequently Used Abbreviations-Continued
|LDH

lactate dehydrogenase

Maf

musculoaponeurotic fibrosarcoma

MAPK

imitogen activated protein kinase

MAPKK

imitogen activated protein kinase kinase

iMAPKKK

mitogen activated protein kinase kinase kinase

MT-1

metallothionein-1

MyoD

myoblast determination protein 1

|NAC

N-acetylcysteine

In FkB

nuclear factor kappa B

NF-E2

nuclear factor-erythroid 2

Nrf2

NF-E2-related factor 2

0 2'

superoxide

Oct-1
OH'

(octomer-binding transcription factor-1
hydroxyl radical

PCR

polymerase chain reaction

qRT-PCR

quantitative real time PCR

ROS...............

reactive oxygen species

R-SOH

sulfenic acid

R-S02H

sulfinic acid

R-S03H

sulfonic acid

SOD

superoxide dismutase

Srxn

~~

TF

.... —

TPA

isulfiredoxin 1
transcription factor
tumor promoter phorbol-ester 12-o-tetradecanoyl phorbol 13acetate

TPEN

.......”

Trx

NXN\N'-Tetrakis(2-pyridylmethyl)ethylenediamine
thioredoxin

TrxR (Txnrdl)

thioredoxin reductase

ZF

zinc finger

Zfp36

zinc finger protein 36

Zn

zinc

.....
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Affymetrix Microarray Quality Control and Data Information
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B1: Quality Control for Microarray Experiments
1 2 3 4 5 6 7 8

The left figure is a picture of a representative stained agarose gel, depicting
cRNA (lanes 1-4) and fragmented cRNA (lanes 5-8). Lane 1, 2, 5, and 6 are from
the same rat (1 and 4 are the control/no addidtion group; 2 and 5 are the Cd
treated group). Lane 3, 4, 7, and 8 are from the same rat (3 and 7 are the
control/no addition group; 4 and 8 are the Cd treated group). The figures in the
middle and the right are representative images of the quality control associated
with the assay and hybridization performance of an individual genechip.

Heat Map View fo r 8 chips

*W* -j

ftSWWliW«IK.g»t,.

2-l6MA,_S... 2-23W..

3-2 MA- • 3-30M .

'

* It

M S C d... 2 2 3 C d . 3-2 Cd.... 3 30 C<J_S.7‘

This is a representative heat map view of the gene expression pattern for all
chips from 4 independent experiments (columns 1-4 are the control/no addidtion
group; columns 5-8 are the Cd treated group).
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B1: Quality Control for Microarray Experiments-Continued

The representative figures and tables of correlation coefficients (R2) between
individual chips and among independent experiments are demonstrated here.
Data was generated using the Spotfire platform.
chip to chip comparison: NA

chip to chip comparison: Cd

experiment comparison: NA vo Cd

NA group comparison:

Cd group comparison:

NA vs Cd comparison:

2-16
2-16
2-16
2-23
2-23
3-02

2-16
2-16
2-16
2-23
2-23
3-02

Rat
Rat
Rat
Rat

vs
vs
vs
vs
vs
vs

2-23
3-02
3-30
3-02
3-30
3-30

0.98
0.98
0.97
0.98
0.98
0.98

vs
vs
vs
vs
vs
vs

2-23
3-02
3-30
3-02
3-30
3-30

0.98
0.98
0.97
0.99
0.98
0.98

1
2
3
4

(2-16)
(2-23)
(3-02)
(3-30)

0.97
0.96
0.97
0.94

The table represents a series of quality control parameters generated from the
Expression Report (.rpt) file from each individual chip.

Control
Treatment
Noise
Background
Average
Present
(%)
Absent
(%)
Marginal
(%)

#1 2-16
NA
Cd
7.00
7.17
206
219
51.5
49.9
46.9
48.3
1.6
1.7

#2 2-23
NA
Cd
6.21
6.24
173
178
51.5
50.0
46.8
48.2
1.7
1.8

#3 3-02
NA
Cd
6.27
6.23
183
187
51.0
48.6
47.4
49.9
1.6
1.5

#4 3-30
NA
Cd
5.93
6.11
165
167
51.5
49.9
47.2
48.5
1.7
1.6
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B2: Microarray Expression Report File (Experiment 1 for NA Group)
Report Type:
Date:

Expression Report
04:39PM 04/27/2005

Filename:
Probe Array Type:
Algorithm:
Probe Pair Thr:
Controls:

JH_021605_NA_1anly.CHP
RAE230A
Statistical
8
Antisense

Alpha 1:
Alpha2:
Tau:
Noise (RawQ):
Scale Factor (SF):
TGT Value:
Norm Factor (NF):

0.05
0.065
0.015
7.000
1.285
500
1.000

Background:
Avg: 206.66
Noise:
Avg: 10.36
Corner+
Avg: 166
CornerAvg: 12141
CentralAvg: 12510

Std: 5.57

Min: 194.00

Max: 221.00

Std: 0.44

Min: 9.30

Max: 11.40

Count: 32
Count: 32
Count: 9

The following data represents probe sets that exceed the probe pair threshold and are not called "No Call"
Total Probe Sets:
Number Present:
Number Absent:
Number Marginal:

15923
8197
7475
251

Average Signal
Average Signal
Average Signal
Average Signal

1305.7
88.1
239.9
717.3

(P):
(A):
(M):
(All):

51.5%
46.9%
1.6%

Housekeeping Controls:
Probe Set
RAT_GAPDH
RATJHEXOKINASE
RAT BETA-ACTIN

Det(5')
Sig(5')
14918.1 P
9.5
A
11006.2 P

Spike Controls:
Probe Set
BIOB
BIOC
BIODN
CREX
DAPX
LYSX
PHEX
THRX
TRPNX

Det(5')
P
P
P
P
A
A
A
A
A

Sig(5’)
220.9
559.0
764.7
4777.3
29.0
23.3
23.7
13.0
5.6

Sig(M') Det(M')
14398.6 P
24.2
A
12443.1 P

Sig(3')
Det(3')
15086.1 P
A
48.7
15966.0 P

Sig(all)
14800.94
27.45
13138.43

Sig(M')
199.8

Det(M')
P

24.9
50.8
3.0
48.3
3.4

A
A
A
A
A

Det(3')
P
P
P
P
A
A
A
A
A

Sig(375')
0.52
0.75
3.80
1.44
0.25
1.13
1.31
0.56
0.70

Sig(3')
115.9
418.5
2907.9
6873.3
7.2
26.3
31.0
7.3
3.9

Sig(all)
178.85
488.74
1836.26
5825.34
20.37
33.45
19.22
22.84
4.29

Sig(375')
1.01
5.10
1.45
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B2: Microarray Expression Report File (Experiment 1 for Cd Group)
Report Type:
Date:

Expression Report
04:44PM 04/27/2005

Filename:
Probe Array Type:
Algorithm:
Probe Pair Thr:
Controls:

JH_021605_Cd_1 anly .CHP
RAE230A
Statistical

Alphal:
Alpha2:
Tau:
Noise (RawQ):
Scale Factor (SF):
TGT Value:
Norm Factor (NF):

0.05
0.065
0.015
7.170
1.322
500
1.000

8

Antisense

Background:
Avg: 219.63
Noise:
Avg: 10.67
Corner+
Avg: 165
CornerAvg: 10596
CentralAvg: 11689

Std: 6.02

Min: 206.80

Max: 236.20

Std: 0.61

Min: 9.00

Max: 12.30

Count: 32
Count: 32
Count: 9

The following data represents probe sets that exceed the probe pair threshold and are not called "No Call".
Total Probe Sets:
Number Present:
Number Absent:
Number Marginal:

15923
7950
7695
278

Average Signal
Average Signal
Average Signal
Average Signal

1380.5
87.7
211.5
735.3

(P):
(A):
(M):
(All):

49.9%
48.3%
1.7%

Housekeeping Controls:
Probe Set
RATJ3APDH
RATJHEXOKINASE
RAT BETA-ACTIN

Sig(5') Det(5']
15858.7 P
18.3
A
9907.0
P

Spike Controls:
Probe Set
BIOB
BIOC
BIODN
CREX
DAPX
LYSX
PHEX
THRX
TRPNX

Det(5')
M
P
P
P
A
A
A
A
A

Sig(5')
163.0
582.4
909.8
4838.6
6.0
10.5
5.6
7.9
9.2

Sig(M') Det(M')
15693.5 P
A
36.9
11892.6 P

Sig(M')
195.8

Det(M')
P

7.5
89.2
3.9
15.2
3.8

A
A
A
A
A

Sig(3')
98.2
446.3
2469.1
6827.8
7.5
7.4
44.3
9.3
3.6

Sig(3')
Det(3')
15409.1 P
A
63.6
15151.7 P

Sig(all)
15653.77
39.60
12317.09

Det(3')
A
P
P
P
A
A
A
A
A

Sig(3'/5')
0.60
0.77
2.71
1.41
1.25
0.70
7.98
1.18
0.39

Sig(all)
152.32
514.31
1689.47
5833.20
7.01
35.71
17.94
10.78
5.54

Sig(3'/5')
0.97
3.48
1.53
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B2: Microarray Expression Report File (Experiment 2 for NA Group)
Report Type:
Date:

Expression Report
01:04PM 05/05/2005

Filename:
Probe Array Type:
Algorithm:
Probe Pair Thr:
Controls:

JH 022305 NA1 stanly.CHP
RAE230A
Statistical
8
Antisense

Alphal:
Alpha2:
Tau:
Noise (RawQ):
Scale Factor (SF):
TGT Value:
Norm Factor (NF):

0.05
0.065
0.015
6.210
1.607
500
1.000

Background:
Avg: 173.01
Noise:
Avg: 8.73
Corner+
Avg: 121
CornerAvg:9883
CentralAvg: 10881

Std: 6.15

Min: 157.80

Max: 189.40

Std: 0.47

Min: 7.60

Max: 9.70

Count: 32
Count: 32
Count: 9

The following data represents probe sets that exceed the probe pair threshold and are not called "No Call".
Total Probe Sets:
Number Present:
Number Absent:
Number Marginal:

15923
8203
7449
271

Average Signal
Average Signal
Average Signal
Average Signal

1314.4
91.4
220.3
723.7

(P):
(A):
(M):
(All):

51.5%
46.8%
1.7%

Housekeeping Controls:
Probe Set
RAT GAPDH
RAT HEXOKINASE
RAT BETA-ACTIN

Sig(5')
Det(5')
15456.7 P
9.1
A
11192.3 P

Sig(M’) Det(M')
15012.7 P
A
25.4
12789.6 P

Sig(3')
Det(3')
14807.4 P
72.1
A
16074.3 P

Sig(all)
15092.27
35.55
13352.08

Spike Controls:
Probe Set
BIOB
BIOC
BIODN
CREX
DAPX
LYSX
PHEX
THRX
TRPNX

Det(5')
P
P
P
P
A
A
A
A
A

Sig(M')
270.3

Det(M')
P

48.7
69.2
7.8
6.4
3.0

A
A
A
A
A

Det(3')
P
P
P
P
A
A
A
A
A

Sig(3'/5')
0.80
0.85
2.76
1.32
0.26
0.36
2.62
1.53
1.80

Sig(5')
206.2
723.2
1240.0
6758.7
46.1
28.3
25.7
6.2
8.5

Sig(3')
165.2
612.4
3418.5
8909.5
12.1
10.3
67.3
9.5
15.2

Sig(all)
213.92
667.77
2329.23
7834.10
35.62
35.93
33.60
7.38
8.91

Sig(3'/5')
0.96
7.93
1.44
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B2: Microarray Expression Report File (Experiment 2 for Cd Group)
Report Type:
Date:

Expression Report
01:07PM 05/05/2005

Filename:
Probe Array Type:
Algorithm:
Probe Pair Thr:
Controls:

JH_022305_Cd1 stanly.CHP
RAE230A
Statistical
8
Antisense

Alphal:
Alpha2:
Tau:
Noise (RawQ):
Scale Factor (SF):
TGT Value:
Norm Factor (NF):

0.05
0.065
0.015
6.240
1.621
500
1.000

Background:
Avg:
Noise:
Avg:
Corner+
Avg:
CornerAvg:
CentralAvg:

178.95

Std: 7.25

Min: 162.30

Max: 195.60

8.48

Std: 0.52

Min: 7.30

Max: 9.90

121

Count: 32

9083

Count: 32

9150

Count: 9

The following data represents probe sets that exceed the probe pair threshold and are not called "No Call"
Total Probe Sets:
Number Present:
Number Absent:
Number Marginal:

15923
7961
7671
291

Average Signal
Average Signal
Average Signal
Average Signal

1394.5
89.3
214.1
744.2

(P):
(A):
(M):
(All):

50.0%
48.2%
1.8%

Housekeeping Controls:
Probe Set
RATJ3APDH
RATJHEXOKINASE
RAT BETA-ACTIN

Sig(5')
Det(5')
14167.7 P
8.9
A
9922.3
P

Spike Controls:
Probe Set
BIOB
BIOC
BIODN
CREX
DAPX
LYSX
PHEX
THRX
TRPNX

Det(5')
P
P
P
P
A
A
A
A
A

Sig(5')
285.3
796.1
1034.3
6447.5
48.4
21.2
6.2
9.8
3.6

Sig(M') Det(M')
15655.4 P
A
28.9
12867.6 P

Sig(3')
Det(3')
15801.7 P
72.6
A
16187.8 P

Sig(all)
15208.26
36.76
12992.56

Sig(M')
228.4

Det(M')
P

20.8
8.8
5.9
10.3
3.2

A
A
A
A
A

Det(3')
P
P
P
P
A
A
A
A
A

Sig(3'/5')
0.58
0.85
3.10
1.41
0.44
1.22
8.61
0.81
5.16

Sig(3')
166.5
677.2
3206.1
9063.2
21.3
25.8
53.0
7.9
18.4

Sig(all)
226.73
736.68
2120.19
7755.36
30.17
18.58
21.67
9.36
8.39

Sig(3'/5')
1.12
8.17
1.63
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B2: Microarray Expression Report File (Experiment 3 for NA Group)
Report Type:
Date:

Expression Report
01:45PM 05/07/2005

Filename:
Probe Array Type:
Algorithm:
Probe Pair Thr:
Controls:

JH 030205 NA lanly.CHP
RAE230A
Statistical
8
Antisense

Alphal:
Alpha2:
Tau:
Noise (RawQ):
Scale Factor (SF):
TGT Value:
Norm Factor (NF):

0.05
0.065
0.015
6.270
1.632
500
1.000

Background:
Avg: 183.77
Noise:
Avg: 8.62
Corner+
Avg: 122
Corner
Avg: 10998
Central
Avg: 9982

Std: 4.60

Min: 174.00

Max: 196.60

Std: 0.65

Min: 7.20

Max: 10.50

Count: 32
Count: 32
Count: 9

The following data represents probe sets that exceed the probe pair threshold and are n<
Total Probe Sets:
Number Present:
Number Absent:
Number Marginal:

15923
8120
7545
258

Average Signal
Average Signal
Average Signal
Average Signal

1346.4
90.0
233.1
733.0

(P):
(A):
(M):
(All):

51.0%
47.4%
1.6%

Housekeeping Controls:
Probe Set
RAT GAPDH
RAT HEXOKINASE
RAT BETA-ACTIN

Sig(5')
16042.9
10.7
12752.5

Det(5')
P
A
P

Sig(M')
Det(M')
18076.4 P
28.1
A
14140.5 P

Det(3')
Sig(3')
17014.9 P
A
11.2
17559.9 P

Spike Controls:
Probe Set
BIOB
BIOC
BIODN
CREX
DAPX
LYSX
PHEX
THRX
TRPNX

Det(5')
P
P
P
P
A
A
A
A
A

Sig(M')
227.5

Det(M')
P

45.9
46.4
5.0
31.9
3.7

A
A
A
A
A

Det(3')
P
P
P
P
A
A
A
A
A

Sig(5')
240.6
859.5
1124.4
6542.0
18.6
3.0
14.5
9.9
8.0

Sig(3’)
117.3
555.4
3362.0
10885.1
24.8
23.1
33.0
9.2
1.8

Sig(all)
17044.73
16.69
14817.65

Sig(3'/5')
1.06
1.05
1.38

Sig(all)
Sig(3'/5')
195.13
0.49
707.44
0.65
2243.18 2.99
8713.55 1.66
29.75
1.33
24.16
7.76
17.52
2.28
17.01
0.92
4.50
0.23
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B2: Microarray Expression Report File (Experiment 3 for Cd Group)
Report Type:
Date:

Expression Report
01:47PM 05/07/2005

Filename:
Probe Array Type:
Algorithm:
Probe Pair Thr:
Controls:

JH_030205_Cd lanly.CHP
RAE230A
Statistical
8
Antisense

Alphal:
Alpha2:
Tau:
Noise (RawQ):
Scale Factor (SF):
TGT Value:
Norm Factor (NF):

0.05
0.065
0.015
6.230
1.801
500
1.000

Background:
Avg: 187.77
Noise:
Avg: 8.45
Corner+
Avg: 139
CornerAvg: 9177
CentralAvg:8311

Std: 4.53

Min: 177.50

Max: 199.50

Std: 0.52

Min: 7.20

Max: 10.10

Count: 32
Count: 32
Count: 9

The following data represents probe sets that exceed the probe pair threshold and are not called "No Call".
Total Probe Sets:
Number Present:
Number Absent:
Number Marginal:

15923
7738
7947
238

Average Signal
Average Signal
Average Signal
Average Signal

1445.0
89.1
228.4
750.1

(P):
(A):
(M):
(All):

48.6%
49.9%
1.5%

Housekeeping Controls:
Probe Set
RAT GAPDH
RAT HEXOKINASE
RAT BETA-ACTIN

Sig(5')
Det(5')
16806.6 P
42.4
A
12883.5 P

Sig(M' )
17799 .3
29.6
14651 .6

Det(M')
P
A
P

Det(3')
Sig(3')
17591.0 P
66.9
A
18426.1 P

Sig(all)
17398.96
46.31
15320.39

Spike Controls:
Probe Set
BIOB
BIOC
BIODN
CREX
DAPX
LYSX
PHEX
THRX
TRPNX

Det(5')
P
P
P
P
A
A
A
A
A

Sig(M')
159.5

Det(M')
P

46.5
46.3
7.3
47.3
1.9

A
A
A
A
A

Sig(3')
156.8
591.1
3192.4
10031.9
8.2
5.0
19.5
9.3
2.2

Det(3')
P
P
P
P
A
A
A
A
A

Sig(3'/5')
0.57
0.82
2.73
1.60
0.67
2.85
2.32
0.24
0.54

Sig(5')
274.5
720.0
1169.5
6266.4
12.3
1.8
8.4
39.0
4.0

Sig(all)
196.92
655.55
2180.96
8149.15
22.34
17.70
11.71
31.85
2.71

Sig(3'/5')
1.05
1.58
1.43
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B2: Microarray Expression Report File (Experiment 4 for NA Group)
Report Type:
Date:

Expression Report
01:33PM 05/14/2005

Filename:
Probe Array Type:
Algorithm:
Probe Pair Thr:
Controls:

JH_033005_NA 2Scan lanly.CHP
RAE230A
Statistical
8
Antisense

Alphal:
Alpha2:
Tau:
Noise (RawQ):
Scale Factor (SF):
TGT Value:
Norm Factor (NF):

0.05
0.065
0.015
5.930
1.946
500
1.000

Background:
Avg: 165.68
Noise:
Avg: 7.74
Corner+
Avg: 123
CornerAvg: 7921
CentralAvg: 7042

Std: 4.93

Min: 155.00

Max: 178.80

Std: 0.63

Min: 6.30

Max: 9.60

Count: 32
Count: 32
Count: 9

The following data represents probe sets that exceed the probe pair threshold and are not called "No Call".
Total Probe Sets:
Number Present:
Number Absent:
Number Marginal:

15923
8133
7516
274

Average Signal
Average Signal
Average Signal
Average Signal

1353.8
86.2
230.3
736.1

(P):
(A):
(M):
(All):

51.1%
47.2%
1.7%

Housekeeping Controls:
Probe Set
RAT_GAPDH
RATJHEXOKINASE
RAT BETA-ACTIN

Sig(5')
Det(5')
15424.9 P
12.7
A
8852.7
P

Sig(M') Det(M')
15020.6 P
A
56.3
12093.9 P

Det(3')
Sig(3')
15233.8 P
91 3
A
15806.6 P

Sig(all)
15226.44
53.42
12251.09

Spike Controls:
Probe Set
BIOB
BIOC
BIODN
CREX
DAPX
LYSX
PHEX
THRX
TRPNX

Det(5’)
P
P
P
P
A
A
A
A
A

Sig(M')
203.2

Det(M’)
P

25.4
23.7
11.3
17.9
3.6

A
A
A
A
A

Det(3’)
P
P
P
P
A
A
A
A
A

Sig(3'/5')
0.37
0.69
3.09
1.70
0.92
1.11
4.41
2.64
1.69

Sig(5')
213.7
688.5
912.4
6015.0
8.4
25.1
6.0
6.2
12.5

Sig(3')
79.5
474.8
2818.6
10250.6
7.8
27.9
26.4
16.3
21.2

Sig(all)
165.49
581.65
1865.49
8132.81
13.90
25.56
14.55
13.49
12.41

Sig(3'/5')
0.99
7.17
1.79
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B2: Microarray Expression Report File (Experiment 4 for Cd Group)
Report Type:
Date:

Expression Report
01:35PM 05/14/2005

Filename:
Probe Array Type:
Algorithm:
Probe Pair Thr:
Controls:

JH 033005 Cd lanly.CHP
RAE230A
Statistical
8
Antisense

Alphal:
Alpha2:
Tau:
Noise (RawQ):
Scale Factor (SF):
TGT Value:
Norm Factor (NF):

0.05
0.065
0.015
6.110
1.978
500
1.000

Background:
Avg: 167.99
Noise:
Avg: 7.94
Corner+
Avg: 137
CornerAvg: 8742
CentralAvg: 8892

Std: 5.88

Min: 156.50

Max: 185.40

Std: 0.51

Min: 6.80

Max: 9.50

Count: 32
Count: 32
Count: 9

The following data represents probe sets that exceed the probe pair threshold and are not called "No Call".
Total Probe Sets:
Number Present:
Number Absent:
Number Marginal:

15923
7950
7716
257

Average Signal
Average Signal
Average Signal
Average Signal

1389.0
86.2
222.2
738.9

(P):
(A):
(M):
(All):

49.9%
48.5%
1.6%

Housekeeping Controls:
Probe Set
RATJ3APDH
RATHEXOKINASE
RAT BETA-ACTIN

Sig(5')
Det(5')
13930.9 P
29.9
A
10653.6 P

Sig(M') Det(M')
14642.9 P
30.1
A
12661.1 P

Sig(3')
Det(3')
14932.5 P
64.2
A
17412.8 P

Sig(all)
14502.11
41.41
13575.85

Spike Controls:
Probe Set
BIOB
BIOC
BIODN
CREX
DAPX
LYSX
PHEX
THRX
TRPNX

Det(5')
P
P
P
P
A
A
A
A
A

Sig(M')
306.8

Det(M')
P

70.0
67.0
23.6
9.2
2.1

A
A
A
A
A

Det(3')
P
P
P
P
A
A
A
A
A

Sig(3'/5')
0.61
0.75
3.10
1.21
0.32
7.38
3.16
0.91
1.18

Sig(5')
261.9
776.5
1047.7
6600.1
31.5
5.3
23.1
11.5
7.9

Sig(3')
158.6
585.7
3246.8
8005.9
10.0
39.2
72.9
10.4
9.3

Sig(all)
242.42
681.11
2147.21
7303.00
37.16
37.17
39.86
10.37
6.45

Sig(3'/5')
1.07
2.15
1.63
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B3: A Complete List of Genes with Significant Changes
B3.1: Gene Up-Regulated under Cd Exposure for Microarray Data (RAE 230A)
Probe Set ID
(Affymetrix)

Gene Title

Gene Symbol

Public ID
(NCBI)

1367577_at

■heat shock 27kDa protein 1

Hspbl

NM_031970

Fold
{Change
33
\

1367795_at

sinterferon-related developmental regulator 1

Ifrdl

NM_019242

1367894_at

ssimilar to Insulin-induced gene 1 protein (INSIG-1)
(Insulin-induced growth response protein CL-6)
(Immediate-early protein CL-6)

LOC683385
LOC688922

NM 022392

(2.2
|

1368050_at

cyclin L1

[Ccnll

NM_053662

35

1368124_at

dual specificity phosphatase 5

■Dusp5

NM_133578

2.9

1368173_at

nucleolar protein 5

Nol5

NM_021754

1.6

1368247_at

iheat shock 70kD protein 1A
iheat shock 70kD protein 1B (mapped)

Hspala
Hspalb

NM_031971

40.6

1368321_at

nearly growth response 1

Egr1

NM_012551

50.5

1368489_at

rfos-like antigen 1

IFosM

NM_012953

I6.4

1368545_at

CASP8 and FADD-like apoptosis regulator

■Cflar

NM_057138

I3.8

1368760_at

chemokine (C-X-C motif) ligand 2

Cxcl2

NM_053647

I2.4

1368852_at

DnaJ (Hsp40) homolog, subfamily A, member 1

■Dnajal

NM_022934

Mafg

AB050011

34
■2.0

;1368874_a_at iv-maf musculoaponeurotic fibrosarcoma oncogene
family, protein G (avian)
1368947_at

■growth arrest and DNA-damage-inducible 45 alpha

iGadd45a

NM_024127

1369268_at

■activating transcription factor 3

IAtf3

NM_012912

14.0

1369788_s_at ■Jun oncogene

(Jun

NM_021835

4.3

1370026_at

crystallin, alpha B

(Cryab

NM_012935

I2.7

1370030_at

■glutamate cysteine ligase, modifier subunit

Gclm

NM_017305

(2.0

i1370080_at

iheme oxygenase (decycling) 1

Hmoxl

NM_012580

■29.7

1370153_at

(growth differentiation factor 15

Gdf15

1370174_at

(myeloid differentiation primary response gene 116

Myd116............................ BI284349

]3(5 .........

{1370177_at

poliovirus receptor

■PVR

] z i .........

1370189_at

isplicing factor, arginine/serine-rich 10 (transformer 2 ISfrs 10
shomolog, Drosophila)

BI290979

1370336_at

............

... .. NM_019216

AI548856

i7.6

1.6

(pregnancy-induced growth inhibitor

Okl38

AY081218

3.3

I1370454_at

■homer homolog 1 (Drosophila)

Homerl

AB003726

5.5

I1370633_at

■gene model 1960, (NCBI)

■Gm1960

D87927

2.4

i1370634_x_at gene model 1960, (NCBI)

*Gm1960

D87927

I2.7

1370695_s_at itribbles homolog 3 (Drosophila)

|Trib3

AB020967

2.0

■solute carrier family 2 (facilitated glucose
■transporter), member 1

Slc2a1

BI284218

I2.3

!1370912_at

heat shock 70kD protein 1B (mapped)

(Hspalb

BI278231

59.5

1370997 at

(homer homolog 1 (Drosophila)

Homerl

AF030088

60.3..........

[1370848_at

11371367_at

TAR DNA binding protein

sTardbp

BE107459

|2.1

1371684_at

■pelota homolog

sPelo

AA799330

(1.9

1371685_at

kelch repeat and BTB (POZ) domain containing 2
(predicted)

■Kbtbd2_predicted
|

Al 178043

1.7

1371754_at

solute carrier family 25 (mitochondrial carrier,
phosphate carrier), member 25

Slc25a25

AI177358

7.4
i
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B3: A Complete List of Genes with Significant Changes-Continued
B3.1: Gene Up-Regulated under Cd Exposure for Microarray Data (RAE 230A)
Probe Set ID
|(Affymetrix)

Gene Title

Gene Symbol

Public ID
(NCBI)

1371785_at

■tumor necrosis factor receptor superfamily, member
12a

Tnfrsf12a

BI303379

1.7

M372024_at

■Transcribed locus

IA1104846

■2.1

1372103_at

■similar to DnaJ (Hsp40) homolog, subfamily A,
member 4

LOC498996

IA1104324

■6.2

1372193_at

imprinted and ancient

Impact

AI408713

2.0

1372211 at

v-maf musculoaponeurotic fibrosarcoma oncogene
■family, protein K (avian)

Mafk

BI284461

2.4

■cytoplasmic polyadenylation element binding protein Cpeb4_predicted
■4 (predicted)

■BG374299

■2.3

1372347. at

■Transcribed locus

■BI289462

■3.1

1372353_at

similar to DNA segment on chromosome X and Y
■(unique) 155 expressed sequence isoform 1

BE096387

■3.6

1372389_at

■immediate early response 2

Ier2

BF420059

■4.9

1372510_at

■Sulfiredoxin 1 homolog (S. cerevisiae)

Srxnl

(AH 72302

■2.5

AJ225654

1.9

1.7

|1372223_at

|1373030_at

■Transcribed locus, strongly similar to XP_580217.1
■PREDICTED: hypothetical protein XP_580217
[Rattus norvegicus]

LOC288526

Fold
■Chan

1373087_at

■Membrane-associated ring finger (C3HC4) 7

March7

■AH 75452

j1373093_at

ERBB receptor feedback inhibitor 1

Errfil

■Al 169756

■2.5

1373094 at

■general transcription factor II H, polypeptide 1
(predicted)

Gtf2h1_predicted

AW917124

■2.3

Al599284

■2.3

AA946467

2.6

|1373209_at
1373679_at

■Transcribed locus

1373767_at

■zinc finger, AN 1-type domain 2A

Zfand2a

1373961_at

■similar to 4930453N24Rik protein

MGC95208

... Al 170410........

■2.7

1373983_at

LOC360807

LOC360807

AH 68986

■2.2

1374139_at

cerebellar degeneration-related 2

Cdr2

BG671589

■2.9

1374143_at

Eph receptor A2 (predicted)

Epha2_predicted

AI602491

2.0

1374204_at

WD repeat and SOCS box-containing 1

Wsb1

(BM388946

■2.3

1374404_at

Jun oncogene

Jun

1BI288619

3.9

BI301532

2.1

AI406908.......

15.4

■1374433_at

■Transcribed locus

H374484_at

■transmembrane protein 39a

Tmem39a

AI230318

2.2

j1374750_at

■Rap guanine nucleotide exchange factor (GEF) 6
((predicted)

Rapgef6_predicted

AI172313

2.1

1374911 at

■oxidative stress responsive gene

RGD1303142

(AW251534

2.2

1374947_at

■breast cancer anti-estrogen resistance 3 (predicted)

Bcar3_predicted

1375029_at
1375043 at

BI286041

2.4

AI235912

4.0

BF415939.....

7.9

IFBJ murine osteosarcoma viral oncogene homolog

Fos

I1375852_at

■3-hydroxy-3-methylglutaryl-Coenzyme A reductase

Hmgcr

BM390399....

2.2

11376066_at

■Transcribed locus

IA1103572

■2.5

11376275_at

■Transcribed locus

IBE101108

2.2

1376673_at

transcription factor 8

Tcf8

BM391853

■2.0

1376916_at

■zinc finger and BTB domain containing 2 (predicted)

Zbtb2_predicted

AW529183

...6.4....

■High mobility group nucleosomal binding domain 2

Hmgn2

IBE113667

■2.7

■1376935_at
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B3: A Complete List of Genes with Significant Changes-Continued
B3.1: Gene Up-Regulated under Cd Exposure for Microarray Data (RAE 230A
Probe Set ID
(Affymetrix)
1376937_at
[1377461 at
|
1377858_at
|1379497_at
I

Gene Title

Gene Symbol

similar to 4631422O05Rik protein (predicted)

RG D1565927_predicted BM389685

2.7

hypothetical protein LOC680485
"hypothetical protein LOC684012

LOC680485
LOC684012

1.6

Public ID
(NCBI)
AI409983

Fold
Char

sPR domain containing 2, with ZNF domain (mapped) Prdm2

BE120443

2.3

Transcribed locus, moderately similar to
XP_574280.1 PREDICTED: similar to Ab2-143
[Rattus norvegicus]

BI275261

)18.1

1379500_at

similar to cDNA sequence BC018601

'LOC498404

'AA860044

1.9

1382059 .at

F-box protein 30

Fbxo30

BI289529

'3.4

'1383160_at

cysteine and histidine-rich domain (CHORD)icontaining, zinc-binding protein 1 (predicted)

'Chordc1_predicted

AA892238

2.8

1383302 at

jiDnaJ (Hsp40) homolog, subfamily B, member 1
'(predicted)

'Dnajb1_predicted

BM384926

23.1

1383305 at

:similarto RIKEN cDNA 5830435K17 (predicted)

' RGD1560454_pred icted iAI013468

2.8

1386935_at

muclear receptor subfamily 4, group A, member 1

'Nr4a1

iN M_024388

14.1

'1386958_at

'thioredoxin reductase 1

Txnrdl

:NM_031614

1.9

i1386971_at

iprotein phosphatase 1, regulatory subunit 10

'Ppp1r10

iNM_022951

3.4

i1387060_at

i'Kruppel-like factor 6

Klf6

'NM 031642

3.6

H387116_at

I'DnaJ (Hsp40) homolog, subfamily B, member 9

Dnajb9

NM 012699

'2.0

'1387219_at

adrenomedullin

iAdm

NM_012715

'8.5

1387788_at

Jun-B oncogene

Junb

NM 021836

'2.6

1387870_at

zinc finger protein 36

Zfp36

AB025017

4.1
2.2

s1388032_a_at gene model 1960, (NCBI)

Gm1960

D87927

1388169_at

jumonji domain containing 1C

|Jmjd1c

:BE102096

1.7

(1388631_at

5-azacytidine induced gene 2

Azi2

Al 177093

3.1

1388663 at

'Similar to death effector domain-containing DNA
(binding protein 2

'LOC687118

Al 100783

3.0

138872?_at

[DnaJ (Hsp40) homolog, subfamily B, member 1
'(predicted)

(Dnajb1_predicted

AA945704

33.3

1388792. at

'growth arrest and DNA-damage-inducible 45 gamma Gadd45g

IAI599423

'3.0

'1388850_at

sheat shock protein 1, alpha

Hspca

BG671521

1.8

I1388868_at

'zinc finger protein 216 (predicted)

'Zfp216_predicted

AH 72425

'3.0

1388898 at

'heat shock 105kDa/110kDa protein 1

[Hsphl

1388986_at

'Transcribed locus

i1389008 at

I

'Transcribed locus, strongly similar to XP_223647.3
'PREDICTED: similar to Spred-2 [Rattus norvegicus]

Spred2_predicted

AI236601

7.7

AI598339

3.1

AI409218

j1.6
[l.9~

1389279_at

Transcribed locus

BM386204

M389402_at

Transcribed locus

'AH 78746

2.5

BI288619

'2.9

11389528_s_at Jun oncogene

Jun

1389569_at

ibrix domain containing 2

;Bxdc2

AW917092

1.7

1389573_at

ChaC. cation transport regulator-like 1 (E. coli)
(predicted)

JChac1_predicted

AH 70665

'3.6

1389685_at

'zinc finger protein 655

Zfp655

Al009613

[2.1

11390000_at

jumonji domain containing 3 (predicted)

Jmjd3_predicted

BE118720

2.6

1390026 at

Bcl2-associated athanogene 3

Bag3

AI231792

7.5
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B3: A Complete List of Genes with Significant Changes-Continued
B3.1: Gene Up-Regulated under Cd Exposure for Microarray Data (RAE 230A)
Probe Set ID Gene Title
i (Affymetrix)

Gene Symbol

Public ID
(NCBI)

Fold
iChar

I1390205_at

[zinc finger, SWIM domain containing 6

:Zswim6

IBE108876

3.4

i1390524_at

ring finger protein 12

IRnf12

IBM392295

1.6

sCTD (carboxy-terminal domain, RNA polymerase II,
ipolypeptide A) phosphatase, subunit 1 (predicted)

Ctdp1 ^predicted

IBE098745

2.4

1390535_at
I1390960_at

Transcribed locus

s1391505_x_at Transcribed locus, moderately similar to
[XP 574280.1 PREDICTED: similar to Ab2-143
[Rattus norvegicus]
!1394012_at
1398343_at
1398767_at
[l 398819_at
1399022_at

AA893602

3.6

BI275261

7.2

2.9

izinc finger, SWIM domain containing 6

Zswim6

IBI303933

:similar to DnaJ (Hsp40) homolog, subfamily A,
jmember4

ILOC498996

AI104324

lubiquitin C
sDnaJ (Hsp40) homolog, subfamily A, member 1
:CDC-like kinase 1

13.0
i

I

” |ubc
sDnajal

............

.... NM 017314

11.8

NM_022934

3.3

’ Clk1................................ IAI177513

2.4

s1399081_at

[pellino homolog 1 (Drosophila)
[similar to pellino protein (predicted)

Pelil
AI712911
RGD1564594_predicted

13.7

*1399141_at

CDC like kinase 4

iClk4

[i.8

BE404428
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B3: A Complete List of Genes with Significant Changes-Continued
B3.2: Gene Down-Regulated under Cd Exposure for Microarray Data (RAE 230A)
Probe Set ID Gene Title
(Affymetrix)
1367919_at

nuclear pore membrane glycoprotein 210

Gene Symbol

Public ID
(NCBI)

Fold
Change

Pom210

NM_053322

-2.1

1368035_a_at ^protein tyrosine phosphatase, receptor type, F

(Ptprf

X83505

-1.7

1368036_at

protein tyrosine phosphatase, receptor type, F

jPtprf

M60103

-1.9

1368711_at

forkhead box A2

,Foxa2

NM_012743

-1.8

1370307_at

agrin

Agrn

M64780

-2.3

1371595_at

Polymerase (DNA directed), alpha 2

Pola2

BM384301

-9 0

1371710_at

ethanolamine kinase 1 (predicted)

lEtnk1_predicted

BM391283

-1.7

1372075_at

similar to dJ862K6.2.2 (splicing factor,
arginine/serine-rich 6 (SRP55-2)(isoform 2))

LOC362264

Al 177866

-1.6

1372081_at

Transcribed locus

BI299305

-2.1

1372202_at

similar to expressed sequence AI597479

IRGD1310553

BF284058

-1.9........

1372522_at

similar to hypothetical protein FLJ10154

RGD1310061

AI556235

-1.8

1372642_at

Transcribed locus

BE113397

-3.4

1372823_at

Similar to RIKEN cDNA 2310005N03 gene

;RGD1309105_predicted BE117126

-3.7

1372993_at

Insulin-like growth factor 2 receptor

Igf2r

BI299621

-5.4

1373540_at

heterogeneous nuclear ribonucleoprotein A2/B1
(predicted)

IHnrpa2b1_predicted
|

AA848306

-2.6

1373595_at

transmembrane protein 43

Tmem43

BM385463

-1 7

1373854_at

Transcribed locus

Al 175795

-1.8

1374417_at

similar to nuclear receptor binding protein

LOC680451
ILOC684607

BE1131H

-1.7

1374567_at

proline/serine-rich coiled-coil 2

iPsrc2

AI408443

-4.0

1377267_at

melanoma antigen, family E, 1 (predicted)

:Magee1_predicted

BF402385

-2.7

1377310_at

Transcribed locus, moderately similar to
XP_580018.1 PREDICTED: hypothetical protein
XP_580018 [Rattus norvegicus]

BG374304

-1.6

1381967_at

RNA-binding region (RNP1, RRM) containing 2

1388575. at

Transcribed locus, strongly similar to XP_575214.1
PREDICTED: similar to Opa-interacting protein 5
[Rattus norvegicus]

1388758_at

Transcribed locus

1388985_at

Transcribed locus, weakly similar to XP 520557.1
PREDICTED: similar to RIKEN cDNA 4833436C18
gene [Pan troglodytes]

1389230_at

Transcribed locus

1389355_at

immediate early response 5

;ler5

1389538 at
-

nuclear factor of kappa light chain gene enhancer in
B-cells inhibitor, alpha

sNfkbia

AW672589 .. -2.5

1389554_at

Transcribed locus

1390024_at

Transcribed locus

1390163_at

Kinesin family member 16B (predicted)

Kif16b_predicted

1390723_at

Catenin (cadherin-associated protein), alpha 1

Catnal

1399018_at

similar to cisplatin resistance-associated
overexpressed protein (predicted)

RGD1307981_predicted AI410301

-1.8

1399109_at

Transcribed locus

BI281673

-2.2

Rnpc2

LOC310926

BE114972

-3.1

AA943740

-1.9

AI009074

-2 5

AI012869

-8.1

AA818910

-3.2

BF285187

-1.5

AA956784

-1.8

AI237685

-28.6

BF282174

-1.9

BF386742

-3.0
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C1: qRT-PCR Quality Control and PCR Amplification Efficiency Check
A representive picture of an agarose gel showing synthesized cDNA

New cDNA synthesized from RNA sample
(ABI 1st RT-reaction kit, #N8080234)

Representive tables of PCR reaction efficiency
Transcription Factors
Egr1
Atf3
Fosll
Zfp36

Efficiency
1.000 ±0.042
1.005 ±0.056
1.009 ±0.050
1.000 ± 0 .0 8

Antioxidant Enzymes
HO-1
Gclm
TrxR
MT-1

Efficiency
1.003 ±0.021
0.998 ± 0.043
1.001 ± 0.192
1.005 ± 0.057

Heat Shock Proteins
HSP70
HSP40

Efficiency
1.004 ±0.036
0.999 ± 0.021

Reference Gene
GAPDH

Efficiency
1.003 ± 0.054

The PCR amplification efficiency (1 equals 100 %) is validated using the software,
Data Analysis for Real-Time PCR (DART-PCR). The fold change (shown in
appendix C3) is first normalized with the reference gene (GAPDH) and
statistically analyzied using Relative Expression Software Tool (REST).

A representive image of the DART-PCR program (left) and the REST program
(middle and right). These two programs are available upon request from genequantification websites (www.gene-quantification.de).
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C2: qRT-PCR Gene Probe Information
The experimental probes (TagMan® Gene Expression Assays) for each target
gene in this project ware purchased from Applied Biosystems (ABI) company.
(http://www.appliedbiosystems.com)
Transcription Factors:
1. Early growth response 1 (Egr1)
Assay ID: Rn00561138_m1 & NCBI RefSeq: NM_012551.1
2. Activating transcription factor 3 (Atf3)
Assay ID: Rn00563784_m1 & NCBI RefSeq: NM_012912.1
3. Fos-like antigen 1 (FosM)
Assay ID: Rn00564119_m1 & NCBI RefSeq: NM_012953.1
4. Zinc finger protein 36 (Zfp36)
Assay ID: Rn01763978_m1 & NCBI RefSeq: NM_133290.2
Antioxidant Enzymes:
1. Fleme oxygenase 1 (HO-1/Hmox1)
Assay ID: Rn00561387_m1 & NCBI RefSeq: NM_012580.2
2. Glutamate cysteine ligase, modifier subunit (Gclm)
Assay ID: Rn00568900_m1 & NCBI RefSeq: NM_017305.2
3. Thioredoxin reductase 1 (Txnrd1/TrxR)
Assay ID: Rn00581106_m1 & NCBI RefSeq: NM_031614.2
4. Metallothionein 1 (MT-1)
Assay ID: Rn02075099_s1 & NCBI RefSeq: not provided by ABI
Heat Shock Proteins:
1. Heat Shock 70KD protein 1A (Hspa1a/HSP70-1)
Assay ID: Rn00583013_s1 & NCBI RefSeq: NM_031971.1
2. DnaJ (Hsp40) homolog, subfamily A, member 1 (Dnajal)
Assay ID: Rn00576012_m1 & NCBI RefSeq: NM_022934.1
Reference Gene (Housekeeping Control):
1. Glyceraldehydes-3-phosphate dehydrogenase (GAPDH)
Assay ID: Rn99999916_s1 & NCBI RefSeq: NM_017008.3
Other Genes Tested:
1. Glutathione peroxidase 1 (Gpx1)
Assay ID: Rn00577994_g1 & NCBI RefSeq: NM_030826.2
2. Superoxide dismutase 1 (Sod1/CuZnSOD)
Assay ID: Rn00566938_m1 & NCBI RefSeq: NM_017050.1
3. Catalase (Cat)
Assay ID: Rn00560930_m1 & NCBI RefSeq: NM 012520.1
4. Glucose-6-phospate dehydrogenase X-linked (G6PDH/G6pd)
Assay ID: Rn00566576_m1 & NCBI RefSeq: NM_017006.1
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C3: Summary Table of the Fold Changes in the qRT-PCR Experiments
Fig11: Cd comparison
M ic ro a rra y C d 3 h /N A
S .E .
q R T -P C R

C d 3 h /N A
S .E .

p-value

Fig12 Top: Cd
C d 1 h /N A
S .E .

p-value
C d 3 h /N A
S .E .

p-value

Fig12 Middle: BSO
0 .4 m M B S O 3 h /N A
S .E .

p-value
0 .4 m M B S O 6 h /N A
S .E .

p-value
0 .4 m M B S O 1 2 h /N A
S .E .

p-value
1 m M B S 0 1 2 h /N A
S .E .

p-value

Fig12 Bottom: BSO+Cd
C d 1 h /N A
S .E .

H O -1

E g rt

H sp 7 0

F o s -lik e

Z fp 3 6

H sp 4 0

G c lm

31.64

51.71

42 88

M T -1

14.61

A tf3

6.68

4.13

3.3

1.99

1 96

4 .5 7

5 .4 3

6 .6 7

1 .8 2

1 .0 5

0 .4 3

0 .2 4

0 .1 7

0 .2 7

76.71

68.77

84.23

20.98

11.49

5.17

2.38

2 35

1 96

2 0 .1 9

1 3 .0 3

2 8 .2

3 .2 2

3 .8 5

1 .2 1

0 .6

0 .6 1

0 .5 1

0.001

0.001

0.001

0.001

0 .0 0 7

0 .0 0 7

0.004

0.028

H O -1

E g r1

H sp 7 0

M T -1

A tf3

F o s -lik e

Z fp 3 6

H sp 4 0

G c lm

T rx R

10.66

25 63

11.79

18.6

4.42

4.23

2.84

1.09

1.37

1.1

3 .1

8 .8 5

5 .4 4

3 .6 4

0 .8 7

0 .8 4

0 .5 6

0 .2

0 .3 5

0 .1 9

0.001

T rx R

0.001

0.001

0.001

0.001

0 .0 0 7

0.001

0.001

0.66

0.21

0 .6 7

76.71

68.77

84.23

7.07

20.98

11.49

5.17

2 38

2 35

1.96

2 0 .1 9

1 3 .0 3

2 8 .2

3 .0 8

3 .2 2

3 .8 5

1 .2 1

0 .6

0 .6 1

0 .5 1

0.001

0.001

0.001

0.001

0 .0 0 7

0 .0 0 7

0 .0 0 7

0 .0 0 7

0.004

0 .0 2 8

H O -1

Z fp 3 6

H sp 4 0

G c lm

T rx R

E g r1

H sp 7 0

M T -1

A tf3

F o s -lik e

1.24

0.68

0.55

1.11

1.35

1.33

0 .3 4

0 .2 2

0 .2 1

0 .6 4

0 .2 3

0 .5 4

0.3645

0.189

0.167

0.855

0.0455

2.22

1.33

0.74

1.84

1.06

0 .4 4

0 .2 1

0 .3

0 .6 2

0.4555

0.001

0.076

1.0

1.02

1.05

1.17

0 .2 6

0 .1 3

0 .3 6

0 .3 3

0.2625

0.99

0.948

0.8675

0.347

1.47

0.93

0.81

1.4

1 39

0 .1 3

0 .5 5

0 .2 4

0 .1

0 .4 6

0 .3 7

0.0795

0.4725

0 .3 0 7

0.1255

n

0.118

0.0085

1.79

2.19

1.17

0.77

1.4

0.96

I I I

i l l

0 76

2.14

0 .5 1

0 .3

0 .1 3

0 .5 5

0 .5 8

0 .0 5

0 .5 5

U. 1

0 .7

0 .4 9

0.001

0.492

0.107

0.327

0.6325

0.0045

0.048

0.0075

0.008

0 .0 0 5

1.83

1.64

1.42

0.92

m

1.06

1.72

0.94

0.9

1 96

0 .2 8

0 .2 8

0 .1 1

0 .2 5

0 .1 5

0 .2 4

0 .1 6

0 .1 1

0 .4 5

0 .3 5

0.031

0 .0 8 3 5

0.3115

0.0445

0.662

0.01

0.6515

0.3515

0.006

0 .0 0 3

H O -1

E g r1

H sp 7 0

M T -1

A tf3

F o s -lik e

Z fp 3 6

H sp 4 0

G c lm

T rx R

58

31.64

11.96

22 86

3.74

3.73

3 82

0.9

1.32

1 .4 9

8 .8 4

5 .0 5

1 3 .3 1

0 .4 8

1 .2 2

1 .2 7

0 .1 2

0 .2 7

0 .2 3

1.3

p-value

0.001

0.001

0.001

0 .0 0 7

0.001

0.0055

0 .0 0 7

0.4375

0.17

0 .7 0 6

1 B S O I 2 h + C d 1 h /C d 1 h

10.81

92.68

14.88

23.09

5,13

8.23

4.33

0.97

2.27

2.12

0 .5 5

6 .9

2 .9 3

3 .8 9

0 .1

0 .9 8

0 .7

0 .0 2

0 .0 6

0 .0 5

0.0045

0.001

0.636

0.968

0.048

0.004

0 .4 7 3 5

0.591

0 .0 7 5 5

0.0335
T rx R

S .E .
p -v a lu e

Fig 13: NAC+Cd
C d 1 h /N A
S .E .

p-value
N A C 1 h + C d 1 h /C d 1 h
S .E .

p-value
C d 3 h /N A
S .E .

p-value
N A C 1 h + C d 3 h /C d 3 h
S .E .

p-value

Fig 14: BSO+NAC+Cd

H O -1

E q r1

H sp 7 0

M T -1

A tf3

F o s -lik e

Z fp 3 6

H sp 4 0

G c lm

10.56

25.63

11.79

18.6

4.42

4 23

2.84

1.09

1.37

1.1

3 .1

8 .8 5

5 .4 4

3 .6 4

0 .8 7

0 .8 4

0 .5 6

0 .2

0 .3 5

0 .1 9

0.001

0.001

0.001

0.001

0.001

0.001

0 .0 0 7

0.66

0.21

0 .6 7

2.73

11.41

2.03

9.71

3.89

3.07

2.17

0.95

1.21

1.08

0 .0 1

1 .6 4

0 .3 7

0 .3 2

0 .1 9

0 .1 4

0 .1 1

0 .0 2

0 .0 6
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0.003

0 .0 7 7

0.001

0.001

0.59

0.17

0 .3

0.16

0.51

76.71

68 77

84.23

7.07

20 98

11*49

5.17

2.38

2 1 5

1 96

2 0 .1 9

1 3 .0 3

2 8 .2

3 .0 8

3 .2 2

3 .8 5

1 .2 1

0 .6

0 .6 1

0 .5 1

0.001

0.001

0 .0 0 7

0 .0 0 7

0 .0 0 7

0.001

0 .0 0 7

0.001

0.004

0.028

58.22

59.49

47,84

13.38

15.13

11.92

4.09

1,49

3.41

2.84

2 .8 6

2 .3 9

4 .2

2 .0 9

0 .4 4

0 .9 1

0 .3 1

0 .0 9

0 .2

0 .1 8

0.085

0.345

0 .0 0 7

0 .7 0 9

0 .0 7 7

0.867

0.452

0.023

0.0385

0.0705

H O -1

E g r1

H sp 7 0

M T -1

A tf3

F o s -lik e

Z fp 3 6

H sp 4 0

58

31.64

11.96

22.86

3 74

3 73

3 82

0.9

1.32

1 .4 9

8 .8 4

5 .0 5

1 3 .3 1

0 .4 8

1 .2 2

1 .2 7

0 .1 2

0 .2 7

0 .2 3

p-value

0.001

0.001

0.001

0 .0 0 7

0 .0 0 7

0.0055

0 .0 0 7

0.4375

0.17

0 .7 0 6

1 B S O I 2 h + C d 1 h /C d 1 h

10.81

14.88

23.09

5.13

8.23

4.33

0.97

2 27

2 12

C d 1 h /N A
S .E .

S .E .

G c lm

T rx R

1.3

0 .5 5

6 .9

2 .9 3

3 .8 9

0 .1

0 .9 8

0 .7

0 .0 2

0 .0 6

0 .0 5

0.0045

0.001

0.636

0.968

0.048

0.004

0.4135

0.591

0 .0 7 5 5

0.0335

B S O + N A C + C d /B S O + C d

5.21

27.95

1.49

25.96

3.37

6.78

3.18

1.0

2.24

2.39

S .E .

0 .3 3

0 .9 9

0 .3 5

1 .0

0 .0 5

0 .1

0 .1 4

0.014

0.0065

0.0325

0.0585

0.014

0.0048

0.0985

p-value

p-value

0 .0 1

0.0545

0 .0 6
0 .9 3 2

0 .3 1

0.3125

Note: (1) The number represents the fold change compared to the control (NA=1). (2) The shaded
results represent a significant difference between two comparison groups (shown on the first
column) and the more detail descriptions are in the legend of each figure in the main text.
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R adiation Safety C om m ittee

Kalam azoo. M ichigan 4 90 0 3 -5 1 6 2
6 16 38 ' -5933 or 6 16 33 8-8293
FAX: 616 3 8 2 -5 8 8 8

Radiation Safety Officer

W

estern

M

ic h ig a n

U n iv e r s it y

March 28, 2007
Dear Ms. Chin-ju Jean Hsiao:
Congratulations on completing your thesis. I wish you good luck in your future
endeavors.
Please keep a copy of this letter with your records as proof of your successful
completion of Western Michigan University's (WMU) Basic Radiation Safety Program.
The topics in which you demonstrated proficiency are radiation safety terms and
definitions, radiation types and sources, radiation signs and symbols, biological effects
of ionizing radiation, contamination control and work practices, ALARA (Time, Distance,
& Shielding), waste management, emergency response, regulatory agencies, radiation
detection instrument theory and use, quality control, and university specific procedures,
policies, and practices.
In addition, I commend you on the safe handling, use, and storage/security of
radioactive materials throughout your time here at WMU.
In the event you need information concerning your approval or use of radioactive
material, please direct your correspondence to:
Radiation Safety Officer
Western Michigan University
Office of Vice President For Research
1903 W. Michigan Ave.
Kalamazoo, Ml., 49008-5410
Respectfully,

James F. Center
Radiation Safety Officer

K a l a m a z o o , M l., 4 9 0 0 8 - 5 4 1 0
P h o n e:

2 6 9 -3 8 7 -5 9 3 3
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Protocol Clearance from the Institutional Animal Care and Use Committee
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Institutional Animal Care and Use Committee

C e . en n t t e e n n n n i i a a l
1903-2003 C e l e b r a t i o n

Date:

O ctober 28,2003

To:

Susan Stapleton, P rincipal Investigator
D aryl A rkw right-K eeler, Si
C hin-ju H siao, Student In v

From : Robert Eversole, C hair
Re:

IA C U C P rotocol No. 03-09-01

Y o u r protocol e ntitled “ R egulation o f Gene Expression in Hepatocytes” has received
approval from the In stitu tio n a l A n im al Care and Use C om m ittee. The conditions and
duration o f this approval are specified in the P olicies o f W estern M ichigan U niversity.
Y ou may now begin to im plem ent the research as described in the application.
The Board wishes you success in the pursuit o f your research goals.

A pproval Term ination:

O ctober 28, 2004

Waiwood Hall, Katamazoo Ml 4 9 0 0 8 -5 4 5 6
PHONE (616) 3 8 7 -8 2 9 3
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From * BJohns@wiley.com
Sent Friday, March 30, 2007 10:11 am
To Chin Ju Hsiao <chin-ju.hsiao@wmich.edu>
Subject Fw: request permission
Dear Ms. Hsiao:
Please be advise permission is granted to reuse pages 133-142 from Journal
of Biochemical and Molecular Toxicology: 18(3) 2004 in your forthcoming
Dissertation which will be published by Western Michigan University.
Credit must appear on every copy using the material and must include the
title; the author (s); and/or editor (s); Copyright (year and owner); and
the statement “Reprinted with permission of John Wiley & Sons, Inc.” Please
Note: No rights are granted to use content that appears in the work with
credit to another source.
Good luck with your dissertation.
Sincerely,
Brad Johnson, Permissions Assistant
John Wiley & Sons, Inc.
111 River Street 4-02
Hoboken, NJ 07030-5774
Tel: 201.748.6786
Fax: 201.748.6008
Email: bjohns@wiley.com
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